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OBJECT OF RESEARCH
The main shortcomings in the present cholera immunisation 
schemes are the incomplete protection afforded by currently available 
vaccines and the short duration of the immunity stimulated.
This study (in laboratory animals) was undertaken to invest­
igate possible alternatives to the current commercial vaccine which is 
a heat-killed, saline suspension of V. cholerae.
The following were considered
1. Use of cholera toxoid as immunogen, either in preference to or in 
conjunction with heat-killed V. cholerae cells. Cholera toxin 
is known to be responsible for the pathogenesis of cholera and 
therefore toxoid-containing vaccines might provide an alternative 
to the whole cell vaccine.
2. Use of oral or combined i/m and oral immunisation schedules. 
Cholera vibrios and toxin are completely confined to the lumen of 
the intestine during infection* therefore it is important to 
stimulate a gut-associated antibody response. Oral immunisation 
may stimulate such a response, perhaps better than the s/c or i/m 
routes of immunisation currently employed.
5. Incorporation of vaccines into adjuvant mixtures. Protection 
against cholera has been associated with high serum antibody 
titres so that stimulation of the immune response to the protein 
enterotoxin by adjuvants was thought to be a worthwhile line of 
investigation.
Wherever possible the practicality of using a vaccine in the 
field was considered. The main aim was to obtain an immunisation 
schedule which could be put into operation with minimal involvement 
of qualified personnel. For this reason the oral route of adminis­
tration was strongly favoured.
IV
INTRODUCTION . Page
I. GENERAL INTRODUCTION 1
II. TYPE OF INFECTION 5
1. The Causative Organism 5
A. Antigenic Constitution 6
B. Variation in Serotype 7
C. Chemical Nature of the Somatic Antigens 7
2. The Disease PO
A. Colonisation of the Intestine and Toxin Production iO
B. Production of Clinical Disease
C. Clinical Symptoms
D. Treatment l8
III. Vibrio cholerae TOXINS 20
1. Types of Toxin 20
A. Endotoxin 21
B. Heat-stable Exotoxin 22
0. Heat-labile Exotoxin 22
2. Production of Enterotoxin 23
3. Purification of Enterotoxin 26
4 . Chemical and Physical Properties of Enterotoxin 27
A. Composition 27
B. Stability 29
C. Naturally Formed Toxoid,"Choleragenoid” 30
D. Charge 31
E. Molecular Weight and Structure 32
F. Antigenicity, Receptor Binding and Toxic 37
Properties
VPage
5. Biological Properties of Enterotoxin ■ ^8
A. Ileal Loop ^8
B. Permeability Factor 50
C. Are Enterotoxin and Permeability Factor 53
Identical?
B. Rat Foot Oedema 5^
E. Lipase Stimulating Factor 5^
IV. IMMUNOLOGY OF CHOLERA 55
1. Antibacterial Immunity 55
A. Antibody Response to Infection 55
B. Antigens Associated with Antibacterial Immunity 56
2. Antitoxic Immunity 60
3. "Location" of Immunity 6H
A. Protective Activity of Serum Antibodies 64
B. Protective Activity of Intestinal Antibodies 63
C. Antibody Classes Involved in Immunity 68
V. CHOLERA VACCINES TO
1. Standard Vaccine TO
2. Experimental Vaccines T1
VI. PROSPECTIVE CHOLERA VACCINES TT
1. Vibrio Antigens TT
A. Cell Fractions TT
B. Enterotoxin Preparations T9
2. Oral Vaccines 8l
A. Vaccines containing Non-Viable Antigens 8l
B. Vaccines containing Live V. cholerae 82
5. Vaccines with Adjuvants 83
va
Pape
MATERIALS Am METHODS
1. Strain of Vibrio cholerae 85
2. Duffers and Diluents 85
A. Physiological Saline 85
B. Phosphate Buffered Saline 85
C. Borate Gelatin Saline 85
D. Veronal Buffered Saline 86
3. Media 86
A. Proteose Peptone 86
B. Nutrient Agar 86
G. Thiosulphate-citrate-bile salt sucrose Agar 87
D. Gel Diffusion Medium 87
4 . N.I.H. Cholera Toxin 87
5. Cholera Toxoid 88
6. Purification of Cholera Toxin 88
A. Ammonium Sulphate Precipitation 88
B. Sephadex Gel Filtration 89
7. Preparation of Cholera Toxin 90
8. Source of Animals 90
9. Immunisation Procedures 91
A. Immunisation of Mice 9I
B. Immunisation of Guinea-pigs 9I
(i) Toxoid Vaccines 91
(a) Preparation and Administration of Vaccines 91
(b) Comparison of Oral Immunisation with 92
Combined Intramuscular and Oral 
Immunisations
vai
(ii) Vaccines Containing Vibrio cholerae organisms ' 94
(a) Combined Vaccines of Toxoid and 94
V. cholerae whole organisms
(b) Whole Cell Vaccines 95
10. Collection of Antisera 95
11. Preparation of Giit-Tissue Extracts 96
12. Tests in Animals 96
A. Ileal Loop Test 96
(i) Toxin Challenge 96
(ii) Viable V. cholerae Challenge 97
B. Intradermal Blueing Tests in Rabbits 98
(i) Toxin Titration ' 98
(ii) Inhibition of Intradermal Blueing 98
C. Intradermal Blueing Test in Mice 99
13. Passive Haemagglutination Test 99
14. Ouchterlony Double Diffusion in Gel 100
15. V. cholerae Agglutination Test 101
A. Microtitration Assay 101
B. "H" Suspension 102
C. "0" Suspension 102
16. Complement Fixation Test 103
RESULTS
1041. Gel Filtration of Enterotoxin
A. Filtration through Sephadex G-lOO followed by
Sephadex G—200
B. Filtration through Sephadex G-lOO and G-200 107
Columns in series
Vlll
Page
C. Filtration through a Sephadex G—200 Column ' 107
D. Purification of Enterotoxin obtained from V. cholerae 107
NGTC 7254 Inaba serotype and Comparison with the 
Elution Properties of N.I.H. Toxin
2. Response in Rabbits to Intradermal Injection of N.I.H. Ill
Toxin
3. Response in Rabbits to Intradermal Injection of Wellcome 111
Toxoid
4 . Response in Mice to Intradermal Injection of N.I.H. Toxin 111
5. Enterotoxin Titration in Guinea-pig Ileal Loops ll4
6. Immunisation Studies in Mice ll4
A. Comparison of NIH Toxin and Immunopurified Toxoid 119
in Vaccines
B. Intraperitoneal Administration of Toxoid in various 119
Injection Mixtures
C. Inclusion of V. cholerae organisms in Toxoid Vaccines 129
B. Complement-Fixing Antibacterial Antibody Response 129
to Immunisation with V. cholerae organisms in 
Mice: Influence of Vaccine Content
7. Immunisation Studies in Guinea-pigs 132
A. Immunisation with Cholera Toxoid in a Liquid 133
Paraffin-Gelatin Base
B. Immunisation with a Single Intramuscular Injection 133
of Toxoid in Incomplete Adjuvant Supplemented 
with Glycopeptides or Whole Mycobacteria
C. Oral and/or Intramuscular Primary Immunisation with 133
Toxoid, plus One Oral Booster Bose
B. Primary Oral or Intramuscular Immunisation with 137
Toxoid: Effect of Oral Booster Doses
IX
Page
E. Measurement of Gut-Associated Antitoxin in Guinea-  ^ 13T
pigs Immunised with Toxoid
F. Primary Oral or Intramuscular Immunisation with
Toxoid and V. cholerae organisms! Effect of 
Oral Booster Boses
G. Measurement of Gut-associated Antitoxin in Guinea-
pigs Immunised with Toxoid plus V. cholerae 
organisms
H. Ouchterlony Gel Diffusion Test 1^0
(i) Determination of Optimum Antigen Concentration 1^0
(ii) Precipitation between Toxoid and Guinea-pig
Antisera, in Ouchterlony Double Gel 
Diffusion
I. Fluid Accumulation in Guinea-pig Ileal Loops in P^7
Response to challenge with Cholera Enterotoxin, 
after Immunisation with Toxoid Vaccines
(i) Choice of Measurement P^7
(ii) Fluid Accumulation in Ileal Loops
J. Agglutination of whole V. cholerae cells by Sera P50
from Animals Immunised with Vaccines containing 
V. cholerae organisms 
K, Agglutination of Vibrio "H" and "0" Cell Suspensions P50
by Selected Antisera 
L. Complement-fixing Antibody Response to Immunisation P^6
with V. cholerae organisms Alone or plus Toxoid 
M. Fluid Accumulation in Guinea-pig Ileal Loops in P^6
Response to challenge with viable V. cholerae, 
after Immunisation with Toxoid or V. cholerae 
organisms, or Both
DISCUSSION
166
i6t
i6t
168
1. Purification of Crude Enterotoxin
2. Biological Tests in Cholera Research
A. Intradermal Blueing
B. Ligated Ileal Loop 
5. Immunisation of Mice with Cholera Vaccines P72
A. Effect of Adjuvant
B. Comparison of N.I.H. Toxin and Toxoid P73
C. Composition of Vaccines P74
4. Immunisation of Guinea-pigs with Cholera Vaccines P75
A. Mineral Oil Component of Vaccines PT5
B. Mycobacterial Component of Vaccines P75
C. Route of Administration of Toxoid Vaccines P76
D. Frequency of Administration of Toxoid Vaccines P79
E. Incorporation of V. cholerae Organisms into
Vaccines
5. P.H.A. Test
6. General Discussion
SUMMARY P^^
REFERENCES
APPENDICES
1, Ileal Loop Response to Injection of graded doses of ^1
N.I.H. Toxin
2. Fluid Accumulation in Ileal Loops challenged with N.I.H. ^
Toxin
5. Fluid Accumulation of Ileal Loops challenged with
viable V. cholerae
188
193
Ak
4* Statistical Analysis of Ileal Loop Test Results ^ P
XI
Il-fDEX OF TABLES Page
1. Cholera vaccine field trials during the years 1965-1971 72
2. Intradermal blueing test in mice 115
5. Antitoxin response in mice to immunisation with either 120
crude NIE cholera toxin or vJellcome immunopurified toxoid
4 . Antitoxin response to injection of toxoid in saline and 123
incomplete adjuvant
5. Antitoxin response to injection of toxoid in incomplete 12^
adjuvant containing M. tuberculosis organisms
6. Passive haemagglutination by sera from mice injected with 125
toxoid in incomplete adjuvant containing M. tuberculosis 
organisms
7. Antitoxin response to injection of toxoid in incomplete 1^^
adjuvant containing glycopeptide ST217
8. Passive haemagglutination by sera from mice injected with 1^1
toxoid in incomplete adjuvant containing glycopeptide ST217
9. Comparison of antitoxin titres resulting from immunisation ^^0
with toxoid, with and without the addition of V.cholerae 
organisms
10, Complement-fixing antibacterial antibody response to ^^1
immunisation with V. cholerae organisms in mice;
Influence of vaccine content
11, Oral administration of cholera toxoid in 15% gelatin mixed 
with liquid paraffin or saline
112, Intramuscular injection of cholera toxoid in incomplete 
and complete adjuvant mixtures.
XI i
Page
15. Intramuscular and/or oral primary administration of 136
toxoid in incomplete or complete adjuvant, followed 
by an oral booster dose
14. Serum antitoxin response to oral or intramuscular 139
immunisation with toxoid in incomplete or complete
adjuvant, and the effect of oral booster doses of 
toxoid in incomplete adjuvant.
15. Gut-associated antitoxin response to oral or intra- 1^1
muscular immunisation with toxoid in incomplete or
complete adjuvant, and the effect of oral booster 
doses of toxoid in incomplete adjuvant
16. Serum antitoxin response to oral or intra- 1^2
muscular immunisation with toxoid and V. cholerae
organisms in incomplete or complete adjuvant, and 
the effect of oral booster doses of toxoid and 
V. cholerae organisms in incomplete adjuvant
17. Gut-associated antitoxin response to oral or intra- 1^^
Muscular immunisation with toxoid and V. cholerae
organisms in incomplete or complete adjuvant, and 
the effect of oral booster doses of toxoid and 
V, cholerae organisms in incomplete adjuvant
18. Ouchterlony double diffusion in gel; testing of l46
guinea-pig antisera against toxoid
19. Statistical analysis of ileal loop test results - 151
Toxin challenge after oral primary immunisation
with toxoid
X I11
Page
20. Statistical analysis of ileal loop test results - ^^2
Toxin challenge after i/m primary immunisation with
toxoid
21. Agglutination of vibrio "H" and "0" cell suspensions
22. Complement-fixing antibacterial antibody response to ^57
immunisation with V. cholerae organisms alone or
plus toxoid
25. Statistical analysis of ileal loop test results -
V. cholerae challenge after oral primary immunisation 
with toxoid
24. Statistical analysis of ileal loop test results -
V. cholerae challenge after i/m primary immunisation
with toxoid
25. Statistical analysis of ileal loop test results -
V. cholerae challenge after oral primary immunisation 
with toxoid and V. cholerae organisms
26. Statistical analysis of ileal loop test results - 162
V. cholerae challenge after i/m primary immunisation
with toxoid and V. cholerae organisms
27. Statistical analysis of ileal loop test results - l6S
V, cholerae challenge after oral primary immunisation
with V. cholerae organisms
28. Statistical analysis of ileal loop test results - l64
V. cholerae challenge after i/m primary immunisation
with V, cholerae organisms
INDEX OF FIGURES
XIV
Page
1. Division of choiera vibrios in terms of "0" antigenicity 8
2. Histological transverse section of the small intestine 17
5. Symptoms of cholera in relation to the amount of fluid 19
loss
4. The various nomenclature systems used to describe cholera 33
toxin subunits
5. Elution of cholera enterotoxin from Sephadex G—100 105
6. 'Elution of peak (l) fractions (Fig 5) from Sephadex G—200 I06
7. Elution of cholera enterotoxin from Sephadex G-lOO IO8
connected in series to Sephadex G-200
8. Elution of cholera enterotoxin from Sephadex G—200 109
9* Elution of partially purified cholera enterotoxin from 110
Sephadex G—200
10, Blueing response in rabbits to intradermal injection of 112
N.I.H, toxin
11, Fluid accumulation per cm of ileal loops injected with II8
N.I,H, toxin
12, Graphical display of antibody response in mice to 128
immunisation with graded doses of toxoid in different
injection mixtures
13, Comparison of the coefficients of variation of the two 1^8
methods of assessing fluid accumulation in ileal loops
14, Graphical representation of decrease in fluid ^53
accumulation in ileal loops after immunisation with
toxoid — Oral primary dose
XV
Page
15. Graphical representation of decrease in fluid 154
accumulation in ileal loops after immunisation with
toxoid - i/m primary dose
16, The proposed route of migration of gut-associated small I83
lymphocytes
XVI
INDEX OF PLATES ' ^ P&ge
1. World map showing spread of cholera during the seventh 4
pandemic.
2. Schematic diagram of the pathophysiology of cholera. 11
3. Some of the separation techniques used in the purification 28
of cholera toxin.
4. The structure of the monosialoganglioside, Gm^. 39
5. A diagramatic representation of the cholera enterotoxin 47
molecule and its cellular action.
6. Intradermal titration of cholera toxin as seen on the outer 113
and inner surface of rabbit skin.
7. Blueing response to intradermal injection of cholera toxin II6
into mice, as seen on the inner surface of the skin.
8. Fluid accumulation in guinea-pig ileal loops eight hours 117
after injection of graded doses of N.I.H. toxin.
9* Neutralisation of intradermal blueing activity of cholera 121
toxin by antiserum.
10, Gel diffusion precipitin tests with gut tissue extracts and 138
sheep anti-guinea-pig immunoglobulin.
11a.) Gel diffusion precipitin tests with guinea-pig sera and
) 145
11b.) toxoid.
12, Fluid accumulation in guinea-pig ileal loops sixteen hours 165
after injection of viable V, cholerae.
XVI1
"AB"
"AB(c )'
"AC"
ATP
A.U.
B.B.
B.G.8. 
cAMP
C.P.T. 
C.V. 
BANSyl 
E
™50
GBP
Gm^
Gm,
5
GTP
G.P.
itjjit
H.Ü.. 
i/d 
Ig 
i/m 
i/p
I.U. 
i/v
LIST OF ABBREVIATIONS 
Ogawa serotype 
Ogawa-Hikojima serotype 
Inaba serotype 
adenosine triphosphate 
antitoxin unit 
blueing dose 
borate gelatin saline 
cyclic adenosine monophosphate 
complement fixation test 
coefficient of variation 
dime thylaminonaphthalene 5-sulphonyl 
extinction 
50% effective dose 
guanosine diphosphate
galactosyl-N-acetylgalactosaminyl- N-acetylneuraminyl 
galactosyglucosyl ceramide
N-acetylneuramonyl galactosyl glucosyl ceramide
guano8ine triphosphate
guinea-pig
flagellar antigen
haemolytic unit
intradermal
immunoglobulin
intramuscular
intraperitoneal
international unit
intravenous
X V l l l
KDO ketodeoxyoctonate
limit of blueing 
LPS lipopolysacchaxide
2ME 2-mercaptoethanol
NAD nicotinamide adenine dinucleotide
NCTC National Collection of Type Cultures
N.I.H, National Institute of Health
"0" somatic antigen
per os by mouth
P.P. permeability factor
PGE^ prostaglandin
PEA passive haemagglutination
R rough
p(rho) rugose
RE ribosome containing fraction
S smooth
s/c subcutaneous
S.E.M. standard error of the mean
TCBS thiosulphate-citrate-bile salt sucrose
Tris TriS“(hydroxymethyl)-methylamine
V.B.S. veronal buffered saline
W.H.O, World Health Organisation
INTRODUCTION
I. GMERAL INTRODUCTION
The existence of cholera, or a similar disease, in the ancient 
civilisations of India and possibly China was suggested by Pollitzer 
(1959)» in an historical review. Cholera was a divine judgement on 
the decrease in "the strength of virtues and merits on earth" - 
according to one piece of evidence dating from the $th century A.D.
From the l6th century onward the epidemic nature of cholera was suggested 
by reports from the west coast of India. With the establishment of a 
hospital board in Madras and Calcutta in I786, the opportunity arose 
to monitor the disease and its spread more carefully.
By I8I9 the Bengal Medical Board accepted that cholera was 
caused by a "pestilential virus", but did not agree with its being a 
contagious disease. Neale (I83I) applied the contagion theory to 
cholera and Boehm (I838) was first to claim to have seen the causative 
organism. This claim was subsequently made by other workers including 
both Pacini and Hassal (1854)» Leyden (I866), and finally KLob (I867) 
described intestinal organisms identical to Vibrio cholerae. Through 
the studies of Koch (I884) on cholera victims in Egypt and India, it 
became generally accepted that V. cholerae was the causative agent.
He reported that comma-shaped organisms increased in numbers in the 
stool during infection and gradually disappeared on recovery. The 
bacteria appeared to be almost invariably present in the intestines of 
the cholera victim and absent in any other morbid disease (cited from 
Pollitzer, 1959).
Until the end of the 18th century cholera, as far as is known, 
was contained largely within India and neighbouring regions. From 
this time, however, there have been a succession of cholera pandemics.
the first six of which were described in detail by Pollitzer (1959)* 
In this author*s account the approximate eras of these pandemics were 
as follows ;
1st Pandemic 1817-1824
2nd fi I829-I85O
3rd It I852-I86O
4th It I863-I879
5th It 1881-1896
6th I I899-I923
In each case the origin of the pandemic could be traced to the 
west coast of India, whence, following a sudden increase in the rate of 
cholera infection, the disease spread throughout India and beyond.
With few exceptions almost every country in the world has been affected 
by cholera at some time during the course of these pandemics. Often 
the spread of the disease was associated with trade routes or movement 
of troops. It was characterised always by high infection and mortality 
rates in each infected community. For example, cholera caused 9>000 
deaths, mostly within a few days, in Grand Canary Island in May I85I, 
and claimed 1,700 victims from Bathurst jLn Gambia in I869, out of a 
population of 5,000.
The seventh pandemic of cholera began in I96I, after an 
absence from most of the world since the nineteen-twenties. During 
the intervening years cholera was confined mainly to the deltas of the 
Ganges and Brahmaputra rivers, and even there only occasionally reached 
epidemic proportions. Since I96I, the disease has gradually spread 
over a large area of the world; a process which can be divided into 
several distinct stages:-
1st Period; 1961-1962;- during which the disease was recognised in
all the countries of south east Asia, e.g. the Phillipines.
2nd Period: 1963-1969;- the disease reached the countries of
mainland Asia, e.g. Thailand.
3rd Period; 1970-197-:- there was a significant rise in the incidence
of cholera in the Middle-East, Africa and Europe (Plate l).
The classical hiotype of V. cholerae, identified by Koch in 
1884, was characterised by its lack of haemolytic activity normally 
associated with the apathogenic vibrio strains, commonly found in 
nature. In I906, however, Gotschlich isolated a haemolytic vibrio 
strain from cholera victims in Egypt, and eventually Moor (1959) found 
endemic cholera in Indonesia was due to the haemolytic (or eltor) 
biotype of V . cholerae. Recently, this eltor biotype of V. cholerae 
has lost its haemolytic characteristic and is now distinguished from the 
classical V. cholerae by its (a) resistance to Mukerjee's phage IV 
(Mukerjee, I963), (b) resistance to polymyxin (Gan and Tjia, I963) and
(c) ability to agglutinate chicken red blood cells (Fihkelstein and 
Mukerjee, I963).
It soon became apparent that the eltor variety of the cholera 
vibrio was more prevalent, in the seventh pandemic, than classical 
V . cholerae. It is considered to be the major etiological agent of 
cholera in the present pandemic. The eltor biotype differs from 
classical V. cholerae in having a longer survival time in the environ­
ment and in being more resistant to antibiotics. It also causes a 
higher incidence of asymptomatic infection than the classical 
V . cholerae; infection;case rates of 4:1 for classical Inaba infection, 
and 36;1 for eltor Ogawa infection were found by Bart et ^  (197O). 
Consequently, there are more undetected and untreated cholera cases 
which preserve a reservoir of infection in eltor epidemics.
Plate 1. World map showing the spread of cholera during the 
seventh pandemic.
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The V.H.O. estimates that half of the world’s population 
lives in or near the cholera endemic areas of Asia, so the disea'se 
obviously poses an immense public health problem. because of the 
enormity of the problem, means of prevention and treatment of cholera 
have been urgently sought. Treatment of the disease is now so refined 
that infection with V. cholerae need not be fatal.
Unfortunately, cholera is endemic where high population density 
and poor sanitation encourage infection, and where restricted medical 
facilities hinder large-scale treatment. While these conditions 
prevail, there is little hope of eradication of the disease. Bnphasis 
should therefore be placed on the production of an effective vaccine 
which is capable of eliciting long-term protection against the disease.
II. TYPE Of INFECTION
1. The Causative Organism
Cholera is caused by the Gram-negative, uniflagellate, facul­
tatively anaerobic rods belonging to the family Vibrionaceae (véron,
1965; Bergey, 1974)- It is contained in the genus Vibrio (Pacini, 
1854)* The species Vibrio cholerae is subdivided into four biotypes:- 
(a) V. cholerae biotype cholerae, (b) V. cholerae biotype eltor (Pribram, 
1919), (o) V . cholerae biotype proteus (Buchner, I885), (d) V. cholerae 
biotype albensis (Lehmann and Neumann, 1896).
Only biotypes (a) and (b) are associated with human cholera.
Biotype (c) causes gastroenteritis in humans and biotype (d) is patho­
genic only to certain animals, e.g. guinea-pigs and pigeons. All four 
biotypes are intestinal pathogens.
On primary isolation from patients, vibrio colonies are smooth, 
glistening and translucent, and by oblique light show a typical
greenish to red-bronze pridescence and fine granular translucency. 
Colonial variants are either opaque and corrugated (rugose variants) 
or rough. The rugose variant is seen especially in old cultures.
The majority of vibrio strains may be classified into six 
antigenic "0” groups. The cholera vibrios (biotypes cholerae and 
eltor) belong to the ”0" ; I group (see Figure l); strains belonging 
to other groups are usually called '’non-cholera vibrios,”
A. Antigenic Constitution
V. cholerae possesses both ”H" and "0” antigens. The "H” 
antigens are non-specific, and are shared with non-cholera vibrios.
The diagnosis of cholera is dependent, therefore, on the use of "0"- 
specific antisera. Lyles and Gardner (1958) found that the smooth (s )  
forms of V . cholerae were agglutinable with ”0” antisera, while the 
rough (r) and rugose (p) forms were not agglutinated unless preheated 
at 100°C for one hour. It was suggested that preheating inactivated 
a thermolabile inhibitor of agglutination present on the surface of R 
and P forms.
Gallut (1962) implicated the cel1-wall as the site of the 
specific ”0” antigen in both the classical and eltor organisms. 
Spontaneous removal of part of the ce11-wall on suspension of the 
vibrios in isotonic saline 4- glucose solution, and their incubation at 
20°C or 57°C, resulted in a considerable reduction of ”0” agglutination; 
the specific agglutinogen was recoverable from the autolysates. Pant 
(1968) confirmed this localisation of the specific antigens by removing 
the outer membrane of V. cholerae with a 0,005 percent sodium desoxy- 
oholate solution. After inoculation of rabbits with the extract it 
was possible to recover ”0” specific antisera from these rabbits in 
high titre.
B. Variation in Serotype
Kauffmann (1950) divided the cholera vibrios of Gardner and 
Venkatraman’s ”0" group I (Gardner and Venkatraman, 1955) (Fig l) into 
two ”0” antigenic forms, Inaba and Ogawa, by agglutination and 
agglutinin absorption tests. The Inaba serotype was given the anti­
genic formula "AC", and the Ogawa (or 0gawa-Hikojima) serotype the 
formula "AB(c)".. Formerly, Ogawa strains were designated as "AB" and 
Hikojima as "ABC", however, Kauffmann (1950) observed that Ogawa 
organisms grown at 20°G could totally absorb the antibody in Inaba sera. 
The variability between Ogawa and Hikojima organisms seemed to be 
largely phenotypic, with a quantitative antigenic difference.
However serological interconversions were reported for both 
Ogawa and Inaba serotypes by Sack and Miller (I969) using germ-free 
mice. It was noted that Ogawa organisms were recovered from mice 
infected with the Inaba serotype and vice versa. These serological 
conversions appeared to be correlated with the appearance of agglutinating 
antibody in the serum and were prevented, or significantly retarded, 
when antibody formation was suppressed with cyclophosphamide, and 
accelerated by prior vaccination with purified antigen homologous to 
the infecting strain. Rough to smooth reversions were found also, with 
both serotypes (Sack and Miller, 1969» Miller at 1972).
C. Chemical Nature of the Somatic Antigens
The exact chemical structures of the "0"-somatic antigens of
V . cholerae are still unknown, despite the efforts of numerous research 
workers. Watanabe and Verwey (I965) isolated a lipopolysaccharide (BPS) 
antigen, from the culture supernate of an Ogawa serotype of the eltor 
vibrio; this BPS appeared to be biochemically and immunologically
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homogeneous. The LPS antigen, isolated by sequential ammonium sulphate 
precipitation, deproteinisation by phenol extraction, lipid removal by 
chloroform-methanol, and cold ethanol fractionation, contained approx­
imately 60% carbohydrate (as glucose), which was composed of glucose, 
glucosamine and glucuronic acid. The nitrogen content was low and the 
principal amino acid was glutamic acid.
Verwey et al (I965) similarly tried to obtain an antigenic 
extract from the Inaba serotype of an eltor vibrio. They extracted 
such a substance from whole Inaba cells by treatment with urea, and 
sonication before precipitation with ammonium sulphate. In comparison 
to the Ogawa LPS antigen obtained from culture supernates, the Inaba 
antigen, obtained by these authors, was more tightly bound to the cells, 
and was severely damaged by phenol extraction. The Inaba antigen also 
contained more nitrogen and lipid, but less carbohydrate than the 
Ogawa LPS antigen. It was proposed that this Inaba antigen was 
similar to a Boivin-antigen, consisting of a protein-carbohydrate-lipid 
complex, and that a heat-labile, phenol-sensitive moiety (probably 
protein) was necessary for full activity.
More recently, Jackson and Redmond (I97I) made immunochemical 
studies on Inaba LPS. Heptose, glucose, glucosamine, mannose and 
glycerol were shown to be the major components, and lipid A accounted 
for 50%  of the preparation. However, a further $0% of the weight of 
this LPS was not identified and ketodeoxyoctonate (KDO) and galactose 
were not detected. It was therefore suggested that there might be 
fundamental differences between the structure of the core region of 
vibrio LPS and that of Salmonella LPS (Westphal, 1975)*
Sur, Haiti and Chatterjee (1974) reported chemical analysis of 
isolated V. cholerae cell envelopes as follows; protein, 42-43%»
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total carbohydrate, 9*2%; hexose, 5.2%; hexosamine, 3*5%î lipid,
18%; phosphores, 1.4%» calcium, 0*18%; magnésium, 0,12%. As 
before, the total envelope weight could not be accounted for. This 
anomaly may be explained by the discovery by Redmond (1975) of & 
highly-labile sugar, 4-amino-4,6-dideoxy-B-mannose, amounting to at 
least 6%, in the LPS of V. cholerae 569B Inaba.
Raziudin and Kawasak (1976) presented detailed analyses of 
V. cholerae cell envelope LPS. The absence of KDO, the typical linking 
sugar between the polysaccharide and lipid moieties in enterobacterial 
LPS, and galactose, a typical core sugar in other gram-negative bacteria, 
was again outstanding.
It is unfortunate that a comprehensive analysis of the 
V. cholerae cell envelope has not been made. Characterisation of the 
protective somatic antigen(s), believed to be located on the envelope, 
is potentially of great importance to the development of an effective 
cholera vaccine.
2. The Disease
A. Colonisation of the Intestine and Toxin Production
Cholera infection is via the orogastric route, the disease 
being dependent on the ingestion of live vibrios in water or food, and 
their subsequent multiplication in and colonisation of the small 
intestine (Carpenter, 1978» Carpenter, Creenough and Gordon, 1974»
Nalin, 1975) (Pl&te 2);y. cholerae organisms are very acid-sensitive so 
that protection from gastric acidity, e.g. within a bolus of food, is 
required for their safe passage into the small intestine. The organism 
grows well at the slightly alkaline pH (7-8) of the small bowel, and is 
resistant to high bile-salt concentrations, so that rapid multiplication
11
Plate 2, Schematic diagram of the pathophysiology of cholera, 
(Nalin, 1975).
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may occur. Growth of the cholera vibrio in the small intestine is 
accompanied by the production of an exo-enterotoxin which is the agent 
responsible for the disease symptoms.
During cholera infection V. cholerae remains localised within 
the intestine, and although no penetration of the tissues occurs,
Freter (I969) demonstrated that 0^% of the infecting vibrios in rabbit 
ileal loops adhered strongly to the intestinal lining. Prior mixing 
of vibrios with specific antiserum while not affecting their viability, 
prevented their adhesion to the mucosal surface.
The mediator of vibrio adhesion has variously been suggested as :
(a) Mucinase production. The inner surface of the intestine is lined 
with a mucus layer. The production of mucinase may enable the vibrio 
to penetrate this layer and avoid removal by peristalsis. However 
production of this enzyme is not restricted to pathogenic vibrios 
(Lankford, I96O).
(b) Heuraminidase production. Durikhin, Popova and Kobrinskii (1976) 
found a high degree of correlation between synthesis of both enterotoxin 
and neuraminidase. It was suggested that these products acted 
cooperatively during the development of cholera, since neuraminidase 
destroyed the protective mucin in the small intestine and increased the 
content of available enterotoxin receptor sites in the epithelial cell 
membranes. This property of the enzyme was rejected, however, by 
Holmgren (1975,a) (see p. 40).
(c) Pili. Pili are known to be responsible for the adhesion of 
several enteric organisms to the intestinal epithelium (Duguid and 
Gillies, 1957)* However, not all pathogenic vibrio strains possess 
these structures (Pinkelstein, 1973)*
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(d) Flagella. A series of recent reports has suggested a correlation 
between possession of flagella and adhesion to mucosal surfaces by 
vibrios. Guentzel and Berry (1975) demonstrated a relation between 
motility and virulence. Non-raotile V. cholerae mutants had a decreased 
ability to kill suckling mice despite the fact that they produced 
enterotoxin. It was suggested that the non-motility of these strains 
greatly decreased their ability to adsorb to the mouse intestinal 
epithelium.
Jones and Freter (1976) and Freter and Jones (1976) found that 
non-flagellate, mutant strains of V. cholerae lacked the ability to 
adhere to the surface of epithelial cells. They also found that 
adhesion of motile V. cholerae strains was significantly reduced by 
L-fucose and to a lesser degree by B-mannose. They concluded that 
vibrios possessed receptors on their flagella which bound to L-fucose 
residues on epithelial cell membranes. Flagella may also be important 
for propelling the vibrios toward these binding sites, since studies by 
Jones, Abrams and Freter (1976) demonstrated that vibrio attachment 
resulted from chance collision with the brush border.
The results of Felson, Clements and Finkelstein (1976), however, 
contradict the observations of Jones and Freter (1976). Using electron 
microscopy Nelson’s group demonstrated vibrios bound to the epithelial 
surface in a horizontal position with their flagella extending into the 
lumen of the intestine. It was suggested that since the cholera vibrio 
was propelled by a single polar flagellum, its first contact with the 
intestinal surface would be via the "front-end". After the initial 
binding, the vibrio was envisaged as aligning parallel to the surface 
to allow greater contact. During this sequence of events it is
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difficult to imagine how a binding site on the flagellum, which apparently 
was not in contact with the epithelial cells, could be effective, as 
proposed by Jones and Freter (1976).
(e) Chemotaxis. Allweiss et al (1977) suggested that chemotaxis might 
play a role in the initial attraction of V. cholerae to the intestinal 
mucosa. They produced evidence of chemotaxis in V. cholerae which was 
absent from three mutant strains.
Whatever the factors involved in the adhesion of V. cholerae, 
it is probably essential to the virulence of the organism, Freter 
(1972) suggested that only vibrios adsorbed to the mucosal surface were 
involved in the pathogenesis of experimental cholera. This suggestion 
was confirmed by Schrank and Verwey (1976) who showed that the villi 
and the intervillous spaces of the gut were usually lined with a layer 
of mucoid material which isolated the epithelial cells from the 
intestinal contents. Onset of fluid accumulation in the gut of rabbits 
infected with V. cholerae, was concomitant with the establishment of 
large accumulations of organisms in the intervillous spaces and crypts 
after the successful penetration of the mucous layer. However, in 
rabbits immunised with a ce11-wall antigen of V. cholerae, or injected 
with anti-cell-wall serum, there was clumping of the vibrios in the 
lumen and restricted distribution in the lumen and luminal edge of the 
mucous zone. The antibodies were non-bacteriolytic in vivo and were 
presumably effective through their prevention of the vibrio-mucosal 
surface interaction. The adhesion of the vibrios to the mucosal 
surface results in the deposition of cholera enterotoxin close to the 
toxin-receptor molecules in the epithelial cell membranes. Aziz and 
Mosley (1972) showed that relatively small amounts of the toxin 
produced by infecting vibrios were recovered in the stool of cholera 
patients, which suggested enterotoxin-binding was highly efficient.
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The localisation of the cholera enterotoxin in the body, during 
infection, was investigated by Vaughan-Villiams and Dohadwalla (*1969) i% 
two-day-old rabbit littermates. Pairs of these animals were linked by 
cross-circulation (blood from one animal was fed, via a roller pump, 
from the heart side of the left carotid artery to the head side of the 
right carotid artery of its mate, and vice versa), and one animal, the
7
donor, was given an intraintestinal inoculation either of $ x 10 
V. cholerae organisms or sterile culture medium; the partner remained 
uninoculated. Fluid accumulation was observed in the intestines of 
both inoculated and uninoculated rabbits. These workers concluded that 
intestinal infection of infant rabbits with V. cholerae led to the 
appearance of a choleragenic agent in the blood, and that intralumi^nal 
instillation of a V. cholerae cell-lysate had a similar effect.
Pierce, Greenough and Carpenter (1971), however, could find no 
trace of cholera enterotoxin in either thoracic duct lymph or in mesen­
teric blood, during experimental cholera. This indicated that the 
enterotoxin was localised in the intestine, and that no other tissue 
of the body was exposed to cholera toxin during infection.
B. Production of Clinical Disease
The events preceding the development of clinical cholera are:-
(a) ingestion of viable V. cholerae, (b) colonisation of the small 
intestine and (c) production of enterotoxin.
The enterotoxin acts on the mucosal cells of the small 
intestine causing them to secrete large quantities of isotonic fluid.
The rate of fluid loss (which may be up to 1 litre per hour) ultimately 
exceeds the rate of reabsorption in the colon, causing a net fluid 
deficit in the body which is responsible for the entire range of 
clinical manifestations of cholera (Carpenter, 1970; Carpenter et 1974)
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Fluid loss, according to the studies of Carpenter ejt ^  (I968) 
and Banwell ak al (1970), occurred only in the small intestine, "both 
in experimental canine cholera and in human cholera. Gross structural 
damage to the intestinal wall was absent both in man (Gangarosa at al, 
i960) and experimental animals (Norris and Majno, I968; Elliot et al, 
1970) during cholera infection. Elliot at al (1970) noted several 
histological changes in the small intestine including the depletion of 
mucus in goblet cells, slight dilation of the crypts and the villous 
capillaries, and minimal oedema of the lamina propria. Peterson, 
LoSpalluto and Finkelstein (1972) studied localisation of enterotoxin 
in vivo, by immunofluorescence techniques. There appeared to be 
binding to the entire mucosal surface of the villus and crypt areas, 
while no penetration into the epithelium or lamina propria was observed.
Whether enterotoxin acts primarily on crypt or villus cells 
(Fig 2) is uncertain. Be Jonge (1975) believed that both cell types
cT -fKfi “tVvQ.or^
were involved, while Weiser and Quill (1975) were in favour^of adenylate 
cyclase stimulation occurring only in villus cells. Elliott et al 
(1970), Schwartz, Kimberg and Ware (1975) a,nd Field (1976) however, 
concluded that enterotoxin acted primarily on crypt cells. The situation 
remains to be clarified.
Nelson ^  ^  (I976) studied the colonisation of the small 
intestine of infant and adult rabbits by V. cholerae, using scanning 
and transmission electron microscopy. They demonstrated a lag period 
of 1 hr before significant numbers of bacteria attached to the adult 
intestinal epithelium. This lag was absent in the infant rabbit where 
colonisation began immediately on infection, and where greater 
concentrations of vibrios accumulated than in the adult. It was 
suggested that natural differences in susceptibility of the intestinal
17
Figure 2. Histological transverse section of the small intestine
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surface to bacterial attachment could be important in the different 
morbidity rates of infant and adult human beings for such enteric 
diseases as cholera.
Nelson et al (1976) noted that after the initial attachment of 
vibrios there was a steady increase in their numbers, until between 4 
and 7 hours post-infection when there was a maximum number of adherent 
bacteria several layers thick. These formed a dense mat over much of 
the villi. A rapid decline in the number of bound V, cholerae was 
subsequently observed and by 12 to 16 hr post-infection only a few 
bacteria were seen on the surface of the villi. After removal of the 
vibrios the adult rabbit villus appeared rough and patchy in comparison 
to control preparations, and the infant rabbit villus had a "fuzzy" 
appearance due to elongated microvilli.
C. Clinical Symptoms
Cholera has an incubation period varying from 24 hr to 5 days 
(Oseasohn £t I966; Hornick ^  1971)- Vomiting occurs in most
patients, beginning shortly after the onset of severe diarrhoea. As the 
disease progresses fluid loss in the stool exceeds the rate of reabsorp­
tion by the colon, resulting in an overall deficit of isotonic fluid in 
the body. Serious isotonic fluid deficit may develop in as little as 
4 hr but 1-2 days may be required for the range of cholera symptoms, 
characterised briefly in Fig 3, to be demonstrated. Pollitzer (1959), 
Pierce and Mondai (1974) and Mahalanabis, Vatten and Wallace (1974) 
comprehensively reviewed the clinical aspects of cholera.
D. Treatment
Methods of treatment of cholera were reviewed by Hirschhorn
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Figure 3. Symptoms of cholera in relation to the amount of fluid loss
Fluid Deficit
As Percentage Body Weight
5%
10^
1 2 %
Symptoms
1. Thirst
2. Faintness on standing
3. Drainage of fluid from soft 
tissues resulting in
(a) poor skin turgor
(b) sunken eyes
4* Decreased renal blood flow 
resulting in
(a) oliguria
(b) anuria
5. Muscular cramps
6. Lethargy
7. Hoarseness or Aphonia
8. Stupor
Coma in children
9. Death
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^  âi. (1974)» and. outlined by Frost (1976). Since the symptoms of 
cholera are entirely the result of water and electrolyte loss from the 
soft tissues and the blood into the gut, replacement of this fluid can 
remedy the ill-effects. Fluid replacement therapy reduces the mortality 
rate from 60 percent in severe, untreated cholera to less than one percent,
The severely-ill cholera patient is given a rapid intravenous 
transfusion of isotonic fluid, according to his state of dehydration, 
and is subsequently maintained so that the amount of fluid administered 
is equivalent to the amount lost. V/here the infection is less severe 
the patient may be protected from dehydration by oral administration of 
electrolyte solution. Glucose is usually included in such solutions; 
inclusion of 2% glucose in oral fluid increases the absorptive capacity 
of the small intestine (Taylor et al, I968). A typical solution for 
oral rehydration of cholera patients was suggested by Frost (1976) to 
be - glucose, 20.0 g; NaCl, 4*2 g; NaHCO^, 4*0 KOI, 1*8 g; 
dissolved in 1 litre of drinking water.
III. VIBRIO CHOLEEIAE TOXINS
1. Types of Toxin
From his studies on the etiology of cholera, Koch, in I884, 
suggested that the disease was an intoxication, since V. cholerae was 
localised in the lumen of the intestine. The precise nature of the 
toxic activity remained obscure for many years until publications such 
as those of De (1959) and De, Ghose and Sen (1960) on the enterotoxicity 
of V . cholerae culture filtrates aroused fresh interest in the subject.
As information on cholera toxins accumulated, Burrows (1968) saw the 
need for a classification capable of differentiating the various toxic 
activities. He divided cholera toxins into 3 groups by heat stability
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and dialyzability, thus:-
Type 1 Toxins 
(endotoxin)
Type 2 Toxins 
(protein exotoxin)
Type 3 Toxins 
(non-protein exotoxin)
Heat-stable
at 100 C
yes
no
yes
dialyzable through 
cellophane
no
no
yes
A. Endotoxin
V, cholerae, like other Gram-negative organisms, possesses an 
outer envelope containing LPS (endotoxin). The LPS is a heat-stable 
moiety and is contained within Burrows’ toxin type 1 group. Pant 
(1968) isolated LPS and found it was responsible for the ’’O’’ antigenicity 
of vibrio cells. However, the relationship of LPS to the pathogenesis 
of the organism, if any, is obscured by the rapid action of V. cholerae 
enterotoxin. Iwert, Leitch and Burrows (I967), found that intra-ileal 
loop inoculations of V. cholerae in the rabbit increased the levels of 
serum glutamic-oxalacetic transaminase and lactic dehydrogenase. These 
increases reflected a type 1 vibrio toxaemia, lethal for mice (Burrows, 
1968), and were compared also by Iwert ^  al to those observed during 
Gram-negative septicaemias in humans, and in experimental endotoxic 
shock in rabbits and dogs. In I968 Iwert ejb ^  compared the levels of 
these enzymes in cholera patients, during the first five days of illness, 
to those found in normal persons. There were significantly higher 
levels of these enzymes in the sera of cholera patients. Elevated 
enzyme levels in rabbits were thought to be due to increased permeability 
of the lower ileum, allowing absorption of endotoxin or Boivin antigen. 
Whether humans respond similarly is not known.
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B. Heat-Stable Exotoxin
The heat-stable exotoxin, or type 5 toxin according to Burrows’ 
classification, is found in V. cholerae culture supernates, and is both 
heat-stable and dialysable through cellophane membranes. Studies by 
Fuhrman and Puhrman (I960), Huber and Phillips (I9é0) and Puhrman,
Fuhrman and Burrows (1962) demonstrated the ability of V. cholerae 
culture supernates to inhibit the active transport of the sodium ion 
across the skin and bladder of amphibia. The latter workers suggested 
that inhibition of sodium transport in the intestine during cholera 
could account for the diarrhoeagenic symptoms of the disease. It was 
calculated that a three per cent inhibition would result in fluid loss 
of the same magnitude as that found in the natural infection. However, 
Grady e;t ^  (I968) showed that there was no relation between the enteric 
toxicity of cholera culture filtrates and the substance causing 
inhibition of the "sodium pump" in the frog skin. They found a similar 
inhibition by supernates from a number of ammonia-producing bacteria; 
inhibition was a linear function of the log^ ^^  (NH^^) in the preparations. 
However removal of ammonia from cholera culture filtrates by dialysis 
(Leitch and Burrows, I968) left behind a non-dialysable, thermolabile 
component, which stimulated fluid accumulation, a characteristic of 
cholera infection, in rabbit intestines.
Thus the heat-stable exotoxin of V. cholerae, demonstrated to be 
dissolved ammonia, could be separated from the heat-labile exotoxin 
associated with the production of fluid imbalance during cholera 
(Burrows, I968).
C. Heat-Labile Exotoxin (Exo-enterotoxin, Choleragen, Permeability
Factor)
The heat-labile exotoxin, or type 2 toxin according to Burrows*
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classification, of V. cholerae is considered to be predominantly 
responsible for the pathogenesis of cholera. This particular oholera 
toxin is referred to in the literature under a number of terms 
(Finkelstein, 1973) including "exo-enterotoxin", implying its action on 
the intestine, and "choleragen". During this review the term "entero­
toxin" will be used except in discussion of the intradermal activity of 
the toxin, where "permeability factor" will be employed; the two terms 
are synonymous.
Craig (1965) showed that intracutaneous injection, into guinea- 
pigs or rabbits, of small volumes of stools from bacteriologically- 
confirmed cholera cases, and from cell-free culture filtrates of 
V. cholerae, gave identical reactions of erythema and induration 6 to 8 hr 
after injection. No such reaction was found on injection of live vibrios. 
The activity of both the stool and culture filtrate preparation was 
completely abolished by heating at 56°C for 30 min, was decreased by 
25-50%! after dialysis against 0*85% NaCl for 24 hr at 5°C, but was not
affected with trypsin (lOO pg/ml) for I5 min at 37^0 and pH 7.0.
Through these experiments Craig established the production of enterotoxin 
by V. cholerae both in natural infections and during ^  vitro culture. 
Following this observation the production and properties of enterotoxin 
were studied in an effort to determine its role in human cholera.
2. Production of Enterotoxin
Richardson (I969) demonstrated that enterotoxin could be 
isolated from culture supernates before any lysis of vibrio cells was 
apparent. Maximum accumulation in culture supernates occurred during 
a transitional period between the exponential and stationary phases of 
growth. The total yield of enterotoxin was shown to be proportional 
to the length of the linear growth phase.
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Aerobic conditions were found to be optimal for production of 
enterotoxin. Craig (1966) recommended the use of Roux bottles,^ 
containing a volume of culture medium which would give a surface to 
volume ratio of 2 cm^/ml. Other workers such as Mosley, Aziz and Ahmed 
(1970) used 100 ml shaking cultures in 3 litre Erlenmeyer flasks, to 
achieve sufficient aeration. Finkelstein and LoSpalluto (1969) 
successfully produced bulk toxin in aerated fermenter cultures.
Craig (1966) specified an incubation temperature of 30°C for 
48 hr for enterotoxin production; however various alternatives have 
been equally successful. Coleman at ^  (1968) grew cultures at 37^C 
for 6-7 hr, thus avoiding the contamination of the culture supernates 
with vibrio endotoxin, which was commonly found in older cultures. 
Richardson, Evans and Feeley (l970) used incubation temperatures of 25“ 
30°G for up to 24 hr.
The optimum pH for enterotoxin production varies with the strain 
of vibrio. Evans and Richardson (I968) noted the pH 6.6 required for 
enterotoxin production by strain VC-12, compared to that of pH 7*2-7.8 
required by strain 569B (Kaur, Burrows and Cercavski, I969). The latter 
workers noted that while no enterotoxin was produced by strain 569B in 
acid conditions, a non-toxic antigen was still formed in normal or 
greater amounts. The rate at which enterotoxin is produced is dependent 
also on the strain of vibrio, Kusama and Craig (I970) incubated two 
vibrio strains, 569# and BI307, at 30°C and 37°C, and found that entero­
toxin was produced in greater amounts at 30°C with both organisms. 
However, with strain 569# the enterotoxin titre reached a peak, at 24 hr 
at 30°C, which was maintained for 96 hr. In contrast, the enterotoxin 
titre produced by strain BI307 declined and was almost undetectable 
after 24 hr at either temperature.
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The enterotoxin moieties produced by the various vibrio strains, 
despite strain differences in production requirements, are immugo-
it
chemically very similar, if not identical (Holmgren, Lonroth and 
Ouchterlony, 1971).
A variety of media have been used for vibrio culture and toxin 
production. These fall into three broad groups
(i) Peptone Media
Peptone water has been used by a number of workers; for 
example Craig (1965) used a 5% solution, and Evans and Richardson (I968) 
reduced the peptone concentration to 3% and found that this was adequate 
for a good yield of enterotoxin, A 3% solution of dialysate of bacto- 
peptone was found by Coleman et ^  (1968) to support good growth and a 
high yield of toxin. This had the advantage that unaltered 
constituents of the medium could be removed from the choleragen in the 
culture supernate by dialysis (through a 10k daltons molecular weight 
exclusion membrane).
(ii) Semisynthetic Media
Finkelstein e^ al (I966) used a sucrose-inorganic salt medium 
supplemented with a 1% solution of casamino acids, "Syncase Medium."
This medium was modified first by Richardson (1969), who used lactate 
instead of sucrose, 0.005% yeast extract and a mixture of trace elements 
in O.OIM Tris buffer, and secondly by Richardson ^  al (I970) by the
addition of potassium and phosphate, substitution of glycerol for lactate,
and the use of Tris-maleate buffer, "TRY Medium,"
(iii) Synthetic Media
Craig (1966) was the first to use a chemically defined medium, 
which contained (NE^)Cl, MgCl^, FeCl^ and sucrose, as carbon and energy 
source, for enterotoxin production, Richardson et ^  (1970) also
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described "TAY Mediiwn" which differed from their "TRY Medium"; the 
casamino acid component was replaced by glutamate, serine, aspartate and 
arginine. Callahan, Ryder and Richardson (197I) demonstrated that 
phosphate and potassium were required also, for maximum enterotoxin 
production when the casamino acid supplement was removed. This 
improved medium was designated "TF Medium."
From the literature, none of the above has emerged as the 
medium of choice. The medium selected by different research groups has 
largely been governed by the purification steps, if any, to be applied 
to the culture supernate.
3. Purification of Enterotoxin
Various methods of purification of enterotoxin have been 
outlined. These include the initial steps of concentration of entero­
toxin from crude culture supernates by filtration through Amicon membranes 
(Duhamel, Talbot and Grady, 1970), or a variety of other concentration- 
partial purification steps, which may be summarised as follows:-
(a) precipitation with 90% saturated (NH^)2S0^ (Finkelstein and 
LoSpalluto, 1969) which yielded up to 80% recovery of active 
enterotoxin
(b) absorption to aluminium compound gels (Spyrides and Feeley, 1970), 
which allowed considerable concentration and purification
(c) dextran sulphate precipitation (Richardson and Evans, I968) which 
permitted a 250-fold concentration of enterotoxin contained in 
culture supernates
(d) ethanol fractionation at -20°C (Heckly and Wolochow, 1970), 44% 
ethanol was sufficient to precipitate enterotoxin.
In addition to these initial steps, further purification was
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achieved by either gel filtration or ion-exchange chromatography.
These techniques were used in a variety of combinations in an effort to 
obtain pure enterotoxin, Richardson and Noftle (I970) used dextran 
sulphate precipitation, followed by (NH^)2S0^ precipitation to free 
enterotoxin from the dextran sulphate. Enterotoxin was separated from
contaminating IPS, dextran sulphate and by gel filtration on
a PI50 polyacrylamide column, Finally it was separated from other 
impurities by ion—exchange chromatography on DEAE Sephadex A-25. 
Alternatively, Pinkelstein and LoSpalluto (I970) used a series of 
membrane filtration steps to concentrate their crude toxin preparations. 
Purification was achieved with Sephadex G—75 and Biogel A-5M columns 
(Plate 3).
With the growing interest in cholera enterotoxin, both as an 
immunogen and as a membrane-active reagent, it became desirable to 
purify it in large quantities. Lewis, Richardson and Sheridan (1976) 
developed a method involving concentration by membrane filtration, cation 
exchange chromatography and preparative gel electrophoresis, which could 
be applied to 6-8 litre cultures.
4* Chemical and Physical Properties of Enterotoxin
A, Composition
With improved purification techniques it was possible to study 
the properties of enterotoxin. Coleman et ^  (1968) studied its 
elution profile from BEAE Sephadex and its sedimentation rate in the 
analytical centrifuge and suggested that it was a lipoprotein with some 
carbohydrate. However, Kaur et ^  (I969) detected heterogeneity in 
the preparation used by former workers, and found that most of the lipid 
could be removed without affecting toxicity (Kaur £t al, 1970). Heckly
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Plate 3* Some of the separation techniques used in the purification 
of cholera toxin.
(Pinkelstein & LoSpalluto, 1970. J. infect. Dis. 121, 3&5)
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and Wolochow (1970) partly substantiated this observation by demon­
strating that toxicity was not affected by treatment with either.ficin 
or pancreatic lipase. According to Pinkelstein and LoSpalluto (I969) 
and LaSpalluto and Pinkelstein (1972), highly purified enterotoxin 
contains only protein, with no detectable lipid or hexose.
B. Stability
Craig (1966) was the first to examine the stability of entero­
toxin. Toxicity was abolished by heating at 56°C for $0 min; dialysis 
of enterotoxin at for 24 hr against 0,85% KaCl caused a 29-50% 
decrease in toxicity. Exposure to trypsin at 100 pg/ml for I5 min at 
37°C at pH 7*0, had no detectable effect on toxicity, Enterotoxin was 
unstable below pH 6.5 and above pH 9*0, but at neutral pH, although still 
labile, could be stabilised by O.OIM phosphate buffer, or by a protect­
ive colloid such as gelatin (Mosley et 19?0a). Van Heyningen 
et al (1971) reported that the toxic activity was inactivated by a water- 
soluble lipid, extracted from intestinal and other tissues, which had 
the properties of a ganglioside. This observation may be explained by 
more recent studies on the binding of enterotoxin to biological 
membranes (see p. 58).
It has generally been observed that as the purity of entero­
toxin is increased, the stability decreases. For example, crude 
preparations of enterotoxin, such as ultrasonic lysates of agar-grown 
vibrios, are stable for up to two years in the freeze-dried form when 
stored under nitrogen at 4°C. However, the estimated half-life of the 
purified material ranges between 12 hr (Grady and Chang, I970) and 18 hr 
(Kaur et I969). Duhamel at ^  (1970) made the startling comment 
that purification of enterotoxin did not cause a significant increase
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in specific activity, since the increase in purity was offset by a 
further loss of toxic activity. According to these workers, after 
passage through Sephadex G-I50, only 10% of the total activity of a 
crude preparation could be recovered, and this figure was reduced to 
around 1% if further purification steps were employed.
C. Naturally Formed Toxoid - "Choleragenoid"
The mechanism whereby the activity of enterotoxin diminished, 
began to be understood when an antigenically identical but nontoxic 
molecule, choleragenoid, was isolated both by Kaur et ^  (1969) and by 
Pinkelstein and LoSpalluto (I969) by a series of gel filtration and 
fractionation steps. The purification procedures employed by both of 
these groups, although different, were capable of resolving the toxin 
"peak", obtained by previous workers (Coleman et I968), into three 
and two peaks respectively. In each study, one of these peaks contained 
enterotoxin, while another contained a nontoxic entity, which appeared 
to be antigenically identical to enterotoxin, and for which Pinkelstein 
and LoSpalluto (I969) suggested the term "choleragenoid."
It became apparent that higher levels of one of these molecular 
species were accompanied by lower levels of the other. As the entero­
toxin level in a preparation decreased, so the choleragenoid level 
increased. Callahan ^  (I97I) demonstrated that the relative 
proportions of the two substances in culture supernates was dependent on
the growth medium. Pinkelstein, Peterson and LoSpalluto (I97I) found, 
151using I -labelled enterotoxin, that an increase in the rate of 
replacement of labelled toxin by labelled choleragenoid resulted from an 
increase in agitation of the V. cholerae culture, regardless of aeration, 
under typical cultural incubation conditions.
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The latter authors concluded that choleragenoid was neither 
a protoxin nor a catabolite of enterotoxin, but was a spontaneous 
degradation product of the enterotoxin molecule,
D* Charge
There was some controversy over the isoelectric point (pi) of 
enterotoxin since values ranging from below pH 6.0 (Heckley and 
Wolochow, 1970), pH 6.6 (Pinkelstein and LoSpalluto, 1970) to pH 7*0 and 
even pH 9*0 (Holmgren e_t al, 1971) were noted. However, this incon­
sistency may be explained by the observation of Kaur at al (I969) that 
ammonium sulphate precipitated enterotoxin required an electrolyte for 
elution from DEAE Sephadex, suggesting, that it was positively-charged. 
Thus, whereas purified enterotoxin preparations were characterised by a 
negative charge, in all probability this charge was modified when the 
toxic moiety was complexe! with another substance.
In the studies of Pinkelstein and LoSpalluto (I97O) highly 
purified enterotoxin was found to have a pi of 6.6. With similarly 
purified choleragenoid, it appeared that the preparation was not 
homogeneous in pi. Three similarly-sized, but differently charged 
proteins were electrofocused; a major species had a pi of pH 7*75 and 
two minor species focused around pH 7*58*
Similarly Roda at ^  (1977) found that purified enterotoxin was 
heterogeneous on polyacrylamide gel electrophoresis. Three forms,
I (5%)f II (15%) and III (80%), were present which were similar in amino 
acid content and molecular weight, and differed only in net charge.
This difference was related to the amide content of the three forms. 
Deamidation of accessible asparagine and glutamine residues was thought 
to occur mostly on the B subunit and to result in the conversion of the 
native toxin. III, to forms II and I via a non-reversible reaction.
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E. Molecular Weight and Structure
The rapidly expanding volume of information on the molecular 
weight and structure of enterotoxin is, unfortunately, confused due to 
the introduction of a variety of nomenclature systems. In an effort to 
clarify the following account. Figure 4 is constructed to show the 
breakdown of enterotoxin into subunits, and to state the synonymous terms 
by which these subunits are known. The subunits of enterotoxin will be 
termed A and B throughout this review, except where the work of 
particular authors is being discussed.
The earlier work on molecular weight determination of enterotoxin 
was plagued by variability in values, depending on the technique employed. 
The values ranged from a few thousand daltons to nearly a hundred 
thousand daltons. At the lower end of the scale values of 12k - 14k 
daltons were reported by Coleman £t al (i960), based on the comparative 
rates of migration on thin-layer gel filtration of lysozyme and entero­
toxin. Pinkelstein and LoSpalluto (I969) obtained a value of less than 
20k daltons, although Holmgren _et al (I971), suggested the slightly 
higher figure of 29k - 38k daltons; both studies used filtration through 
Agarose A-9M. Values of around 60k daltons were reported by (a) 
Pinkelstein and LoSpalluto (I969), using filtration through Sephadex G—79»
(b) Heckly and Wolochow (197O), using analytical ultracentrifugation,
(c) Duhamel ^  (I97O), using Sephadex G-I90 filtration, and (d)
Holmgren at ^  (I97I), using Sephadex G—79 filtration. Finally, 
LoSpalluto and Pinkelstein (1972), studying highly purified enterotoxin, 
calculated its molecular weight to be 82k daltons, using sedimentation 
velocity diffusion, and %4k daltons, according to meniscus depletion 
studies.
Figure U. The various nomenclature systems used to describe
cholera toxin subunits
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r-POLYPEPTIDE A,
(a)(II,)
ENTEROTOXIK
(holetoxin)
L-POLYPEPTIDE A,
(|3)(II,)
L) (y)(I)
Nomenclature References
"^1 * 2^. * ^ (a) Van Hyeningen (1^76)
(b) Lai et ^  (1976)
(c) Ohtomo et ^  (1976)
H, L Holmgren and Lonroth (1975)
G,P,Y Euro sky et ^  (1976)
III, Ilg, I S^attler ^  (1975)
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As the polymeric nature of enterotoxin became apparent, it vas 
possible to explain the range of molecular weights. The extent of 
polymerisation or dissociation depended on the treatment to which the 
subunits were exposed. On heatfng (Pinkelstein al, 1971b), the 
enterotoxin monomers formed even larger molecular weight aggregates, 
with a sedimentation coefficient around $0S. These aggregates possessed 
low levels of toxic activity, but were highly immunogenic in mice 
(Pujita and Pinkelstein, 1972). Pinkelstein ejt ^  (l971b) used the 
term "procholeragenoid" for this material, and envisaged that it was an 
intermediate in the formation of choleragenoid from enterotoxin.
About this time the monomers comprising enterotoxin began to 
be investigated. Pinkelstein £t al (1971a-) suggested that both entero­
toxin ('^ 90k daltons) and choleragenoid ("^ 6Ok daltons) could be split 
irreversibly into similarly-sized subunits of approximately 15k daltons. 
However, in a later publication, Pinkelstein ^  ad (1974) presented 
results which suggested that two distinct subfractions were obtained on 
filtration of enterotoxin through Bio-Gel P-60 under dissociating 
conditions in acid urea. The first fraction eluted from the gel, 
subunit A, was unique to enterotoxin, while the second fraction, subunit 
B, was present in both enterotoxin and choleragenoid. Isolated A and 
B fractions gave a reaction of non-identity, against antiserum prepared 
against enterotoxin, in an Ouchterlony gel diffusion plate. Neither 
subunit was significantly toxic in experimental animals. It was 
suggested that subunit B was responsible for the binding to host-cell 
receptors, while subunit A was thought to be responsible for the 
activation of adenyl cyclase by enterotoxin. Subunit B was non- 
covalently associated with subunit A, which was dissociated into two 
parts by treatment with thiol reagents.
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These results were complemented by those of Holmgren and 
Lonroth (1975) who, by sodium dodecyl sulphate polyacrylamide electro­
phoresis, identified two types of subunit in the enterotoxin molecule - 
one of approximately 28k daltons and the other approximately 8k daltons, 
termed H (heavy, i.e. A) and L (light, i.e. B) subunits respectively.
The H subunit was further degraded into two components by reduction and 
alkylation and it was suggested to be a disulphide bridged dimer. The 
results suggested that enterotoxin was composed of ’]'L + IH subunits, 
while choleragenoid was composed entirely of aggregated L chains.
Holmgren and Lonroth (1975) indicated also that enterotoxin 
possessed both enterotoxin-specific antigenic determinants and 
determinants shared with choleragenoid. The choleragenoid-shared 
determinants were present in the L-type subunit, while the H-type 
subunit contained the specific determinants. In the same study, it was 
demonstrated that enterotoxin and choleragenoid shared the ability to 
attach to the ganglioside Gm^ (see p. 58), which suggested that the 
L subunits were responsible for binding.
Van Heyningen (1976) stated that enterotoxin was composed of 
two types of subunit, A and B. Subunit A could be split into two 
polypeptide chains and was unique to enterotoxin. Subunit B, however, 
was common to enterotoxin and choleragenoid. It was suggested that 
subunit B, by binding enterotoxin to the Gm^-ganglioside receptor 
molecule in the host cell membrane, facilitated the interaction of 
subunit A with the adenyl cyclase system.
Although it is generally agreed that enterotoxin can be broken 
down into the subunits described by Van Heyningen (1976), the precise 
molecular weights of these subunits remain to be determined. Recent 
estimations of the molecular weights of these species are summarised 
below.
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Subunit ^1 -^2 B‘ Heference
27 8 8 Cuatrecasas, Parikh and 
Hollenberg (1975)
25 7 10 Sattler et ^  (1975)
molecular 25-24 5.5 10.6 Gill (1976)
weight 24 9.7 9.7 Kurosky e_t ^  (1976)
(k daltons) 20 7.5 9.5 Lai, Kendez and Chang (1976)
25 2.5 11 Ohtomo <et ^  (1976)
22 5 14 Van Heyningen (I976)
21.5 7.3 10 Klapper, Pinkelstein and 
Capra (1976)
Having isolated the snbnnits of cholera enterotoxin, studies 
of their primary structure began. Jacobs, Hiall and Sharp (1974) 
reported tte 20 amino terminal residues of each subunit. Hakashima 
et al (1976) presented the entire sequence of i05 amino acids of the B 
subunit, as did Lai (1977)» Klapper et al (1976) elucidated the amino 
terminal sequences of all thpee subunits.
The secondary structure of enterotoxin was studied by Mendez, 
Lai and V/odnar-Filipowicz (1975)* Lai (1977) and Klapper ^  ^  (I977). 
The latter workers produced the following diagram on the basis of their 
finding on di-sulphide bridging:-
cys 9
cys y
B
cys 9j
cys ft
Amino acid 
in position
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The position of the cysteine residue in the was unknown, hut was
located at position 5 in the chain. Each of the B chains had an 
identical amino acid sequence and a single disulphide loop beginning 
at position 9* Lai et al (1977) suggested the di-sulphide bridge in 
the B subunit to be between cysteine 9 and cysteine 86.
The exact orientation of the three subunits still poses a 
problem. An "AB^" configuration was suggested by Jacobs e_t ^  (1974), 
Van Heyningen (1976) and Kurosky at ^  (1976). Holmgren and Lonroth
(1975), however, suggested that 6 or 7 B chains were associated with 
the A chains, and Lai at al (1976) agreed on 6 B polypeptides to every 
”A^, Ag" complex. The most recent reports by Lai (1977) and Klapper 
et al (1976) have put the B;A ratio at 5 si'.
Gill (1976) proposed that the B subunits were arranged in a ring 
with A on the axis. Ag was suggested to hold A-^  onto the B-ring,
When examined by electron microscopy (Ohtomo e_t 1976) cholera entero­
toxin molecules were found to be of uniform size and arranged in V, Y 
or ring forms. Roda ^  al (1977) thought it possible that charge 
differences among enterotoxin molecules, brought about by deamidation, 
could account for the difference in conformation noted by the previous 
workers,
P. Antigenicity. Receptor Binding and Toxic Properties
Kimberg et ^  (I971) and Sharpe and Hynie (1971) demonstrated 
that enterotoxin markedly enhanced the activity of the membrane bound 
enzyme, adenyl cyclase, which catalyses the conversion of ATP to cyclic 
AMP. It was also found to have a depressive effect on Ka-K—dependent 
adenosine triphosphatase in the intestinal mucosal cell. The net 
effect was an increase in cAMP concentration in the mucosal cell which
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unbalanced the normal ion transport processes, closely dependent on ATP 
levels. The net efflux of ions from the mucosal cell into the'lumen 
of the intestine, with a concomitant outflow of water from the cell, 
was judged to be directly responsible for the diarrhoeal effects 
induced by enterotoxin.
As mentioned already (p. 54) the A subunit was thought to be
responsible for the interference with the adenyl cyclase system, while 
the B subunit was associated with the binding of enterotoxin to the 
cell surface. Cuatrecasas (1975a, b, c, d), while studying the binding 
of enterotoxin and choleragenoid to liver and fat cell membranes found 
that binding to cell membranes could effectively be inhibited by 
concentrations as low as 1 ng of the monosialoganglioside, Gm^ 
(galactosyl-ll-acetylgalactosaminyl |^B-acetylneuraminylj galactosyl- 
glucosyl ceramide) (Plate 4). That this ganglioside was the membrane 
receptor for cholera enterotoxin was suggested by the work of Van 
Heyningen (l974a). Van Heyningen (l974h), Hollenberg et al (1974), 
Holmgren et af (1975a) and Moss^Manganiello and Pishman (1977).
This Gm^ ganglioside was spontaneously incorporated into cell 
membranes and thereby greatly increased the sensitivity of the cell to 
enterotoxin: for example, increased the rate of lipolysis in fat cells
due to an increase in cAMP concentration. It also became evident that 
sensitive cells preincubated in the presence of choleragenoid were no 
longer influenced by exposure to active enterotoxin. The conclusion 
drawn from this work was that enterotoxin and choleragenoid both 
interacted with the same receptor molecule on the cell surface, namely 
a ganglioside.
Van Heyningen (1974&) noted that treatment of isolated 
epithelial cells with sialidase, which is secreted by V. cholerae.
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Plate 4* The structure of monosialoganglioside, Gm^.
(Van Heyningen, 1977* Biol. Rev. 517).
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increased their ability to bind enterotoxin, since sialidase-sensitive 
membrane gangliosides lost sialic acid residues to become Gm^.
Although V. cholerae sialidase was active in vitro, Holmgren ad 
(1975a) found that it had very little effect on the number of toxin 
binding sites on the intestinal cells in vivo, and did not alter the 
sensitivity of the small bowel.
Cuatrecasas (1973) noted a lag phase of up to 3O min after the 
addition of active enterotoxin to sensitive cells, before the appearance 
of toxic effects. It was therefore suggested that the original entero­
toxin- and choleragenoid-receptor complexes were very similar, but only 
the enterotoxin-receptor complex was capable of undergoing a subsequent 
rearrangement during the lag phase, within the structure of the 
membrane, which converted it to a biologically active form.
Contrary to the above reports which implicated Gm^ as the 
membrane receptor for cholera enterotoxin, Kanfer, Carter and Katsen 
(1976) suggested that Gm^ (H-acetylneuraminylgalactosylglueosyl- 
ceramide) was the major ganglioside involved in binding enterotoxin to 
fat cells. Van Heyningen, Van Heyningen and King (1976) suggested that 
the receptor may be more complex than Gm^ alone since they showed that 
enterotoxin binding did not increase proportionally with the amount of 
Gm^ incorporated into pigeon erythrocytes, and that the resulting cAMP 
response did not increase in proportion to the extra toxin bound. It 
would seem that the function of the receptor may be dependent on 
additional properties of the surrounding membrane.
Lonnroth and Holmgren (1974, 1975) and Holmgren and Lonnroth 
(1976) described the effect of chemical modification of enterotoxin on 
its various properties. Reagents which decreased the ability of 
enterotoxin to bind to the Gm^ ganglioside-receptor, caused a correspond-
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ing decrease in toxicity. A close association was found between 
destruction of the ganglioside binding capacity and the antigenic 
properties of enterotoxin. However, there was also a group of protein 
modifying reagents, e.g. cyclohexanedione, which abolished the toxicity 
of the molecule, but had no effect on its receptor binding or antigenic 
properties - it was suggested that such reagents might prove to be 
useful in the production of toxoids for immunisation procedures.
These results were in agreement with the proposal that ganglioside- 
binding and most of the antigenic properties of enterotoxin were 
located on the B subunits, while the toxic activity was associated with 
another part of the molecule, the A subunit. They also indicated that 
enterotoxin must be bound to the cell membrane via the B subunit, 
before the A subunit could become active,
Lonnroth and Holmgren (1975) suggested that lysine residues 
were involved in the binding of enterotoxin to the acidic Gm^ receptor, 
since amino-group reactive substances were particularly effective in 
decreasing its binding capacity. Similarly, substances which did not 
affect binding or the aggregation state of enterotoxin but which 
decreased toxic activity, were found to be arginine-specific. The 
involvement of arginine residues at the "toxic site" was therefore 
suggested.
Recently the kinetics of toxin binding and the interaction 
between the two subunit types' required to produce the toxic effect have 
been studied in detail. For example Holmgren and Lonnroth (I976) 
found that enterotoxin binding to cells was apparently not temperature
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dependent, since equal amounts of I -labelled choleragenoid bound to 
thymus cells at O^C and at 57°G. However, after the addition of 
unlabelled enterotoxin and choleragenoid it became obvious that binding
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at O^C was a largely reversible process, whereas irreversible binding 
required incubation at 57°C. It was apparent from the work of Craig 
and Cuatrecasas (1975) that even after irreversible binding of entero­
toxin to the cell membrane, activation of adenyl cyclase was not 
certain. Their results indicated that partial inhibition of adenyl 
cydase activation by anti-enterotoxin IgG could still occur after 
incubation with toxin for JO min at 57*^ 0. It was suggested, therefore, 
that only some of the cell bound toxin formed irreversibly active 
complexes with the cyclase at the same time.
The events which occur during the lag phase, between entero- 
toxin-binding and the activation of adenyl cyclase, are still obscure. 
However, the work of Craig and Cuatrecasas (1975) and of Sedlacek _et al
(1976) have been illuminating. The former workers studied the inter­
action of fluorescein-labelled enterotoxin and receptor gangliosides in 
lymphocyte cell membranes. The latter workers incorporated a synthetic 
ganglioside carrying a DAH8yl-flucre scent label into lymphocyte cell 
membranes and observed the resulting interaction after the addition of 
choleragenoid. Similar observations were made on the binding of 
enterotoxin/choleragenoid to the receptor molecule, in both cases.
The receptor molecules which were originally distributed evenly across 
the cell membrane were seen to move together to form patches or caps 
(seen as areas of fluorescence). This phenomenon was apparently 
temperature-dependent since the number of cap-forming cells, on 
incubation at O^C, was greatly exceeded by that at 57°C (Sedlacek et al, 
1976). This observation, therefore, raises the question as to whether 
cap formation constitutes the irreversible step in enterotoxin binding.
The mechanism involved in the lateral movement of enterotoxin 
receptor complexes across the membrane ^o form caps is entirely open to
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speculation at the moment. The capping process was found to be 
inhibited by substances, such as colchicine, which are knov/n to be 
inhibitors of the microtubule-microfilament system (Craig and Cuatre­
casas, 1975). Although these colchicine-binding, submembrane proteins 
are thought to be involved in translocation of surface proteins, it 
appears unlikely that gangliosides are directly linked to submembrane 
proteins since the hydrophobic portion of their structure, being only 
5 nm in length, is too short to span the membrane. Similarly, the 
polar group of the ganglioside is judged to be too small to contain more 
than one toxin-binding site, so that cross-linking of gangliosides via 
toxin molecules is equally unlikely.
Craig and Cuatrecasas (1975) considered that enterotoxin was 
at least bivalent and on these grounds suggested a possible capping 
mechanism. They suggested a specific association between erythrocyte 
ghost glycolipids and membrane proteins, and envisaged a similar effect 
with Gm^ ganglioside molecules. If this were so, a membrane protein 
with several associated ganglioside receptors would act as a single 
multivalent entity for toxin binding, and would allow lattice formation. 
They proposed that antitoxin could interfere with this process by 
reducing the effective valency of cell bound enterotoxin, thus preventing 
the rearrangement of ganglioside molecules within the membrane, which 
seemed to be necessary for adenyl cyclase activation.
However, it was also pointed out by Craig and Cuatrecasas (1975) 
that choleragenoid, which was unable to stimulate adenyl cyclase, was 
as efficient as enterotoxin in production of capping. It was therefore 
obvious that receptor cross-linking and rearrangement were not sufficient 
to initiate enzyme activation. Instead, the release of the relatively 
hydrophobic subunit A into the membrane and its subsequent interaction
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with adenyl cyclase was suggested as the remaining step essential for 
enzyme activation. Such an interaction between subunit A and adenyl 
cyclase seems probable from the results of Bennet, O’Keefe and 
Cuatrecasas (1975)* Gel filtration of solubilized, stimulated adenyl 
cyclase demonstrated the co-migration of the enzyme with the "active"
36k dalton enterotoxin subunit. It was also found that enterotoxin 
stimulated adenyl cyclase could be immunoprecipitated with either anti- 
enterotoxin or anti-"active" èubunit antibodies. Berkenbile and 
Delaney (1976) studied solubilised adenyl cyclase and also favoured 
the association of subunit A with the enzyme. However, stimulation of 
adenyl cyclase was unaffected by solubilisation in detergent when the 
entire enterotoxin molecule was present. Since the low level of adenyl 
cyclase stimulation produced after incubation of rat liver plasma 
membrane with isolated A subunits (also previously shown by Van 
Heyningen and King, 1975) was completely abolished in the presence of 
detergent, the authors suggested that some biological modification of 
subunit A might occur prior to enzyme activation by cell-bound entero­
toxin .
Bennet and Cuatrecasas (1975)» Craig and Cuatrecasas (1976) 
and Bennet ejt af (1976) discussed in detail the events preceding the 
activation of adenyl cyclase, The exact mechanism of enzyme activation, 
however, is still not fully understood.
Cholera enterotoxin and several hormones have the ability to 
increase intracellular levels of cAMP (Berry, 1975). This suggested 
that enterotoxin and such hormones may have a similar mode of action. 
Ledley ^  ^  (1976) demonstrated a degree of sequence similarity between 
the peptide chains of enterotoxin and several hormones known to 
activate adenyl cyclase and suggested that this may account for the 
similar metabolic effects of these proteins.
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Levinson and Blnme (1977) showed that, at least in the case of 
Prostaglandin (PGE^), the hormone need not have the same site of 
action to proauce the same effect, i.e. accumulation of cAI'IP. These 
workers presented the following model for guanine nucleotide regulation 
of adenyl cyclase(e )
GTP
GTPase
GTP enterotoxin
GDP
f
PGE,
V/hen GTP is bound to the guanine nucleotide regulatory site of adenyl 
cyclase, the enzyme is in a state of high catalytic activity.
When this site is unoccupied (E^) or filled with GDP (Eqjjp) the enzyme 
has little or no activity. GDP functions as an inhibitor by blocking 
the binding of the activator nucleotide (GTP). Thus the properties of 
the enterotoxin activated enzyme are due to the decrease in the 
conversion of E ^ ^  -+ E^^p, which normally occurs rapidly via a divalent 
cation-dependent GTPase. Secondary enzyme regulators such as PGE^ 
exert their influence on a different regulatory process, i.e. the 
affinity of GDP for the nucleotide regulatory site on adenyl cyclase.
It was found by both Parkinson et al (1972) and Grady, Keusch 
and Deschner (1975) that adenyl cyclase situated in the basal and 
lateral membranes of the brush border coulc be stimulated by enterotoxin 
bound to the mucosal surface. It was suggested that the stimulatory
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process did not talce place entirely within the membrane since the 
enterotoxin remains localised on the mucosal surface. Indeed it has 
been shown by several workers that components of the cell cytosol are 
essential for enzyme activation. Van Heyningen ejb ^  (1976) indicated 
that NAD, an unidentified macromolecular factor, and glutathione, which 
possibly facilitated the separation of A-j^ and A^ peptides, were 
essential for enzyme activation, Flores and Sharp (1976) implicated 
NAD and an unidentified cytosol component and noted the stimulatory 
effect of guanyl nucleotide and certain nonhydrolysable analogues of 
guanosine triphosphate on adenylate cyclase activity. These workers 
suggested the possibility, later elaborated by Levinson and Blume (1977), 
that enterotoxin acted on the guanyl nucleotide regulatory protein of 
the adenyl cyclase complex.
Further confirmatory evidence of the requirement for NAD in 
enzyme activation was presented by Johnson and Bourne (1977) and Martin, 
Housley and Kennedy (1977)* Moss and Vaughan (1977) found that entero­
toxin catalyses the conversion of NAD to ADP-ribose and nicotinamide, 
and that the production of nicotinamide was greatly enhanced by the 
presence of L-arginine methyl ester. These workers proposed, therefore, 
that enterotoxin-induced activation of adenyl cyclase involved the 
ADP-ribosylation of arginine, or a similar amino acid residue, in an 
acceptor protein.
The identity of the ADP-ribosylated protein has not been
determined, however the GTPase converting in the system of
U-JLir
Levinson and Blume (1977) offers one possibility.
As outlined by Holmgren and Lindholm (1976) (Plate 9) it is 
generally accepted that enterotoxin causes a build up of cAMP in the 
mucosal cell and this is thought to result in increased fluid secretion.
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Plate 5» A diagramatic representation of the cholera enterotoxin 
molecule and its cellular action.
(Holmgren & Lindholm, 1976).
The B subunits bind the toxin to the Gm^ ganglioside 
receptors on the cell surface. After a ”lag^* period 
the A subunit activates adenylate cyclase, resulting in 
increased cell production of cyclic AMP.
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However, Wu (1976) found in immunised animals, that despite a
suppression in the fluid secretion response there was still a maximum 
stimulation of mucosal cell adenyl cyclase. A small fraction of the 
intracellular cAMP pool was thought to he responsible for fluid 
secretion, and immunisation might prevent either the generation or 
mobilisation of this pool. The authors also suggested that their 
results could be explained if only a small population of the mucosal 
cells was responsible for the secretion. Thus protection of these cells 
from enterotoxin action could prevent secretion, although nearly 
maximum stimulation of the total mucosal adenyl cyclase mi^t be observed.
Field (1976) suggested that only crypt cells were active in 
secretion (see p. I6 ), and constituted slightly less than Q^P/o of total 
epithelial cell mass. Since 40^ 0 of the crypt cells are non-proliferative 
and secretory they would constitute less than 20% of the total epi­
thelial cells. Thus changes in the cAMP content of these cells might 
not be obvious from measurements on whole mucosa.
5* Biological Properties of Enterotoxin
A. Ileal Loop
Several biological properties of enterotoxin have been 
discovered which can be used for detection and assay. Among the most 
useful of these is its ability to induce fluid accumulation following 
injection into the intestine of experimental animals - a reaction which 
is thought to parallel closely the response of the human intestine to 
enterotoxin during infection. This fluid accumulation occurs after 
administration of both viable toxinogenic V. cholerae or active entero­
toxin.
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Fluid accumulation may be studied by the induction of 
diarrhoeic disease of infant rabbits (butta, Panse and Kulkarni, 1959) 
or infant mice (Pitkin and Actor, 1972) or by swelling in ligated 
segments of the intestines of experimental animals (ileal loops).
The latter technique was exploited mainly in the adult rabbit (be _et al, 
i960), although a variety of other species were examined (basu and 
Picket, 1969). Among the more useful were the dog ileal loop 
(Carpenter at I968) and the rat ileal loop (Aziz et al, I968).
By eliminating, as far as possible, the factors which led to 
variation in results, this technique was adapted to allow titration of 
enterotoxin (Burrows and Musteikis, I966; Kasai and Burrows, I966).
For example, it was noted that the variability in response to toxin in 
normal rabbits was minimised if 8 to 10 week old animals were used. 
Leitch and Burrows (I968) studied the area of the rabbit intestine best 
suited for this titration. The duodenum was most sensitive to exposure 
to enterotoxin^ however the rate of fluid accumulation in this area was 
not linear during the course of reaction and thus it was considered to 
be unsuitable. Sensitivity to enterotoxin in the lower ileum was found 
to exceed that in the upper ileum, while the colon was completely 
insensitive. This suggested that the lower ileum was the best site for 
assay. Other recommendations, such as careful washing of the gut 
segments before use (Aziz et al, I96B) led to an improvement in 
reproducibility.
This enterotoxin titration technique in its developed form 
(Kasai and Burrows, I966) involved injection of the material into 
ligated segments of the lower ileum and measuring the reaction at a 
constant time, usually 8 to 12 hr, after inoculation. The degree of 
reaction is quantified as the ratio of ml accumulated fluid/cm ligated
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segment, which, when plotted against the logarithm of the toxin concen­
tration, gives a typical sigmoid dose response curve. The points 
making up this curve should he averages of the results of at least 4 
loops, one in each of 4 animals - the accuracy of the result is not 
increased usefully hy numbers of animals greater than 8. The linear 
portion of the curve allows interpolation of a 50% effective dose 
(E.D.^q) - one unit of toxic activity being defined as the
The ileal loop technique may also be adapted for antitoxin 
titration (Kasai and Burrows, I966). Serial dilutions of antiserum 
are prepared and mixed with three units of a standard toxin preparation, 
at 57°0 for 30 min, before injection. The E.D.^q is determined, which 
corresponds to one unit of residual, unneutralised enterotoxin; thus 
where 2 toxic units have been neutralised. An antitoxic unit is 
defined as the amount of antibody capable of neutralising one unit of 
toxin.
B. Permeability Factor (P.P.. cholera toxin)
In addition to its enterotoxic properties, cholera toxin produces a 
number of other effects in tissues with which it does not come into 
contact during natural infection. Among these is its ability to 
increase the permeability of surrounding small blood vessels after 
intradermal injection into experimental animals such as rabbits and 
guinea-pigs (Craig, I965). A discrete area of firm swelling, whose 
diameter is related to the toxin dose, results from this increased 
permeability. Pontamine sky blue, a dye which binds rapidly to plasma 
proteins, particularly albumin, has been used extensively to study this 
reaction, since on intravenous injection the substance is rapidly 
extravasated at sites of increased permeability. The diameter of the 
blueing reaction following intradermal injection of toxin is always
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slightly smaller than the diameter of visible swelling; both 
parameters are thought to be equally satisfactory for toxicity 
titrations. However the increase in permeability, as a zone of
4
blueing, is used to avoid confusion which might arise where cholera 
toxin preparations are contaminated with endotoxin. Endotoxin would 
result in redness and induration but have no effect on vascular 
permeability.
Although the earlier studies of Craig (1965) suggested that 
the diameter of the blue lesion was linearly related to the logarithm 
of the toxin dose, in the 5 to 12 mm range, later work (Craig, 1968) 
indicated that the dose-response was curvilinear. However, within the 
limits of 6 to 8 mm diameter lesions the curve was found to have only 
a very gradually increasing slope, which, for practical purposes, may 
be regarded as a straight line. The toxin dose eliciting a mean 
diameter of 7 mm in the rabbit is designated one blueing dose (or 1 B.b.). 
However due to the marked interanimal variation in P.E. sensitivity, 
which can be up to 16-fold in pairs of rabbits, it is essential that a 
reference cholera toxin preparation of assigned potency be titrated in 
every test animal. For assay purposes the distance between the dose 
response lines elicited by the reference preparation and the test 
material, at the 7 mm diameter level, may be taken as a reflection of 
relative potency, providing that the lines are parallel. By carrying 
out all tests with replicate injections at randomised sites, the 
combined error of interanimal variation, injection technique and reading 
is minimised.
A more accurate assay technique has evolved, however, 
involving the neutralisation of toxic ‘activity. This has the advantage 
of rendering the skin response specific for cholera toxin by
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demonstrating its neutralisation by cholera antitoxin. The use of an 
antitoxic rather than a toxic unit of reference is also better because 
of the greater stability of antitoxin preparations in comparison with 
cholera toxin preparations.
For such toxin-anti toxin titrations, serial dilutions of 
toxin are mixed with equal volumes of antitoxin, which contain either 
1 or 1/3 A.TJ./ml. The mixtures are incubated at 37^0 for 1 hr before 
intradermal injection in 0.1 ml volumes, thus giving either 1/20 or 
1/60 A.U. per injection site. In this way a neutralisation curve may 
be constructed, which is sigmoid in shape, and the straight line 
portion of which proves to be highly reproducible. Since a 4 imn 
diameter of blueing reaction represents the approximate midpoint of 
the straight line portion, and therefore the most reproducible point, 
the toxin dose yielding this reaction was arbitrarily designated as 
the end-point in such titrations.
The limit of blueing (Lb) dose of cholera toxin is defined as, 
"The Lb dose of the PF is that amount of PF which, when mixed with one 
unit of antitoxin and injected intradermally into experimental rabbits, 
evokes, on average, an area of increased vascular permeability 4 mm in 
diameter, provided the toxin-antitoxin mixture is injected in a total 
volume of 0.1 ml." The Lb values thus obtained are highly reproducible, 
variation in titrations being as low as 1.25 fold, which is in 
favourable contrast to the high degree of variability in response to 
toxin alone. Where an injection site has received 1/20 or I/6O A.IT. 
the toxin potency is expressed as the corresponding fraction of the Lb 
dose, in other words Lb/20 or Lb/60 respectively.
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G. Are Enterotoxin and Permeability Factor Identical?
Since the production and purification methods, as well as 
observations on stability, apply equally to the enterotoxin, and the 
intradermal permeability factor, it was assumed that the two 
activities were different properties of one toxic entity. In general, 
the two activities were inseparable even with highly purified forms of 
enterotoxin. Two notable exceptions to this generalisation, however, 
were the studies of Lewis and Freeman (I969), who reported the complete 
separation of PF and enterotoxin, and of Grady and Chang (1970) who 
were apparently able to completely isolate enterotoxin, although their 
PF preparation retained enterotoxin as a contaminant.
More recent evidence has tended to contradict the finding 
of these latter workers by supporting the conclusion that only one 
toxin molecule exists. For example, Holmgren et ^  (I97I) found that 
the toxin active as PF in the intradermal test produced a reaction of 
identity in double diffusion gels with the toxin causing cholera-like 
symptoms in experimental animals. This strongly suggested that a 
single toxin molecule was active in the two different experimental 
systems. A similar conclusion was reached by Mosley at ^  (l970a) 
who titrated three different toxin preparations against a variety of 
hyperimmune antitoxic sera. In each case identical end points with 
both skin and ileal loop tests were found. These workers considered 
that two independent antigens were unlikely to produce almost identical 
titres, in each of the sera tested, and suggested that the two assay 
systems were measuring the same antigen-antibody reaction.
Curlin, Mosley and Greenough (1975)» in addition to the ileal 
loop and skin assays, employed the fat cell assay (see p. 54 )•
Although the sensitivity of the three assay systems differed, these 
workers found that the antibody titres of various sera tested against
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several toxin preparations, were very closely related in each of the 
three assays. Curlin et al (1975) suggested that one toxin molecule 
could quite conceivably be responsible for these apparently different 
activities, if each was the result of a common mechanism - that of 
increasing intracellular cAMP concentrations.
D. Eat Foot Oedema
Finkelstein, Jehl and Goth (19&9) found that injection of 
enterotoxin into the foot pad of the adult rat, resulted in a reaction 
analogous to that associated with intradermal injection of PF. An 
increase in vascular permeability in the rat foot resulted in a marked 
oedema. The extent of the reaction was measured by immersing the 
foot in mercury and noting the displacement, from which it was noted 
that the reaction reaches a peak around 24 hr. This experimental 
system was related to the intestinal toxic activity since it was 
inhibited by cycloheximide, which also inhibited fluid accumulation in 
rabbit ileal loops. This technique was also used successfully 
(Finkelstein and Hollingsworth, 1970) as a means of evaluating the 
immunogenicity of several potential antitoxic vaccine preparations.
E, Lipase Stimulating Factor
Another biological activity of enterotoxin is its ability to 
induce the release of glycerol and free fatty-acids from viable fat cells 
(Greenough, Pierce and Vaughan, I970). The resultant increase in 
intracellular cAMP levels on incubation with enterotoxin at 57^0 is 
responsible for the release of these substances. The increase in cAMP 
concentration results in the stimulation of intracellular lipase 
activity which in turn leads to the liberation of glycerol and free fatty 
acid. This lipase-stimulating activity may be abolished by prior
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incubation with antitoxic serum, which supports the proposal that 
there is only one toxic entity. Curlin e_t ^  (1973) presented a 
detailed assay technique for enterotoxin, utilising the lipolytic 
reaction,
IV. IMMimOLQGY OF CHOLERA
1. Antibacterial Immunity
A. Antibody Response to Infection
An increase in the serum levels of both vibriocidal and 
agglutinating antibodies, in response to infection with V. cholerae has 
been shown by several groups of workers. Sack et al (1966) demon­
strated peak antibody titres 8 to 10 days after the onset of symptoms, 
and a gradual decrease of both vibriocidal and agglutinating titres 
during the subsequent 6 weeks. After 2 to 7 months, the vibriocidal 
antibody titres were reduced to their level at the onset of disease, 
whereas the agglutinating antibody titres remained slightly higher. 
McCormack et al (I969) reached similar conclusions and stated that the 
fall in titre to baseline antibody levels was more marked, within 5 
months of infection, in children under the age of 4 years, than in an 
older group of children up to I4 years.
An increase in serum antitoxin levels was also found after 
cholera infection. Pierce et al (I970) reported that the antitoxic 
titre in convalescent cholera patients remained elevated for at least 
12 to 18 months, as compared with the rapid fall in vibriocidal antibody 
titres within 5 months.
Woodward (1971) after a study of cholera reinfections in 
Bangladesh, concluded that the duration of immunity derived from cholera 
infection was short, especially in persons whose subsequent reinfection
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was due to the heterologous organism. He also stated that the risk of 
reinfection with V. cholerae was probably only slightly less than the 
risk of initial infection.
B. Antigens Associated with Antibacterial Immunity
The idea of immunisation with whole V. cholerae was introduced 
as early as I884 by Ferran, who employed a live cell vaccine. Haffkine 
(I894) carried out more extensive immunisation studies with what he 
believed to be a live, attenuated V. cholerae vaccine. His results 
demonstrated that immunisation with V. cholerae could lead to immunity 
to infection (cited from Cvjetanovic, 1975)*
After the field trials of cholera vaccines in Bangladesh and 
the Philippines, the value of immunisation against cholera was firmly 
established. With this in mind, many attempts were made to isolate 
the protective antigen(s) from the vibrio cells with a view to vaccine 
production. The vaccines used in the field trials were killed whole 
cell vaccines which elicited both vibriocidal and agglutinating 
antibodies, but obviously were incapable of inducing production of 
antitoxin. Studies by Mosley, Benenson and Barui (I968) and Mosley 
et al (1968b) revealed a correlation between the decrease of cases and 
the increase of vibriocidal antibody titres; the doubling of the 
vibriocidal titres after vaccination was associated with a 50% decrease 
in the case rate, in a cholera endemic region of Bangladesh. There 
was a linear relationship between vibriocidal and agglutinating 
antibody titres in sera from acute and convalescent cholera patients, 
as reported by Barua and Sack (I964) and Sack et ^  (1966). Thus cell 
fractions capable of reproducing the effect of the whole cell vaccines 
in elevating vibriocidal and agglutinating antibody titres would be 
potentially important as immunogens. This is particularly true since
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the potency of whole cell vaccine is dose-dependent, and the dose is 
limited by the inherent endotoxic properties of the preparation.
Several purified antigens which stimulate the production of 
agglutinating and vibriocidal antibodies have been reported. Pant and 
Shrivastava (I96O) obtained two fractions of purified polysaccharide, 
neutral and acidic, from agar grown cholera vibrios by phenol-water 
extraction followed by fractionation with cetyl-trimethyl-ammonium 
bromide. These fractions were apparently homogeneous with regard to 
electrophoretic mobility and Ouchterlony gel diffusion. Antiserum at 
high dilution (10 could precipitate these fractions. Several 
purified polysaccharides of Ogawa, Inaba, non-cholera and eltor vibrios 
were prepared by Kaur and Shrivastav (I964)» by extraction of cells 
with 0,5% phenol, followed by acid precipitation, co-precipitation with 
GaPO^ and cold acidic 8N HCl alcohol. These preparations were found 
to contain approximately 0.8 to 2.4% total nitrogen and 55 to 70% 
polysaccharide. They gave a single precipitin band in Ouchterlony 
gel diffusion tests (Kaur and Shrivastava, 1965).
Similarly Gallut (I965) extracted cell-wall antigens from 
classical, eltor and non-cholera vibrios, by heating the autolysed vibrio 
suspensions at 100°C for 2 hr, and subsequently dialysing before 
chloroform and alcohol precipitation. A polysaccharide fraction was 
obtained by phenol extraction, and this produced one precipitin band in 
Ouchterlony gel diffusion tests. Watanabe and Verwey (I965) prepared 
an LPS fraction from the culture supernate of an eltor Ogawa organism, 
which was homogeneous in the ultracentrifuge and electrophoretically. 
Verwey at ^  (I965) prepared a Boivin anti^n-type material, from 
sonicated Inaba cells, which contained two antigens one of which was 
heat-labile. Yoshioka et al (1970) reported the isolation of a
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fraction, from mildly sonicated eltor vibrios, which was composed 
mainly of polysaccharide with only a trace of protein, and which was 
mouse-protective.
Although these various preparations were obtained by different 
techniques, several similarities emerged. For instance, all the 
preparations contained heat-stable and non-dialysable polysaccharide 
(or lipopolysaccharide) analogous to the type 1 toxin of Burrows* 
classification. These preparations were capable of stimulating the 
production of vibriocidal and agglutinating antibodies in either man or 
experimental animals.
Pittman and Feeley (1963) supported the use of classical 
cholera vaccines, based on their finding that the mouse protection 
afforded by five commercial vaccines following challenge with eltor 
vibrios, was as good as that against the classical cholera vibrio of 
the same type. A similar, comparable cross-protection between classical 
and eltor vibrios belonging to the same type was observed by Watanabe 
and Verwey (I965) when a purified Ogawa LPS was evaluated by the same 
mouse protection test.
There has, however, been a great deal of controversy during 
this pandemic concerning the incorporation of both the Ogawa and Inaba 
types of biotype eltor into cholera vaccines. The evidence obtained, 
from the preceding study of cell fractions, indicated that the cell-wall 
antigens, which do not differ between classical and eltor V. cholerae, 
played a crucial role in human antibacterial immunity. The antigenic 
determinants, AB(c) of the Ogawa and AC of the Inaba 0-specific poly­
saccharides, seem to be the key antigenic determinants for protection, 
although the oligosaccharides of each determinant have not been clarified 
yet. The common antigen. A, of the Ogawa vibrio seems to be weaker
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than the common antigen of the Inaha organism in stimulating vibrio­
cidal and agglutinating antibodies in the rabbit and in protecting 
the mouse against heterologous Inaba vibrio challenge.
On the other hand, the common antigen of the Inaba vibrio, 
stimulates appreciable levels of antibody and protection against 
heterologous Ogawa vibrio challenge. This is confirmed by results 
obtained in field trials of monovalent vaccines. Mosley et ^  (l970b) 
found that immunisation with a monovalent Ogawa vaccine did not 
stimulate the production of protective vibriocidal antibodies against 
Inaba infection in children in Bangladesh. However during the 
Philippines field trial an Inaba monovalent vaccine was found to confer 
cross-protection against Ogawa infection in children of a similar age 
group to those in the previous report (Philippines Cholera Committee, 
I973&)" It was suggested that these results supported the conclusion 
of Shrivastava (I965) that the use of the Inaba vibrio for the 
manufacture of cholera vacciïie should be adequate. However there were 
reservations about the possibility of monovalent vaccines enhancing 
antigenic shift, as had been demonstrated by Sack and Miller (I969) 
in experimental animals.
In addition to the cell-wall antigens containing polysaccharide 
or LPS, Heoh and Rowley (1970) isolated a protein antigen from the 
cell-wall of a classical Inaba strain. This antigen was extracted 
with phenol-water followed by alcohol precipitation. The final protein 
fraction contained a small amount of carbohydrate; the protein:carbo­
hydrate ratio was 10.7:1.0. The authors found that the antigenic 
specificities, against which vibriocidal antibodies were directed, were 
contained in the stable polysaccharide determinants of LPS and in a 
protein associated with them. The anti-protein antibodies, in terms of
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weight of antihody-protein, were at least as effective as the anti-LPS 
antibodies in the vibriocidal antibody assay system used. This 
protein component could be isolated from both Inaba and Ogawa strains, 
which suggested its possible usefulness as a "universal" cholera 
vaccine, protective against all serological types.
In a subsequent publication Heoh and Rowley (1972) evaluated 
three types of protective antibody, which corresponded to anti-LPS, 
anti-protein and anti-choleragen, in the infant mouse system of Ujiiye 
et al (1968). They showed that antibacterial immunity, against either 
the LPS or the protein antigen, was achieved with a smaller amount of 
antibody (approximately 2.0 pg per 50% protective dose) than that 
required for an antitoxic immunity (more than 40 pg of antibody protein).
2. Antitoxic Immunity
There are various lines of evidence, mainly from studies in 
experimental animals, which suggest the importance of antitoxic immunity 
in V. cholerae infection. Finkelstein (I965) showed that antitoxin was 
capable of neutralising the toxic effect if enterotoxin and antitoxin 
were mixed before being fed to rabbits. Further studies by Kasai and 
Burrows (I966) led to the development of the ileal loop method for the 
titration of cholera antitoxin, since their studies verified the 
abolition of fluid accumulation in the rabbit intestine if enterotoxin 
and antitoxin were mixed before injection. This method was useful in 
the study of serum antitoxic responses either in human beings or 
experimental animals after immunisation with cholera vaccines, or in the 
parallel response in man to natural infection (Mosley and Ahmed, I969).
Such studies only demonstrated that a toxin-antitoxin 
reaction, capable of neutralising enterotoxin activity, could occur 
after mixing the two in vitro. Could this neutralisation reaction occur
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naturally in the gut? This question was partly answered by Finkelstein 
and Atthasampunna (I967) who demonstrated that parenteral immunisation 
with a preparation of enterotoxin induced immunity to ileal loop 
challenge of rabbits, with either enterotoxin or viable Y. cholerae.
The enterotoxin preparation used in this work still contained traces of 
somatic antigen which might have been responsible for protection. 
However, Finkelstein (1970) stated that the same immunity to challenge 
was obtained where purified enterotoxin, or choleragenoid, was used 
to immunise the rabbits, and where a significant antibacterial antibody 
response was absent.
Later experiments by Pierce, Kaniecki and Northrup (1972) in 
which dogs were immunised with purified enterotoxin left no doubt that 
protection against live vibrio challenge could be achieved by a purely 
antitoxic immune response. Logs immunised parenterally with purified 
enterotoxin in an adjuvant mixture had elevated titres of antitoxin in 
their serum for 18 months, and were protected against challenge with 
viable V . cholerae for up to 10 months. However, parenteral 
immunisation with formalinised toxoid or choleragenoid gave lower titres 
of antitoxin, and protection of only 5 months duration. Also dogs 
previously immunised with formalinised toxoid were given oral doses of 
toxoid after antibody titres due to parenteral immunisation had 
subsided. Although no rise in serum antitoxin occurred, the animals 
were once again highly protected against challenge with viable
V. cholerae. Ho such protection was achieved after oral administration 
of toxoid to dogs which had not been previously immunised parenterally.
Other investigations into the value of oral or intraintestinal 
immunisation procedures in inducing a protective antitoxic immunity in 
experimental animals were carried out. For example, Bhattacharya, 
Harayanaswan and Mukerjee (I968) found that after intraintestinal
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immunisation of rabbits with an apathogenic eltor strain, and challenge 
with toxin 10-12 days later in ligated intestinal loops, there was a 
significant decrease in fluid accumulation compared to loops in control 
animals.
Also Burrows, Kaur and Cercaviski (1971) and Kaur, Burrows 
and Furlong (I97I) induced immunity to toxin challenge in rabbits 
immunised with crude enterotoxin by both the parenteral and intra­
intestinal routes; the results indicated that the parenteral route was 
superior. Holmgren £t al (1972) found, however, that subcutaneous and 
intraintestinal immunisation gave approximately the same level of 
resistance to ileal loop challenge with enterotoxin, at least after two 
administrations of the antigen. In this capacity enterotoxin was a 
better immunogen than formalin-induced toxoid and much better than 
choleragenoid.
In experiments with highly purified, antigenic derivatives 
of enterotoxin (i.e. choleragenoid, procholeragenoid and formalin 
toxoid) Fujita and Finkelstein (1972) showed that mice fed single 
moderate doses of these antigens developed resistance to intraintestinal 
challenge with live vibrios, or lethal intravenous challenge with 
enterotoxin. The purity of the antigens used, apart from the formalin 
toxoid, appeared to rule out antibacterial immunity as an important 
component in protection of the mice challenged intraintestinally with 
live vibrios.
There are several indirect lines of evidence which suggest the 
importance of antitoxic immunity in protection of human beings. For 
example, studies by Burrows at ^  (l97i) ori serum antitoxin levels in 
asymptomatic cholera carriers indicated that about 80% of bacteriology 
ically positive carriers had antitoxin levels comparable to those found 
in convalescent cholera patients shortly after recovery.
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Martin, Vernon and Mosley (I969) using a skin test with 
enterotoxin, in an analogous manner to the Schick test for diphtheria, 
were unable to demonstrate any correlation between results of skin tests 
and the likelihood of developing cholera in family contacts. Although 
these results seem to imply that naturally acquired antitoxic immunity 
plays little or no role in protection against cholera, it is also 
possible that the levels of antitoxin measured may have been too low 
to contribute significantly to immunity. The latter possibility 
correlates with the results of Pierce ejt al (1972) who found little or 
no protection of dogs unless their antitoxin titres were at a fairly 
high level.
The few available results from toxin/toxoid immunisation of 
human beings include those of TJngar et al (1970) who found that 
immunisation with a relatively pure enterotoxin preparation stimulated 
low titres of agglutinins and vibriocidal antibodies, so that the 
protective effect, if any, of the low levels of antitoxin produced could
not be assessed if such a preparation were used in the field. An AlPO.
4
adjuvant used with this preparation was found to increase titres of 
agglutinins and vibriocidal antibodies while having no effect on anti­
toxin levels. The authors showed that parenteral injection of entero­
toxin into human beings was well tolerated, and suggested that vaccination 
should be done with toxoid stabilised with formaldehyde.
One formalinised toxoid of low somatic antigen content was 
tested in man for antigenicity and safety (Verwey at al, 1972; Hornick 
et al, 1972). However, unexpected delayed-local reactions, apparently 
due to partial reversion of the toxoid to active enterotoxin at the 
injection site (Northrup and Chisari, 1972), prevented evaluation of its
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antigenicity at adequate dosage levels. Hornick et al (1972) found 
that immunisation of human volunteers with this product led to 
protection, at least against severe, potentially life-threatening 
diarrhoea induced by challenge with viable V. cholerae. This 
protection could not confidently be ascribed to the antitoxic immunity 
(a) because of the relatively small number of volunteers and (b) because 
of the borderline vibriocidal antibody titres stimulated by this product.
5* "Location" of Immunity
During the course of the cholera infection V, cholerae is 
localised within the intestinal lumen and enterotoxin is capable of 
penetrating the tissues only as far as the epithelial cells of the 
intestine. Thus, any protective immunological reaction must also take 
place within the confines of the intestine. However, it is unclear 
whether the antibodies involved in such a protective reaction are 
synthesised locally in the intestine or whether they are transported 
from the serum. Experiments testing the protection of either 
experimental animals or human beings during field trials do not 
generally permit a differentiation between local and systemic immune 
mechanisms stimulated by active immunisation, since both seirum and 
copro-antibodies may be elicited simultaneously. Ahmed, Bhattacharjee 
and Mosley (1970) pointed out that serum vibriocidal antibody levels 
may be correlated with levels of protection, only because they are a 
direct reflection of the presence of intestinal antibodies,
A. Protective Activity of Serum Antibodies
Evidence that serum antibodies may play an active role in 
protection against cholera has come from several sources. Finkelstein
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and Hollingsowrth (1970), using rat foot oedema as an indicator of 
biological activity of enterotoxin, found that resistance could be 
transferred passively by antibody-containing serum from previously- 
immunised rats. Holmgren at ^  (1972), using the ileal loop technique, 
demonstrated that intravenous administration of antitoxin to non­
immunised rabbits was capable of conferring some resistance to ileal 
challenge with enterotoxin - a result which bore more relevance to 
natural human infection.
Pierce and Reynolds (1974) agreed with the previous observations 
on the possible protective role of serum antibodies. These workers 
studied the protective role of antitoxic IgG in dogs transfused with 
either whole plasma or purified serum IgG from hyperimmunised dogs.
They found that IgG antitoxin could be recovered in washings from jejunal 
loops in non-immunised, plasma-transfused dogs, and also that dogs were 
protected against intrajejunal challenge with enterotoxin. They were 
also able to show that dogs transfused with antitoxic IgG were highly 
protected against orogastric challenge with viable V. cholerae.
B. Protective Activity of Intestinal Antibodies
There is also a substantial amount of evidence which suggests 
that if an immune response to cholera is to be effective, antibacterial 
and antitoxic antibodies must be available in the intestine to neutralise 
an invasion by V .  cholerae.
As early as 1947» Burrows, Elliott and Havens suggested the 
importance of copro antibody in cholera infection, by studying the 
relation of copro antibody titre and numbers of V .  cholerae secreted by 
experimental animals. Jenkin and Rowley (196O) also predicted the 
importance of a defence mechanism against V . cholerae, involving 
antibody and macrophage, in the gut. Mosley and Ahmed (I969) showed
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that unless enterotoxin was rapidly neutralised by excess antitoxin 
present in the intestine, fluid accumulation occurred in ileal loops. 
Thus under natural conditions it would appear that antitoxin,to be 
effective, must be present in the intestine to neutralise enterotoxin 
in the short interval between its release from the vibrio cell and its 
binding to the epithelial cell membrane.
It is also known that anti-bacterial antibodies in the
A
intestine are capable of decreasing the a/sorption of vibrios to the 
intestinal wall of rabbits (Preter, 1970). Schrank and Verwey (1976) 
showed that the villi and intervillous spaces in the rabbit intestine 
were covered by a layer of mucoid material, which formed a zone between 
the intestinal contents and the tips of the villi (see Fig 2). In 
normal animals the onset of fluid accumulation was concomitant with 
the establishment of large masses of organisms in the intervillous 
spaces and crypts of the intestine, after the successful penetration 
of this mucus zone. However, with animals immunised with a cell-wall
antigen of V, cholerae, the bacteria were clumped and restricted to
L
distribution in the lumen and luminal border. These results implied 
that antibacterial antibodies, if they are to cope with infection, must 
be present inside the intestine.
Other studies by Kaur et ^  (1971) and Kaur, McGhee and 
Burrows (1972) implicated tissue-associated antibodies in immunity to 
cholera, at least in rabbit ileal loops. The intestinal epithelium of 
rabbits, immunised either intraperitoneally or intraintestinally, was 
separated into crypt and villus cell fractions, and the enterotoxin- 
neutralising antibody content of ultrasonic lysates of these cells was 
assayed. Antibody was found primarily in the crypt cells, while villus
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cells contained only small amounts of antibody later in the immune 
response. The finding of such tissue-associated antibodies was 
consistent with the idea that antibodies might be present continuously 
at the site of infection, in the intestine, without being subject to 
the enzymic degradation processes going on in this region. The results 
of Kaur ^  ^  (l9?l) were substantiated by Pierce and Reynolds (1974) 
who found that protection in dogs, against intrajejunal challenge with 
enterotoxin, was not diminished by extensive washing of the jejunum 
prior to challenge.
The preceding reports demonstrated that antibodies produced 
in the serum in response to immunisation were capable of passing into 
the intestine and intestinal tissues where they could best afford 
protection against V, cholerae infection. Recent studies by Pierce 
and Gowans (1975) suggested that coproantibodies m i ^ t  be produced, in 
response to immunisation with choleragenoid, independently of serum 
antibody production. These workers found that dogs could be protected, 
for up to 8 months, against orogastric challenge with viable V. cholerae, 
in the absence of a lasting elevated level of serum antitoxin titres.
In this case, therefore, protection was not associated with antibodies 
derived from the serum. This work established that a coproantibody 
response could be entirely responsible for protection against cholera. 
However, it is still unknown whether serum antibodies can protect 
against naturally-acquired cholera. On the one hand there are workers 
(pierce and Reynolds, 1974; Schrank and Verwey, ' 1976) who found that 
passively administered serum antibodies, either antitoxic or anti­
bacterial, were capable of protecting experimental animals against 
intraintestinal challenge. On the other hand Holmgren ^  ^  (I975h)
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suggested that, with enterally administered enterotoxin, only locally 
produced antibodies were protective. The question remains to be 
resolved.
C. Antibody Classes Involved in Immunity
Over the past few years the classes of antibody produced in 
response to cholera infection, and their location in the body have been 
revealed. In general, serum antibodies were IgM in the primary response 
and IgG in the primary and secondary responses; however, XgA stimulation 
was noted particularly in association with the intestine.
Merrit and Sack (1970) and Feigner, Bucken and Richter (1975) 
studied the sensitivity of serum immunoglobulins to 2-mercaptoethanol 
(2-ME), after natural infection and after cholera vaccination. The 
former workers examined acute and convalescent cholera sera and found 
2-ME sensitive antibodies in acute phase sera, while in convalescent 
sera and sera from patients demonstrating a secondary immune response 
the antibodies were mainly 2-ME resistant. The latter workers obtained 
evidence to support the view that in non-endemic countries 2-ME 
resistant vibriocidal antibodies reflected antibacterial immunity 
against cholera, following vaccination, more than did the total vibrio­
cidal activity. In endemic areas Mosley ^  ^  (1969b) demonstrated 
that vibriocidal activity paralleled protective activity. Feigner et al 
found that 2-ME resistant antibodies persisted no longer than 6-9 months 
in 50% of vaccinees despite frequent revaccinations at 6-8 monthly 
intervals.
This work indicated the importance of serum IgG levels in 
determining resistance to cholera infection. Pierce and Reynolds
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(1974) suggested that serum IgG was protective since they found that 
dogs transfused with IgG antitoxin were highly protected against 
orogastric challenge with viable V. cholerae. However, Northrup, 
Bienenstock and Tomasi (1970) found secretory IgA together with 
significant amounts of IgA material of the size of serum IgA and 
smaller, as well as IgG and I^, present as molecular fragments, in 
cholera stools. They suggested that these immunoglobulin fragments 
were probably the result of enzymatic degradation of the antibody 
molecules after their secretion into the ^t.
Mostly IgA has been the immunoglobulin found in the stools of 
cholera patients and in the intestine of experimental animals. Sasaki 
et al (1970) found IgG and I ^  in the sera, and IgA in the intestinal 
walls and intestinal contents of germfree mice monocontaminated with 
V. cholerae. Waldman e;t al (197I) and Waldman et ^  (1972) studied 
human cholera patients in an endemic area, and found elevated mean 
levels of IgG, IgM and most markedly IgE in their sera, compared to the 
mean levels detected in Europeans. IgA was the predominant class of 
immunoglobulin in samples from faeces and intestinal contents. The 
elution pattern from Sephadex G-200 and the association with secretory 
component was indicative of secretory IgA. The levels of serum IgA 
rose significantly in cholera patients during convalescence.
Steel, Chaicumpa and Rowley (1974) isolated three classes of 
antibody from rabbits immunised with V. choleraé. IgG and I ^  were 
isolated from the sera of animals inoculated parenterally, while IgA 
antibodies in intestinal washings and colostrum were found only where 
oral immunisation was used. The preparations of IgA contained little 
complement-mediated vibriocidal or opsonic activity. However when
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studied in the infant mouse lethality test this IgA was considered, 
on the basis of weight, to protect as well as IgG or I^.
Kaur et al (1972) studied ultrasonic lysates of intestinal 
epithelial cells of rabbits immunised by the intraperitoneal or intra­
intestinal routes. The intracellular antibody appeared to be almost 
exclusively IgA. Pursuing a similar line of investigation, Pierce and 
Gowans (1975) found mainly IgA in the antitoxin-containing cells in 
the lamina propria of rats immunised with choleragenoid.
V. CHOLERA VACCINES
1. Standard Vaccine
The cholera vaccine now in use is a saline suspension
containing 8 x 10^ killed vibrios/ml. The killing and preserving
agent used is commonly phenol, although formaldehyde, organic mercurials 
(e.g. thiomersal), or mild heat (56°C for $0 min) may be employed.
The vaccine is bivalent, containing equal numbers of the Ogawa and Inaba 
serotypes.
Two doses of 0.5 ml and 1.0 ml are given to adults (O.I-O.3 ml
for children under the age of 10 years) by the subcutaneous or intra­
muscular route. In epidemics, however, single 1.0 ml doses are used 
for mass immunisation, and may be almost as effective as the two-dose 
regime in an endemic area.
The immunity induced by this vaccine is of short duration, 
persisting for no longer than 6 months. The dosage can not be increased 
since concentrations greater than 8 x 10^ cells/ml tend to produce 
local tenderness, and less frequently lead to a slightly more severe 
reaction, lasting for several days (Peeley, I970) .
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2. Experimental Vaccines
A number of controlled field trials have been done during the 
present cholera pandemic to study the efficacy of whole cell vaccines. 
These vaccines differed in content and concentration and the vaccination 
schedules varied. The studies were made mainly in Bangladesh, where 
the greatest proportion of cases was due to infection with the Inaba 
serotype, and in the Philippines where cholera was due almost exclusively 
to the Ogawa serotype. Cholera is endemic in both of these regions, 
however in Bangladesh classical and eltor vibrios are equally prevalent, 
while eltor vibrios are almost entirely responsible for cholera 
infection in the Philippines. Table 1 outlines the vaccines used in 
these field trials. The efficacy of the vaccines was judged from the 
percentage of vaccinees who did not contract the disease within the 
stated period of observation.
As a result of these studies, a number of important factors, 
pertinent to cholera vaccination programmes, have come to light 
"Cholera vaccines prepared from only classical V. cholerae protect 
against eltor infection"
During the field trials in the Philippines, where eltor 
vibrios were responsible for infection, it was noted that both classical 
and eltor bivalent vaccines conferred protection to 50% of vaccinees, 
for up to two months. The immunity derived from the classical vaccine 
declined more rapidly than that with the eltor vaccine, which suggested 
that the use of the strain homologous to the infecting strain was 
preferable. However, a classical bivalent vaccine incorporated in an 
oil-adjuvant gave levels of protection above 0^% for 6 months at least, 
in the same trial. Unfortunately this vaccine could not be recommended
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for practical use because of severe reactions in approximately 2^ o of 
vaccinees (Azurin et I967). As yet no field trial has provided 
information on the protection derived from eltor vaccines against 
classical cholera infection,
"The Inaba serotype induces protection against infection with the 
heterogolous as well as the homologous strain”
When monovalent Ogawa and Inaba whole cell vaccines were used 
in the Philippines (1970-71), against Ogawa infection, it was found that 
the Inaba vaccine afforded protection which was not significantly less 
than that resulting from the Ogawa vaccine. These vaccines protected 
60-'JCP/o of the vaccinees for up to 7 months, which was surprising 
(Philippines Cholera Committee, 1973&) since the previously studied 
bivalent vaccines had offered maximum protection for only 3 months post 
vaccination. However, in the O-4 year age group, wliioh is the group 
at highest risk of infection in endemic areas, the homologous Ogawa 
vaccine seemèd to be more effective than the heterologous Inaba vaccine.
These two vaccines were also used in Bangladesh (I968-69) 
against Inaba infection. In this case the Inaba vaccine was far 
superior in eliciting protection (approx 84%) than was the Ogawa vaccine 
(approx 48%) ' The Ogawa vaccine failed to protect children under 
5 years, and the cross-protection it produced in older children was 
thought to be due to the boosting of their naturally acquired immunity 
(Mosley et 1973) • The latter observation probably explains why 
the Inaba vaccine was less effective than the Ogawa vaccine in the 
0-4 year age group studied in the Philippines.
Sack and Miller (I969) pointed out that monovalent vaccines 
carry the risk of enhancing antigenic shift in the infecting strain.
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This together with the fact that it is advantageous to vaccinate the 
high-risk under five-year-olds with the homologous strain, precludes 
the use of a monovalent Inaha vaccine.
It was also pointed out by Sinha and Bhaskaran (1975) that 
immunity against V .  cholerae was strictly serotype specific. Two 
different serotypes were used for the immunisation of rabbits and 
for their ileal loop challenge. Cross protection was only evident 
between Ogawa and Inaba subtypes of serotype X. Bivalent serotype I 
vaccine was found to confer protection against both subtypes, although 
immunity to Inaba infection was of shorter duration than to Ogawa 
infection,
"Older members of a cholera endemic community are immune by virtue of 
their constant exposure to the cholera antigens"
Throughout the field trials on cholera vaccination, it was 
noted that the highest infection rates occurred in young children. In 
older people, however, constant exposure to V ,  cholerae resulted in the 
build up of a naturally acquired immunity which was boosted by cholera 
vaccination. The older group therefore derived greater levels of 
protection from vaccination,
Azurin et al (I967) found that the vaccines used in the 
Philippines (I964) produced poor levels of protection in the youngest 
age group (6 months - 9 years) but fairly high levels in the oldest age 
group (over 25 years)% however, both these groups had higher attack 
rates than the intermediate age group (10-25 years) • Lowering of the 
body's natural resistance to infection by factors such as poorer 
general health, probably accounted for the higher infection rate in 
the over 25 year age group.
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"Children are likely to withstand higher dose levels of whole cell 
cholera vaccine, without adverse reaction, than are their adult 
counterparts"
Benenson et ^  (1968a,h) reported results of studies in 
Bangladesh on a whole cell vaccine of particularly high mouse protective 
potency (see p. 72 ). Belayed reactions to this vaccine, although not 
severe, were noted in adults 4-7 days post vaccination. Children, 
however, were free of adverse reactions. The fact that children could 
withstand higher vaccine doses was interesting since, as previously 
mentioned, this age group probably require a larger dose than adults, 
for maximum protection,
"Bosage of cholera vaccine administered to adults is of little 
importance"
The Philippines Cholera Committee (I96B) studied the effect 
of concentration of bivalent eltor cholera vaccine, and the number of 
applications, on the resultant levels of protection over the following 
6 months. Their results are shown below.
vaccine number of cells per ml Bo, of vaocinees percentage 
group 1 ml doses of vaccine protected protection
_______________________________________________________________of vaocinees
1 1 8 X 10^ 45,977 55
2 2 8 X 10  ^ 47,712 55
3 1 16 X 10^ 50,515 58
Although the third group demonstrated the highest protection 
level, this was not significantly different from that afforded by either 
of the remaining two vaccination schedules.
In a separate study in parenterally immunised human volunteers 
Verwey et ^  (19&9) studied the effect of the immunisation schedule on
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vibriocidal antibody response to whole cell vaccines. It was found 
that two initial doses separated by 1 week were most advantageous: 
if the interval was increased to 4 weeks the response was no better 
than that obtained by a single administration. Reimmunisâtion after
6 months yielded vibriocidal titres which were generally lower than 
those obtained on initial immunisation. The response was not improved 
by employing two reimmunisation doses.
"Levels of protection in children are increased by multiple doses of 
cholera vaccine"
In Bangladesh in I966-67 a cholera vaccine of average potency 
was tested in 40,000 children between the ages of 3 months and I4 years, 
in one or two dose schedules. A single dose protected 46%, and two 
doses, at an interval of 1 month, protected 64% of vaocinees. The 
single dose was ineffective in children under 5 years of age, but 
induced significant protection in older children. This protection, 
however, even with 2 doses, did not extend beyond the first 3 months of 
an 8 month cholera season. It was also noted that prior administration 
of vaccine did not affect the clinical course of cholera; thus 
preexisting antibodies did not reduce the severity of the disease.
This one or two dose schedule was followed by annual injections 
for 3 years. It was established that increasing protection reached a 
maximum after 3 doses, as shown below.
number of No. of vaocinees percentage of
doses____________ protected______ vaocinees protected
1 4,600 46
2 6,400 64
3 8,100 81
4 7,600 76
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Protection was also more sustained after reimmunisation being (^T/o 
and 5^ 0, 1 and 2 years respectively after the fourth injection.
However in comparison to treatment costs, this was an expensive programme, 
"Route of vaccine administration may be important"
Although this subject has not been studied extensively, the 
Philippines Cholera Committee (l973a,b) noted that both the subcutaneous 
and intradermal routes of inoculation gave a significant degree of 
protection against infection. However, with the subcutaneous route, 
protection was evident for up to 6 months after vaccination, compared to 
4 months when the administration was intradermal, and was more effective 
in children in the 1-5 year age group.
Unfortunately none of the field trials has discovered a 
cholera vaccine or vaccination programme which will provide lasting 
levels of protection in all sections of the community, and which is 
economical enough for widespread use,
VI, PROSPECTIVE CHOLERA VACCINES
1. Vibrio Antigens
A. Cell Fractions
The possibility of cell fractions being effective immunogens 
against cholera infection was explored in several studies. This work 
has ranged from the specific treatment of whole vibrio cell suspensions, 
to the isolation of distinct antigenic moieties from the vibrio cells, 
Altieri _et ai (1970) examined the possibility of preparing 
an anticholera vaccine by extracting cell suspensions with Genetron-113 
(fluorocarbon extraction). In comparison to control vibrio suspensions 
not treated with Genetron, the experimental vaccine had a lower nitrogen 
content and was also less toxic to mice. However, it was also less
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effective in protecting mice against infection and in inducing 
agglutinating and vibriocidal antibody responses in rabbits. The 
authors suggested that this procedure would be useful in the production 
of cholera vaccines with fairly high antigenic content and yet relatively 
low toxic capacity. A similar result was obtained by Nagy (1972) who 
treated whole cell cholera vaccine with sodium deoxycholate. This 
procedure resulted in a substantial reduction of toxicity with a 
concomitant reduction in immunising capacity of the vaccine for mice.
Among the earlier investigations of particular protective 
vibrio cell antigens, were those of Watanabe and Verwey (1965) and 
Verwey et al (1965) (see p. 7 ). These studies led to the isolation 
of a lipopolysaccharide antigen from Ogawa cell supernates, which was 
protective against homologous but not heterologous challenge in mice 
(Vatanabe and Verwey, I965) and a Boivin-antigen-like material from 
Inaba cells which protected mice both against homologous and hetero­
logous challenge (Verwey et 1965)* These materials were re-examined 
in experimental animals and human volunteers by Watanabe ^  (I969),
for immunogenicity compared with whole cell vaccine. The deproteinated 
Ogawa BPS antigen was protective in mice in less than 0.01 |ig amounts, 
and was therefore considered on a weight basis to be a good antigen. 
However it was less efficient in stimulating vibriocidal antibody 
production in human beings. The Inaba protein-LPS complex on the other 
hand elicited vibriocidal responses which were at least equal in height 
and duration to those elicited by a whole cell vaccine of equivalent 
mouse protective activity, Nagy (1972) showed that crude endotoxin 
extracted from heat-killed vibrios, conferred protection on mice, no 
less than that conferred by whole cell vaccine. It would thus appear 
that an effective cholera vaccine could be prepared from the outer 
envelope layers of V. cholerae.
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There has been some interest in the protective capacity of 
V . cholerae, ribosome preparations, and their fractions, as immunogens. 
Pitkin and Actor (1972) immunised mice with a ribosome-containing 
fraction (HF) obtained from V. cholerae Ogawa, and studied the passive 
immunity conferred to the progeny, via the colostrum, of these mice to 
lethal challenges of Ogawa and Inaba organisms. A 20 |ig dose of RF 
protected 58% of the offspring against the homologous challenge, at 
7.5 weeks of age, and significant protection was observed up to I5 weeks 
of age. The protection achieved against the heterologous serotype, 
however, was of limited duration. Jensen _et ^  (1972) stated that 
ribosomal preparations from V. cholerae Ogawa and Inaba were protective 
immunogens for mice challenged with either serotype. These workers 
isolated a protective antigen from the ribosomes by column chromatography. 
This antigen was found to be a heterogeneous colloid containing protein, 
lipid and carbohydrate in the ratio of - not unlike the protective
antigen of Verwey et ^  (I965).
B. Enterotoxin Preparations
Whole cell cholera vaccine contains no enterotoxin (Peeley
and Roberts, 19&9)1 however, due to its central role in the production
of disease, this toxin can not be ignored as a potentially very 
important immunogen (Finkelstein, 1969). The former workers prepared 
toxoids by (a) treating culture filtrates with 0.2% formalin at 35°C 
for 4 days, and (b) by heating the filtrates at 56°C for 45 min. The
formol toxoid was found to be 5-5 times more antigenic than the parent
toxin, while the heated preparation was less antigenic. Holmgren ejb al 
(1972) studied the resistance to challenge with enterotoxin in ileal loops 
of rabbits immunised with enterotoxin, choleragenoid or formalin-
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induced toxoid. They found that both subcutaneous and intraintestinal 
immunisation stimulated a protective immunity. However in comparison 
to Feeley and Roberts (1969) these workers found enterotoxin to be a 
better immunogen than formol toxoid, which in turn exceeded the 
efficacy of choleragenoid.
Similarly Thomson, Walter and Knight (1972) demonstrated anti­
toxic responses in rabbits after immunisation with (a) formol crude 
toxoid or with (b) crude or purified enterotoxin detoxified by heat 
(choleragenoid).
Although enterotoxin preparations were shown to be immunogenic, 
and toxoids which lacked the characteristic biological properties of 
enterotoxin were found to induce protective immunity, there was a 
problem in the spontaneous reversion of choleragenoid to active toxin. 
However, means have been developed whereby the reversion of cholera­
genoid to the toxic state can be safely abolished, thus making 
choleragenoid preparations more acceptable for general use. Thomson 
et al (1972) found that formol toxoids prepared by incubation of 
purified enterotoxin for 2 days in 0.2% v/v formalin, reverted to the 
active state in vitro on incubation at 37^0. Immunisation of 
experimental animals with these toxoid preparations resulted in death 
after about 6 days, in some cases due to reversion to active enterotoxin, 
However, data presented by Finkelstein et ^  (1971%) showed conversion 
of enterotoxin to choleragenoid after heating at 60°C for 2 hr.
Thomson et ^  demonstrated that such a toxin would remain irreversibly 
non-toxic. Saletti and Ricci (1974&) nsed glutaraldehyde to detoxify 
enterotoxin which had been (a) partially purified with A1(0H)^ only 
or (b) further purified by Biogel A-3M and Sephadex G—75 filtration.
81
These toxoids appeared to have no residual toxicity when injected into 
the skin of rabbits. The partially purified toxoid retained most of 
the immunising capacity of the native enterotoxin, however the highly 
purified preparation did not retain immunogenicity in rabbits. These 
workers (Saletti and Ricci, 1974%) also studied the possibility of 
detoxifying their partially purified enterotoxin with formaldehyde and 
glycine. This process appeared to be successful since no histological 
changes were seen after injection of the toxoid into the skin of monkeys, 
while appreciable -titres of antitoxin were elicited,
Rap;^rt _et ^  (1974) produced a toxoid which was unable to 
revert to the active form either ^  vitro or vivo. Purified toxin 
was treated with large volumes of gluteraldehyde at pH 7*8, to yield a 
toxoid capable of producing elevated, prolonged antitoxin in rabbits, 
and of protecting immunised guinea-pigs from intradermal injection of 
enterotoxin. After acrylamide gel electrophoresis and gel filtration 
of this toxoid, a correlation was suggested between irreversible 
elimination of toxicity and the formation of higher molecular weight, 
polymeric toxoid molecules.
2, Oral Vaccines
A. Vaccines containing Non-viable Antigens
An ideal cholera vaccine would be one which stimulated 
prolonged antibody production at the mucosal surface of the intestine. 
However, results have indicated that oral or enteral vaccination is 
inferior to parenteral administration of vaccines, and requires multiple 
applications before a reasonable level of protection is obtained 
(Holmgren _et 1975%)* Agarwal and Ganguly (1972) worked with heat 
inactivated lysates of V. cholerae Ogawa L-forms, using the oral route
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of administration, and found that 5 biweekly doses were required to 
produce an adequate antibody response lasting up to 6 weeks. In both 
of these cases the oral vaccines stimulated copro antibody production.
An interesting advance in oral immunisation was published 
recently by Pierce and Gowans (1975) who found that a maximum increase 
in the number of antitoxin-containing cells resulted when enteral 
immunisation was preceded by a parenteral inoculation two weeks earlier. 
These workers suggested that the primary inoculation established 
immunological memory in the secretory IgA system of the intestine, so 
that subsequent enteral application of choleragenoid acted as a "booster."
B. Vaccines containing Live V, cholerae
To overcome the problem of multiple oral immunisation, the 
possibility of using a live, avirulent vaccine was studied, so that the 
multiplication of the vibrios would provide the necessary prolonged 
antigenic stimulus, Bhattacharya and Mukerjee (I968) and Bhattacharya 
et al (1968) studied the increase in vibriocidal and antitoxic 
antibodies respectively, after oral administration of an apathogenic 
eltor strain to rabbits. A rise in intestinal vibriocidal antibodies, 
associated with a superior rise in serum vibriocidal antibodies, was 
found after oral immunisation. The level of these antibodies was 
maintained by repeated administration of this live vaccine. Where the 
antitoxic response was concerned, oral immunisation of rabbits was 
found to stimulate significant protection against ileal loop challenge 
in these animals with graded doses of enterotoxin, after 10-12 days.
Subsequently this avirulent eltor vaccine was tested in human 
volunteers (Sanyal and Mukerjee, I969). After neutralisation of 
gastric acidity, the vaccine was administered orally to 25 subjects.
and gave significantly increased serum and gut associated vibriocidal 
antibody titres which were maintained over 3 and 6 month periods of 
observation of copro-antibody and serum antibody, respectively. No 
ill effects were noted in any of the volunteers.
Contrary to these findings. Cash et ^  (1974) found that only 
5 out of 32 vaocinees developed a significant rise in vibriocidal or 
antitoxic titre, two weeks after immunisation with one of two possible 
live vaccine strains studied. In 5 of the vaocinees the rate of 
clinical infection after challenge with virulent V. cholerae was no 
different from that in unvaccinated controls. The reason suggested 
for this poor result was that, in comparison to the strain used by 
Sanyal and Mukerjee (I969), these vaccine strains did not remain viable 
in the intestine long enough to act antigenically.
3. Vaccines with Adjuvants
In the 1964 Philippines field trial (Azurin et I967) a 
cholera oil-adjuvant vaccine was used with promising results. The 
vaccine stimulated protection for up to 6 months after vaccination in 
50-60% of individuals, which was far in excess of that recorded for the 
plain vaccines used at the same time. Unfortunately the oil-adjuvant 
produced severe reactions in a small percentage of the vaocinees,despite 
having been subjected to the usual safety tests (Ogonulci, Hashizume and 
Takashashi, I967) by testing in experimental animals and in a small 
group of human volunteers. For the most part the only reaction seen in 
these volunteers was erythema and slight swelling at the site of injection, 
and in the worst cases the diameter of this reaction was 8 cm or less. 
Although these results were considered acceptable, the results of the 
field trial were not so encouraging. Cases of abscess and granuloma
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formation at the site of injection were reported about a month after 
inoculation and continued to be noted for over a year. All the 
biopsies examined showed granuloma formation with infiltration of 
lymphocytes, macrophage, plasma cells and frequently epitheloid cells
as well as multinucleate giant cells. In some cases there was a marked
proliferation of connective tissue and formation of small patchy scars. 
The softening and liquefaction of necrotic tissue which resulted was 
associated with marked infiltration of leucocytes. It was suggested by 
Ogonuki e_t al that these local changes were due to the combined effects
of both foreign body and local hypersensitivity reactions.
Promising results were obtained by Joo, Csizer and Juhasz 
(1972) with adsorbed cholera vaccines -at -least in experimental animals. 
These workers assayed the potency, by rise in vibriocidal antibody 
titres, of whole-cell vaccines adsorbed to either aluminium hydroxide 
or sodium alginate in comparison to a plain vaccine. They found that 
in mice, rabbits and monkeys the immune response to the Al(OH)^-adsorbed 
vaccine significantly exceeded the response to the plain vaccine. The 
sodium alginate adsorbed vaccine and the plain vaccine did not differ 
in efficacy in mice. A field study is however required, as was the 
case with the oil-adjuvant vaccine, to assess the true potential of the 
Al (oh) ^-adsorbed vaccine in future vaccination programmes.
MATERIALS AKD METHODS
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1. strain of Vibrio cholerae
Vibrio cholerae NCTC 7254 Inaba serotype, was originally 
isolated during a cholera epidemic in Egypt in 1947* A sub-culture
of this strain was kindly provided by Dr. T.F, Elias-Jones, City
y
Laboratories, Glasgow.
2. Buffers and Diluents
A. Physiological Saline (O.l^M)
Sodium chloride (34*8 g) was dissolved in distilled water and 
the volume made up to 4*0 litres.
B. Phosphate Buffered Saline (p.B.S.) pH 7.2 
(O.OIM phosphate buffer, O.I5M BaCl)
Solution A: 3*58 g Na^HPO^.^HgO were dissolved in 1.0 litre
distilled water.
Solution B: I .56 g BaH^PO^.ZH^O were dissolved in 1.0 litre
distilled water.
For use 72.0 ml of solution A and 28.0 ml of solution B were mixed and 
the volume made up to 200 ml with distilled water to give O.OIM 
phosphate buffer. Sodium chloride (8.766 g) was added to each litre of 
phosphate buffer.
C. Borate Gelatin Saline (B.G.S.) pH 7.5
Solution A; 58.91 8 boric acid were dissolved in 1.0 litre 
of distilled water.
Solution B; 87.66 g sodium chloride were dissolved in 1.0 
litre of distilled water.
Solution 0: 60.0 g gelatin were dissolved in 1.0 litre of
distilled water.
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Solution D; 4*8 g sodium hydroxide were dissolved in 1,0 litre 
of distilled water.
For use 100 ml of A, 80 ml of B, 3*5 ml of C and 22 ml of B were mixed. 
The volume was made up to 1,0 litre with distilled water and the pH was 
adjusted to 7»5*
D. Veronal Buffered Saline (V.B.S.) 5X
Solution A: NaCl 85 g 1400 ml 
distill
Solution B: Barbituric acid 5*75 g ) 580 ml hot
distilled H^O
Solution C; Stock l.OM MgCl 20.32 g MgCl^.ôH^O j 100 ml
Sodium Barbiturate 3*75 g ) distilled HgG
distilled 
3.OM CaClg 3.55 g CaClg ) H^O
To make 5% concentrated V.B.S., Solution A, Solution B and 5 ml of
Solution C are added together and the total volume made to 2 litres.
oThe concentrated buffer is stored at -20 C. Working solutions are 
prepared freshly before use by diluting the concentrated solution 1:4 
in distilled H^O. The pH of the resulting solution is checked to be 
pH 7.5-7*4.
3. Media
o
A. Proteose Peptone (2%) pH 7*5
Proteose peptone (Difco Laboratories, Michigan, U.S.A., 2.0 g) 
was dissolved in 100 ml distilled water. The pH was adjusted to 7*5 
using sodium hydroxide.
B. Nutrient Agar pH 7.4
Nutrient agar, code CM5 (Oxoid, London; 28 g)* was dissolved in
1,0 litre of distilled water by heating at lOO^C and sterilised at 121^0 
for 15 min. The medium was cooled to 58°C, an aliquot was retained to 
confirm pH and the remainder was dispensed into petri-dishes.
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c . Thiosulphate-citrate-bile salt sucrose (T .C.B.S.) Agar pH 8.6 
(Becton Dickinson Co. Ltd., Edinburgh)
Constituents : yeast extract, 5.O g; sodium citrate, 10.0 g; peptone,
10.0 g; sodium thiosulphate, 10.0 g; oxgall (dehydrated), 5.O g;
sodium cholate, 3.0 g; sucrose, 20.0 g; sodium chloride, 10.0 g;
ferric citrate, 1,0 g; thymol blue, O.O4 g; bromothymol blue, O.O4 g;
agar, I4.O g.
The powdered T.C.B.S. agar (86.0 g) was evenly suspended in
1.0 litre of distilled water. The suspension was heated,
with frequent agitation, before boiling for 1 min. The medium was 
cooled to 45°-58°C, an aliquot retained to confirm pH, and dispensed 
into petri-dishes.
D. Gel Diffusion Medium
Ion Agar No. 2 (Oxoid, I5.O g) and sodium chloride (I6.O g) 
were added to 1.0 litre of distilled water and steamed for 45 min. 
Methyl orange (0.12 g) and 58 ml of 10% (w/v) phenol saline solution 
were added. The medium was filtered through Whatman filter paper 
(grade II3) and dispensed in 25.8 ml amounts in universal bottles until 
required.
4* N.I.H. Cholera Toxin
Ereeze-dried filtrate from cultures of V. cholerae, strain 
BI3O7 grown in a medium containing 2.0% Bacto-peptone broth (Difco) and 
0,5% sodium chloride adjusted to pH 7*5 with sodium hydroxide solution, 
according to the method of Craig (I966), was obtained from the National 
Institute of Allergy & Infectious Diseases, Bethesda, Maryland. When 
reconstituted with diluent on the basis of 48 ml per 1.0 g of material 
the potency was 5,800 blueing doses (B.D.) per ml as determined by
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intradermal injection in guinea-pigs, i.e. 1 mg was equivalent to 200 B.D. 
The material was also tested in the canine model and caused a cholera­
like diarrhoea; 1,0 g was active in the dog intestinal loop and 1-20 mg 
in the rabbit intestinal loop,
5» Cholera Toxoid
The sample of cholera toxoid VT 2144 was kindly provided by 
Dr. B.C. Thomson, Wellcome Research Laboratories, Beckenham, Kent.
V. cholerae (inaba 569%) was grown in fermentera, then killed 
and detoxified with formalin. The organisms were removed by centri­
fugation and filtration and the culture filtrate passed down an immuno- 
adsorption column. The toxoid was eluted with acid, the eluate being 
then neutralised. This purified toxoid then had to be reformolised to 
prevent reversion to toxin. The method of immunopurification used is 
described in Hughes, Thomson and Knight (1974), J* applied Bact. 603 
using cholera antitoxin in place of tetanus antitoxin. This was 
incorporated into toxoid vaccines.
6. Purification of Cholera Toxin
A. Ammonium Sulphate Precipitation
N.I.H. cholera toxin (3.O g) was dissolved in 5*0 ml B.C.S. and 
dialysed overnight at 4°C against 95 ml of a 100% saturated (NH^)2S0^ 
solution. The contents of the dialysis sac were removed and centrifuged 
at 8,000 rpm for 30 min to deposit the precipitate. The precipitate 
was resuspended in a small volume of B.C.S. and dialysed against B.C.S. 
for 4 days at 4^0. The protein-containing solution (lO mg/ml), C.T.II, 
was stored at -20°C.
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B. Sephadex Gel Filtration
Choiera toxin (lO.O g; N.I.H.) was dissolved in a small volume
of B.C.S. and precipitated with 90^  ^saturated at 4°C overnight.
The precipitate was isolated by centrifugation at 8,000 rpm for 0^ min. 
The precipitate was resuspended in B.C.S. and dialysed against B.C.S. for 
24 hr at 4^0. The toxin-containing solution obtained was concentrated 
with Carbowax (polyethylene glycol; B.B.H. Chemicals Ltd., Poole, 
England).
Gel filtration columns contained either Sephadex G-lOO or 
Sephadex G—200 (Pharmacia, Uppsala, Sweden) and were equilibrated with
B.G.S. by running several litres of this buffer through the gel. The 
void volume of each column was found by applying 2 ml of Blue Dextran 
2000 (Pharmacia) (2 mg/ml B.G.S.). This material was eluted with
B.G.S. The volume of buffer collected from the column before the 
elution of Blue Lextran was the void volume.
The concentrated toxin solution was applied to the column and
run into the gel bed. A few ml of B.G.S. were pipetted onto the column 
and run into the gel in order to rinse the toxin solution from the wall 
of the column. The head of B.G.S. buffer was connected to the column 
and the E28O nm bhe eluate was recorded constantly using a Uvicord 
ultraviolet absorptiometer and chart recorder (L.K.B., Bromma, Sweden), 
The eluate was collected in 2.0 ml volumes.
The protein peak containing cholera toxin was determined using 
the mouse blueing test and Ouchterlony precipitin test against cholera 
antitoxin. Fractions comprising this peak were pooled and concentrated 
using Carbowax. The toxin-containing solution obtained ( c . T . I I l )  was 
stored at -20°C.
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7. Preparation of Cholera Toxin
V. cholerae NCTC 7254 was inoculated into 10.0 ml of 2.0% 
protease peptone (Pifco Laboratories, Michigan) pH 7.5 and incubated at 
57^0 for 24 hr. Aliquots of this culture (0.5 ml) were inoculated 
into 100 ml 2,0% protease peptone containing 1.0% sodium chloride, in
1.0 litre Roux bottles. The bottles were incubated on their sides for 
18 hr at 37^0.
Vibrios were removed from these cultures by centrifugation at
6.000 rpm for min. The supernate was filtered through a O .65 pm 
cellulose acetate membrane (PAWP O47OO; Oxoid, Basingstoke, England), 
before the addition of (1^ 1^ )280^ to give a final saturation of 90%. 
Precipitation was allowed to occur overnight at 4°C before removal of 
the precipitate by centrifugation at 8,000 rpm for 30 min. The 
precipitate was resuspended in a small volume of B.G.S. and dialysed 
against B.G.S. for 48 h before concentration with carbowax.
The concentrate was applied to a column of Sephadex G—200 and 
eluted with B.G.S. Fractions (2.0 ml) were collected and tested for 
blueing activity in hairless mice. The fractions within the toxin- 
containing peak were pooled and concentrated with carbowax and 
subsequently stored at -20°C.
8. Source of Animals
New Zealand White rabbits. Ham l/Cr mice and hr/hr hairless 
mice were obtained from the closed colonies maintained in the animal 
house of the Microbiology department. Bunkin Hartley guinea-pigs were 
either obtained from the same source or purchased from Porcellus Animal 
Breeding Ltd., Heathfield, Sussex.
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9. Immunisation Procedure
A. Immunisation of Mice
Adult mice (20 per group) were used for the production of 
antisera. Cholera toxoid or whole cell vaccine, either in saline or 
an adjuvant mixture (O.l ml) was injected into each mouse intraperi- 
toneally (i/p). Three weeks after inoculation the mice were sacrificed; 
blood from 5 animals was pooled and the serum was collected.
B. Immunisation of Guinea-Pi^
Guinea-pigs were used for the production of antiserum and gut 
tissue extracts, and for the ileal loop test. The guinea-pigs were 
divided into groups with respect to the nature of the vaccine to be 
administered,
(i) Toxoid Vaccines
(a) Preparation and Administration of Vaccines 
Guinea-pigs 256-279* Single oral dose
In the first series of experiments involving oral administration 
of cholera toxoid, vaccine mixtures were prepared. The 0.1 ml oral 
dose was composed of 50 pg cholera toxoid in saline containing 7*5% (w/v) 
gelatin alone, or together with 25O |ig mycobacterial glycopeptide 
(ST217) or 250 pg M. tuberculosis strain BT heat-killed organisms.
A similar series of vaccines was prepared with the addition of 25% 
sterile liquid paraffin.
The measured dose of each vaccine was administered to each of a
group of four guinea-pigs, using a 1.0 ml syringe without a needle as an
applicator and releasing the mixture at the back of the mouth.
Guinea-pigs 280-301. Single intramuscular dose
The second series of experiments was done using a single intra­
muscular injection of cholera toxoid in water-in-mineral oil emulsions
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containing mycobacterial adjuvant preparations. The 0.1 ml injection 
dose contained 60 pg cholera toxoid alone, or together with 250 pg of 
either,one of the glycopeptides ST208, 210, 217, or whole organisms of 
M. tuberculosis strain DT, suspended in water-in-oil emulsion (0.3 ml 
saline, 0,2 ml Arlaoel A (Atlas Powder Co., Vilkington, Delaware) and 
0,5 ml Bayol F (Esso Petroleum Co, Ltd., Purfleet, Essex)).
(b) Comparison of oral immunisation with combined intramuscular (i/m) 
and oral immunisations
For parenteral immunisation the guinea-pigs were injected with 
0.5 ml of vaccine i/m into the hind leg. For oral immunisation gelatin 
capsules were filled with O .5 ml of vaccine. Guinea-pigs were divided 
into equal groups and treated according to the following immunisation 
schedules:
Primary Immunisation; Animals were immunised either orally or i/m.
Four weeks later the blood and small intestines were removed from one 
group of guinea-pigs, and the ileal loop test was done in another group. 
Primary Immunisation plus one oral Booster: Six weeks after the
primary inoculation a secondary oral booster dose was given to each
guinea-pig. Two weeks later groups of animals were tested as described
above.
Primary Immunisation plus two oral Boosters; Four weeks after the 
secondary dose a tertiary oral booster dose was given to each animal.
Two weeks later groups of animals were tested as described above.
The vaccines given to each group of animals were;-
Guinea-pigs 503-520. Primary oral, i/m, or combined oral/i/m dose,
followed by an oral booster dose
A water-in-oil emulsion containing 2.0 mg cholera toxoid in 
3*5 Dll saline, 1.0 ml Arlaoel A, 2.5 nil Bayol F and 2,5 ml n-Octadecane
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- BDH Chemicals) was prepared. This was used with and 
without the addition of 10.0 mg glycopeptide ST208.
For oral administration 0,3 ml of the vaccine emulsion was 
placed in a gelatin capsule. These capsules were obtained from Folaron 
Equipment Ltd., Watford, England and are normally used in the embedding 
process for electron microscopy.
The guinea-pigs were given 5% sodium bicarbonate solution to 
drinlc 18 hr prior to oral immunisation, in an attempt to reduce acidity 
in the stomach. The capsule was held in artery forceps and was placed 
at the back of the mouth, from where it was instinctively swallowed when 
the animal's mouth was held closed.
The groups of guinea-pigs received an oral capsule, an i/m 
injection of 0,5 ml of vaccine, or both. After an interval of two 
months each animal was given a booster 0,3 ml capsule orally.
Guinea-pigs 521-345 and 410-421. Oral immunisation alone.
These animals received oral capsules containing 0,3 ml of the 
adjuvant mixture described above, without a mycobacterial component 
(incomplete adjuvant).
Guinea-pigs 344-564 and 434-445. Oral immunisation alone.
These animals received 0,3 ml oral capsules containing the 
adjuvant mixture including glycopeptide ST208 (complete adjuvant). 
Booster doses in incomplete adjuvant were given.
Guinea-pigs 365-365 and 422-433* Primary i/m and oral booster
immunisations with incomplete adjuvant
An initial i/m injection of 0.5 ml of the incomplete adjuvant 
mixture, was followed by oral booster doses of incomplete adjuvant.
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Guinea-pigs 386-406 and 446-457
Primary i/m and oral booster immunisations with complete adjuvant
An initial i/m injection of 0.5 ml of the complete adjuvant 
mixture was followed by oral booster doses of incomplete adjuvant.
(ii) Vaccines Containing Vibrio cholerae organisms
V. cholerae strain NCTC 7254 Inaba was grown for 18 hr at 57°C, 
in 10 ml of 2.0% protease peptone (Difco) pH 7*5* Aliquots of this 
culture (0.2 ml) were spread onto the surface of nutrient agar in small 
petri-dishes, and incubated for 24 hr. The growth from these plates 
was scraped off, using a sterile wire loop, and resuspended in sterile 
saline pH 7*8* Samples of this suspension were plated onto T.C.B.S. 
and nutrient agar to check purity. The vibrio cells were killed by 
heating the suspension at 55^8 for $0 min. The effectiveness of 
killing was checked by plating onto nutrient agar. The number of 
vibrio cells in the suspension was determined using a Thoma chamber, 
and dilutions were prepared in physiological saline, to provide the 
appropriate concentration of cells for immunisation purposes.
(a) Combined Vaccines of Toxoid and V. cholerae Whole Organisms
Combined vaccines containing both cholera toxoid and V. cholerae 
organisms were prepared in the incomplete and complete adjuvant mixtures.
Guinea-pigs 458-476. Oral immunisation alone.
These animals received 0.3 ml oral capsules containing incomplete 
adjuvant mixture for primary and booster immunisations.
Guinea-pigs 500-520. Oral immunisation alone.
These animals received 0.3 ml oral capsules containing complete 
adjuvant mixture followed by booster doses of incomplete adjuvant.
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Guinea-pigs 497-499. Primary i/m and oral booster immunisations.
These animals were injected i/m with 0,5 ml incomplete adjuvant 
followed by 0,3 ml oral boosters of incomplete adjuvant.
Guinea-pigs 521-541. Primary i/m and oral booster immunisations.
These animals were injected i/m with 0,5 ml complete adjuvant 
followed by 0,3 ml oral boosters of incomplete adjuvant.
(b) Whole Cell Vaccines
Whole cell vaccines were prepared in a similar manner to the 
toxoid vaccines. The suspension of V. cholerae in saline was 
substituted for the toxoid in saline, in both the incomplete and complete 
adjuvant mixtures.
Guinea-pigs 542-562. Oral immunisation alone.
Oral capsules containing 0.3 nil incomplete adjuvant mixture
were used for primary and booster immunisations.
Guinea-pigs 584-604» Oral immunisation alone.
Oral capsules containing 0,3 ml complete adjuvant mixture
were used for primary immunisation. Booster doses of incomplete 
adjuvant were administered.
Guinea-pigs 565-583. Primary i/m and oral booster immunisations.
Injections of 0.5 ml incomplete adjuvant were followed by 0.3 ml 
oral boosters of incomplete adjuvant.
Guinea-pigs 605-625. Primary i/m and oral booster immunisations.
Injections of 0.5 ml complete adjuvant were followed by 0,3 ml 
oral boosters of incomplete adjuvant.
10. Collection of Antisera
All animals were exsanguinated by cardiac puncture. Approx­
imately 1.2 ml of blood from each mouse and 20 ml of blood from each
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guinea-pig was obtained. The clotted blood was left at 4^C overnight 
before the serum was removed. Any residual erythrocytes were removed 
from sera by centrifugation at 2,000 r.p.m. for 10 min. The sera were 
stored at -20^0 until required.
11. Preparation of Gut Tissue Extracts
The small intestine of immunised guinea-pigs was removed at 
post-mortem. Partially digested food in the intestine was removed and 
discarded. The intestine was placed in 5*8 ml of cold P.B.S., minced 
coarsely with scissors, and homogenised using a Silverson blender.
The homogenate was centrifuged at 2,500 r.p.m. for 15 min to 
deposit the tissue debris. The supernate was removed and was added to 
an equal volume of lOO^ é saturated ammonium sulphate, (#8^)280 ,^ solution. 
The mixture was kept at 4°C for 48 hr and the precipitate was removed 
by centrifugation at 2,500 r.p.m. for I5 min. The precipitate was 
extensively dialysed against cold P.B.S. to remove (88^)280^. The 
tissue extract obtained was stored at -20°0.
12. Tests in Animals
A. Ileal loop Test
(i) Toxin Challenge
Guinea-pigs were starved of solid food and provided with a 5% 
glucose solution for 72 hr, as a preoperative measure. The animals 
were anaesthetised with ether and sedated with a dose of Veterinary 
Nembutal (0,6% pentobarbitone sodium; Abbott Laboratories Ltd., 
Queensborough, Kent) proportional to their weight. A length of small 
intestine above the caecum, was lifted out of the peritoneal cavity, 
and the lumen was washed by injection of approximately 10 ml of 
physiological saline. The contents were easily drained into the caecum.
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The intestine was ! ligated with sterile cotton 2,0 cm and
9.0 cm above the caecum, A third ligature, 7.0 cm above the caecum, 
was tied loosely, resulting in a 5*0 cm long test loop and a 2.0 cm 
long interloop. To prevent leakage from the test loops the toxin 
solution was injected by inserting the hypodermic needle into the 2,0 cm 
interloop and through the loose ligature into the test loop. The 
ligature was tightened onto the needle before injection of toxin, and 
finally tied off after removal of the needle.
Four 5*8 cm loops, separated by 2.0 cm interloops were 
prepared in each animal. Graded doses of crude cholera toxin (N.I.H.),
1.0 mg, 0.5 mg and 0.25 mg, suspended in O .5 ml B.G.S., were injected 
into the three loops respectively, while O .5 ml B.G.S. was injected 
into the fourth loop.
The intestine was replaced in the peritoneal cavity and the 
wound was stitched with monofilament nylon (metric 2; Ref. No, V4022; 
Arnolds Veterinary Products Ltd., Ayr) and the animal was allowed to 
recover from the anaesthetic. After 8 hr the animal was sacrificed 
and the ileal loops were removed. Measurements of the length and 
diameter of the loops were made using calipers (Camlab, Cambridge, 
type 6921). The accumulated fluid in each loop was emptied into a 
small beaker and the volume was measured in a pipette.
(ii) Viable V. cholerae Challenge
A 0,5 ml aliquot of an overnight culture of V. cholerae 
NCTC 7254» grown in 2^ o protease peptone pH 7*5f was transferred to 20 ml 
of this medium in a 25O ml conical flask. The culture was incubated, 
without shaking, at 37°G for 4 hr. The viable cell count of the 
culture was estimated by the method of Miles and Misra (1938). The
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range of repetitive viable cell counts of Y. cholerae was between 
1,6 and 2,1 x 10*^  cells/ml. Basu and Picket (I969) found 1 x 10^
Y, cholerae cells to be sufficient to set up an effective ileal loop 
challenge; 0,1 ml of a 4 hr culture was therefore used for ileal loop 
testing.
Ileal loops were prepared in guinea-pigs as described above.
Two interloops of approximately 2,0 pm were left between the test loop, 
inoculated with Y, cholerae, and the control loop inoculated with 0,1 ml 
sterile 2% proteose peptone.
The animals were sacrificed 16 hr after challenge and the 
ileal loops were examined. Measurements of length and diameter of the
loops were made. To avoid dissemination of Y, cholerae, instead of
measuring the fluid volume contained in the loop, the whole loop was 
cut out of the intestine, immersed in disinfectant solution, and the 
displaced volume was measured.
B. Intradermal Blueing Tests in Rabbits
(i) Toxin Titration
Serial two-fold dilutions of crude cholera toxin (N.X.E.) 
were prepared in B.G.S. These dilutions (O.l ml) were injected intra- 
dermally (i/d) into the skin of rabbits, previously shaved with Oster, 
Animal Grooming Clippers (Model A-5)• After 18-24 hr, 3 ml of a 5*05^  
solution of Pontamine Sky Blue 6XB (Bifco) were injected i/v into the 
ear. One hour later the diameters of the zones of blueing on the skin 
were measured. The toxin dose which produced a blue zone of 7 mm in 
diameter was equivalent to one blueing dose (1 B.B.).
(ii) Inhibition of Intradermal Blueing
Serial two-fold dilutions of each antiserum, in 0,2 ml amounts.
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were prepared in B.G.S. Crude cholera toxin (h.I.H.) solution 
(120 B.B./G.2 ml) was added to each dilution and the mixtures were 
incubated at ^Y^C for 1 hr, with intermittent shaking. As soon as 
possible after incubation each mixture (O.l ml) was injected i/d into 
the shaven skin of a rabbit.
Thereafter the technique was as described above. A standard 
titration of the crude toxin preparation was carried out simultaneously 
in each animal. The end-point of the antitoxin titration was recorded 
as that dilution which yielded an area of blueing 4 mm in diameter.
C. Intradermal Blueing Test in Mice
Dilutions of crude cholera toxin (K^I.H.) were prepared as for 
the rabbit intradermal blueing test. Each dilution (O.l ml) was 
injected into four sites in the skin of hairless mice. After 24 hr,
0.2 ml of a 1% solution of Pontamine Sky Blue dye was injected i/v into 
the tail. The mouse skins were removed 3 hr after the administration 
of the dye, and the outer and inner surfaces were examined for blueing 
reactions.
13» Passive Haemagglutination (P.H.A.) Test
Cholera toxin, CTIl (lO ml) (see p. 88 ) was added to $0 ml 
P.B.S. pH 7.2. Washed, packed sheep erythrocytes (4.O ml) were added 
followed by 2.5% aqueous glutaraldehyde solution, with continuous 
stirring. The mixture was stirred at room temperature for 1 hr to 
allow coating of the erythrocytes with the toxin. The toxin-coated 
cells were deposited by centrifugation at 2,000 r.p.m. for 10 min, the 
supernate was discarded and the pellet of cells was washed three times 
in P.B.S. pH 7.2. The coated erythrocytes were finally resuspended in 
l.O^ 'o normal rabbit serum in P.B.S. and stored at -20°C.
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Control cells were prepared by the same procedure with the 
omission of cholera toxin.
Before use, a 1,0% suspension of coated erythrocytes was 
prepared, A capillary tube was filled with the erythrocyte suspension, 
sealed at one end and spun at 1,000 rpm for 10 min in an Haematocrit 
centrifuge, M.S.E. The packed cell volume in the capillary tube was 
read using an haematocrit and the suspension was diluted accordingly in 
P.B.S. containing 1,0% normal rabbit serum.
Serial two-fold dilutions of each antiserum were prepared in 
P.B.S. pH 7.2, in 0,025 ml volumes in a Cooke Microtitre plate (Sever, 
1962), from N -^ 1/512, using Titertek automated microtitrâtion 
equipment (Plow Laboratories, Irvine). Toxin-coated cells (O.O25 ml of 
the 1.0% suspension) were added to each well on one plate, and 0.025 ml 
of the 1.0% control-cell suspension was added to each well of a 
duplicate plate. The contents of each well were mixed by gently 
tapping the sides of the plates. The plates were covered, to prevent 
evaporation during incubation at for 1 hr and storage overnight at
4^0. The end-point of this titration was taken as the highest dilution 
of antiserum showing visible haemagglutination. Where non-specific 
agglutination occurred with the control suspension, the titre obtained 
was subtracted from the end-point with the toxin-coated cells.
14. Ouchterlony Double Diffusion in the Gel Precipitin Test
Molten gel diffusion medium (20,0 ml) was poured into scratch-
free glass petri dishes. The agar was hardened by storing the plates 
at 4°C for 1 h 
King (1957)1-
r before cutting out the template pattern described by
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0^00 5 cm Iogo
One drop of molten medium was added to each well to prevent 
leakage of reagents underneath the agar layer. Antigen and antibody- 
containing solutions were used to fill opposing wells and the 
resulting precipitin lines were examined after incubation of the 
plates at 37°C for 24 hr.
15. V. cholerae Agglutination Test
A. Microtitration Assay
A suspension of V. cholerae MCTC 7254 was prepared as 
described for whole cell vaccine production (p. 94 ). The optical 
density of this suspension was adjusted visually using a V/.H.O, 
International Reference Preparation of Opacity, as described by 
Perkins ^  ^  (1973)* The reference preparation is a perspex rod 
of 10 International Units (l.U.) of opacity, which is placed in a 
6 X 5/8 glass tube for use. The cell suspension was diluted in 
identical glass tubes and the dilutions were compared to the standard 
by simultaneously looking throu^ reference and dilution at bold 
black type. The dilution which had the same visual opacity as the 
standard contained 10 I.TJ./ml; 1 I.U, is approximately equivalent to 
1 X 10'' cells.
Serial two-fold dilutions^were prepared in microtitre plates 
(1. ^1/128), using tne Titertek equipment, in 1,025 ml volurues.
V. cholerae cells (0,025 ml of a 1,0 I.U, suspension) were added to
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each well and the sides of the plate were tapped gently to ensure 
mixing. The plates were covered and incubated at 57^0 for 1 hr.
Plates were kept at 4*^ C overnight before examination. The 
last serum dilution in which no button of unagglutinated vibrios was 
present, was recorded as the end-point.
B. "H" Suspension
An overnight culture of V. cholerae NCTC 7254i grown in 2.0% 
proteose peptone, was centrifuged at 6,000 r.p.m. for 50 min. The 
pelleted vibrios were resuspended in 20,0 ml of saline containing 0,1% 
formalin (v/v) and kept at room temperature for 1 hr.
This suspension was diluted in formol saline to an optical 
density of 2,0 I.U. before 0.5 ml aliquots were added to 0.5 ml serial 
dilutions of test antisera in 4 % n" tost tubes. These mixtures were 
transferred to Breyer tubes, as was a control suspension containing no 
anti serum. The mixtures were incubated at in a water-bath for
2 hr before examination for agglutination. After storage at 4°0 
pellets of agglutinated vibrios accumulated at the bottom of the tubes. 
The degree of pelleting was recorded.
C. ”0” Suspension
V. cholerae HCTG 7254 was grown as described above. The 
culture was heated at 55°C for 0^ min in a water-bath, to kill the 
organisms, before the centrifugation step. The vibrios were resuspended 
in absolute alcohol and placed in a 45^C water-bath for 10 min. The 
suspension was centrifuged at 2,500 r.p.m. for 50 min, the supernate 
was removed and the vibrios were washed and resuspended in sterile 
saline. The optical density was adjusted and the agglutination test 
was carried out as described above.
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l6. Complement Fixation Test
The complement contained in sera to be tested was inactivated 
by incubation at for 50 min. Serial doubling dilutions of each
serum were prepared in 0,025 ml volumes in V.B.S. across the 12-well 
rows of a microtitre agglutination plate, N - I/2O48. A suspension of 
heat-killed V. cholerae (lO^ cells/ml, 0,025 ml) was added to each well. 
Guinea-pig complement (Wellcome Reagents Ltd., Beckenham, England,
2 units/ml) was added to each well in 0,025 ml amounts, and the reagents 
were thoroughly mixed by gently tapping the sides of the plate.
Several controls were set up simultaneously; (a) normal serum was 
substituted for test serum, (b) V.B.S. was substituted for serum, and
(c) V.B.S. was substituted for V. cholerae suspension.
After incubation at 57°C for 40 min, 0.025 ml of sensitised 
sheep erythrocytes, prepared by adding an equal volume of 2% erythrocytes 
to haemolysin solution (Wellcome Reagents Ltd., 2 haemolytic units 
(H.TJ.) per 0.5 ml), was added to each well. The contents of the wells 
were mixed and the tests reincubated at 57^0. During the 1 hr incubation 
period the erythrocytes were maintained in suspension by tapping the 
side of the plate at regular intervals.
After storage at 4°C for 18 hr, the end-point, i.e. the 
dilution of serum preceding that which allowed 100% lysis of the 
sensitised erythrocytes, was determined.
RESULTS ..y"
IC4
1. Gel Filtration of Enterotoxin
Several 10 g samples of crude cholera toxin (hlH) were prepared 
for gel filtration (see p. 89). Three methods of enterotoxin 
purification were compared:
A. Filtration through Sephadex G-lOO followed by Sephadex G-200
Crude enterotoxin, partially purified by (KH^)2S0^ precipitation, 
gave the elution profile shown in Fig 5 on a Sephadex G—100 column of 
25 ml void volume (v.v.). Since the exclusion limit of this gel is 
around lOOk daltons, the cholera enterotoxin (84k daltons) was expected 
to be eluted soon after the void volume. Fractions contained in the 
first peak (l), were pooled and concentrated by (118^ )280  ^precipitation 
at 4°G for 18 hr. The mixture was centrifuged at 8,000 rpm for 50 min 
and the pellet was resuspended in B.G.S. The solution was dialysed 
against 2 litres of B.G.S. at 4^C for 24 hr.
The dialysate was applied to a column of Sephadex G-200, 24 ml
V . V . ,  and eluted with B.G.S. (Fig 6 ) .  The four 2 ml fractions of the 
single peak were examined in Ouchterlony gel diffusion against antiserum 
from guinea pig BSTGP, 298, which was known to give precipitin lines 
with the iramunopurified toxoid preparation. Faint precipitin lines 
were observed between the guinea-pig serum and column fractions. These 
fractions were also injected, in 0.1 ml volumes, into the skin of a 
hairless, hrhr, mouse, to determine their blueing activity; blue zones
of approximately 20 mm were produced, on the inner surface of the skin,
by each fraction.
The four column fractions were pooled and concentrated, to a 
volume of 4 ml, using Ccrbowax (polyethylene glycol), before testing for 
activity in the rabbit intradermal blueing test.
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Figure 5. Elution of Cholera Enterotoxin from Sephadex G-lOO 
(void volume = 25 ml, flow rate = 10 drops/min)
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Figure 6. Elution of Peak (l) fractions (Fig 5) from Sephadex G—200 
(void volume = 24 ml, flow rate = 10 drops/min)
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B. Filtration tlirough Sephadex G—100 and G—200 columns in series
The two Sephadex columns were connected in series and the 
precipitate of 10 g of crude FJIH enterotoxin was pipetted onto 
the bed of Sephadex G—100. Elution was carried out using BGS. The 
material in peak (2) (Fig 5) B^.s retained, in the G-lOO column, while 
the enterotoxin-containing peak was eluted and filtered again on the 
G-200 column. The elution profile is shown in Fig 7* The presence of 
active enterotoxin in the main peak, (4)» was demonstrated by the mouse 
intradermal blueing test. This purified material contained 1 B.b. 
per 2 |Lig of protein, in comparison to the crude NIE enterotoxin, 
which contained 1 E.b. per 4 M-g of protein,
0. Filtration through a Sephadex G—200 column
Elution of partially purified NIE enterotoxin from a Sephadex 
G-200 column, (60 ml void vol) showed an isolated enterotoxin containing 
peak, (6) (Fig 8). The presence of active enterotoxin was confirmed by 
mouse intradermal blueing.
This method was judged to be as efficient as the other two 
methods in separating a peak containing partially purified enterotoxin 
from a brown pigment and low molecular weight substances in the culture 
filtrate (NE^)gSO^ precipitate.
b. Purification of enterotoxin obtained from V. cholerae NCTC 72^4 
Inaba serotype and comparison with the elution properties of 
NIB toxin
Cholera enterotoxin was produced from V. cholerae NCTC 72^4 
(see p. 85 ). The elution profile obtained when this material was 
applied to a Sephadex G-200 column, was compared to the elution profile
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Figure 7 Elution of Cholera Enterotoxin from Sephadex G-lOO 
Connected in Series to Sephadex G-200 
(total void volume = 49 ml, flow rate = 10 drops/min)
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Figure 9 Elution of Partially Purified Cholera Enterotoxin 
from Sephadex G-200
(void volume = 60 ml, flow rate = 10 drops/rain)
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V. cholerae strain NCTC 7254 enterotoxin 
purified as NIH enterotoxin (Fig 8)
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obtained when partially purified NIH enterotoxin was eluted from the 
same column (Fig 9)- The enterotoxic activity of the preparation
from V. cholerae NCTC 7254 was confirmed by intradermal blueing in mice.
2. Response in Rabbits to Intradermal Injection of NIH Toxin
The results of 22 replicate titrations of crude cholera toxin
(NIH) were averaged. The log^^ of the toxin dose was plotted against
the average blue zone diameters (Fig lO), As shown, 4 Hg of this toxin 
was equivalent to 1 B.D.
A typical response obtained on titration of cholera toxin in 
the rabbit intradermal blueing test is shown in Plate 6.
5* Response in Rabbits to Intradermal Injection of Wellcome Toxoid
The toxoid preparation used in vaccination schedules was 
examined for active toxin by the rabbit i/d blueing test. Serial two­
fold dilutions, in B.G.S., of the preparation were injected in 0,1 ml 
volumes into the skin. The diameter of the blue zones measured after
injection of the blue dye were:-
Toxoid dilution 1/2 I/4  1/8 I/I6 I/52
diameter of blue 8.2 6.9 5*5 4*5
zone (mm)
It was apparent that 0.1 ml of the I/4  dilution of toxoid contained 
1 B,D. (~7 Mm zone). Thus the preparation contained approximately
40 B.D, per ml or 20 B.D. per mg of protein.
4* Response in Mice to Intradermal Injection of NIH Toxin
Graded doses of NIH cholera toxin were injected i/d into 
hairless mice. The 4 doses of toxin studied were interchanged among
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Plate 6. Intradermal titration of cholera toxin as seen on the 
outer and inner surfaces of rabbit skin.
Inner Outer
Surface Surface
Note the decreasing blueing reaction from the lowest dilution 
(a ) to the highest dilution (B),
1i
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the 4 available injection sites on each mouse. The results vere read 
5 hr after i/v injection of Pontamine dye (Table 2).
The blueing reaction on the outer surface of the mouse skin was
rather faint and difficult to read. One hr after dye injection there
were blue zones, 4-6 mm in diameter, on the outer surface of the skins. 
After 3 hr the colour was slightly more dense and the zones were 
measured at this time. There was no visible firm swelling on the outer 
surface of the skin, as there was with the rabbit skin test.
Mice were sacrificed and their skins were carefully removed
3 hr after dye injection. On the inner surface of the skin swollen 
blue zones were clearly visible at the sites of injection and were more 
easily measured (Plate ?)• The zones were not always circular, 
however, and this decreased the accuracy of the test; the mean of two 
measurements for each spot are given in Table 2.
5* Enterotoxin Titration in Guinea-pig Ileal Loops
A typical ileal loop test with NIH enterotoxin is shown in
Plate 8,
Fluid accumulation (ml/cm) in ileal loops increased sharply 
from base-line levels, on injection of graded doses of NIH enterotoxin, 
between the 200 jig and 250 |ig dose levels (Fig 11 ). The data from a
number of titrations is contained in Appendix 1,
In toxin neutralisation experiments in vivo it was decided to 
use challenge doses of 25O (ig, 500 p.g and 1000 |ig of enterotoxin,
6. Immunisation Studies in Mice
Immunisation studies in mice had four main aspects, (i) choice 
of best available immunogen for antitoxin production; (ii) comparison
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Plate 7* Blueing response to intradermal injection of cholera 
toxin into mice, as seen on the inner surface of the 
skin.
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Plate 8. Fluid accumulation in ^linea-pig ileal loops eight hours 
after injection of graded doses of N.I.H, toxin.
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of varied toxoid doses incorporated into different vaccine mixtures;
(iii) effect of inclusion of V. cholerae organisms into toxoid vaccines;
(iv) possibility of stimulating an antibacterial antibody response by 
injection of whole dead V. cholerae organisms* Each of these aspects 
will be considered in turn.
A. Comparison of UIH Toxin and Iimnunopurified Toxoid in Vaccines
An initial experiment was done in mice to determine the relative 
benefits of using either crude enterotoxin or purified toxoid for 
immunisation. Mice were given a single injection (O.l ml, i/p) 
containing the toxin or toxoid preparation in saline, incomplete adjuvant 
or complete adjuvant with mycobacterial glycopeptide ST208. After 21 
days the antitoxin levels in the serum were measured.
It was apparent that the antitoxin levels stimulated by the 
crude enterotoxin were low in all animals. The animals injected with 
toxoid in incomplete and complete adjuvant mixtures showed significantly 
greater levels of antitoxin than found in the animals which received 
toxoid in saline (Table 5) • The incorporation of ST208 into the 
injection mixture did not stimulate a further increase in the antitoxin 
levels.
B. Intraperitoneal Administration of Toxoid in various Injection Mixtures
Twenty one days after a single i/p injection of variable amounts 
of toxoid in saline, incomplete adjuvant or complete adjuvant containing 
varying quantities of M. tuberculosis strain BT organisms or myco­
bacterial glycopeptide, ST217» mice were sacrificed and blood was 
collected. Antitoxin levels were measured using the intradermal blueing 
inhibition test (Plate 9) and the haemagglutination of cholera toxin- 
coated-erythrocytes.
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Plate 9* Neutralisation of intradermal blueing activity of cholera 
toxin by antiserum.
Un-neutralised
Neutralised
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With toxoid in saline or incomplete adjuvant there was a 
general increase in antitoxin levels according to the dose of toxoid 
in the vaccine (Table 4)• The incorporation of 5OO pg M. tuberculosis 
organisms into the vaccines did not produce a greater response than the 
controls. When the quantity of organisms was reduced to 60 pg, $0 pg 
or 15 pg, stimulated levels of antitoxin were detected by the i/d blueing 
test with the 40 pg, 20 pg and 10 pg doses of toxoid. With 10 pg, 5 pg 
or 2,5 pg amounts of M. tuberculosis a stimulatory effect was observed 
only with the two higher doses of toxoid (Table 5)* The PHA titres 
appeared to be more variable and although some values were greater than 
those in control animals, in general there was little evidence of 
increased titres of haemagglutinating antibodies (Table 6).
Incorporation of the mycobacterial glycopeptide ST217 into 
toxoid vaccines significantly increased antitoxin levels as measured by 
the i/d blueing test (Table 7)* The antitoxin response was greater 
than that observed with any dose of toxoid in saline, incomplete adjuvant 
or complete adjuvant containing similar weights of M. tuberculosis 
organisms. The effect was most pronounced with 60 pg, $0 pg and 15 pg 
of ST217, where the immune response was markedly stimulated at all doses 
of toxoid. With 10 pg, 5 pg or 2.5 pg of ST217 the stimulatory effect 
was noted with the vaccines containing IO-4O pg toxoid. Some increased 
PHA titres were evident with vaccines containing 50 pg and 15 pg ST217 
(Table 8) but with other vaccines there did not appear to be increased 
titres of haemagglutinating antibody.
Pig 12 shows a graphical representation of the geometric mean 
antitoxin response (as A.TJ./ml) obtained in groups of mice on 
immunisation with the various vaccine mixtures used.
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C. Inclusion of V. cholerae organisms in Toxoid Vaccines
The inclusion of 1 x 10^ V. cholerae organisms per mouse in 
vaccines had little effect on the stimulation of the antitoxin response 
to toxoid in saline. In incomplete adjuvant there appeared to he a 
stimulated response where low toxoid concentrations, 1.25 M-S and 2.5 pg, 
were injected together with 1 x 10^ V. cholerae per mouse (Table 9)*
The PHA titres obtained were generally low and showed no 
increased levels,
D. Complement-Fixing Antibacterial Antibody Response to Immunisation 
with V. cholerae organisms in Mice: Influence of Vaccine Content
The results indicated that the antibody response to injection 
of V. cholerae in saline was dependent on the number of organisms 
administered. The complement fixation titres of pooled sera from 
groups of ten animals are shown below:-
No. of V. cholerae 10^ lO"^  10^ 10^
organi sms/mouse
Reciprocal complement
fixation titre/0.025 ml 64 64 256 256
Since the complement fixation titre of serum from mice
injected with 10^ V. cholerae, against whole organisms, was I/256 it 
was decided to explore the possible adjuvant effect of toxoid, 3snown to 
contain small amounts of active toxin. Increased levels of complement
fixing antibodies were not obtained by incorporating the organisms into
(0
any of the vaccine mixtures (Table 10). Indeed, in some instances the 
titre was considerably lower than I/256, e.g. in the vaccine group 
injected with toxoid and V. cholerae organisms in saline.
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The incorporation of V. cholerae organisms in water-in—oil 
emulsions containing mycobacterial glycopeptide adjuvant, ST208, did 
not stimulate the immune response, at least over the concentration range 
of ST208 studied,
7• Immunisation Studies in Guinea-pigs
Immunisation schedules in guinea-pigs were designed to study 
variables pertinent to cholera vaccination, (i) effect of using parenteral 
or oral immunisation routes, or a combination of the two; and (ii) effect 
of vaccine content. The results obtained are presented in the following 
sequence
I Serological tests, for antitoxin production, on sera from a
preliminary group of guinea-pigs in which route of vaccine 
administration and vaccine content were studied.
II Serological tests, for antitoxin production, on sera and gut
tissue extracts from guinea-pigs given 1, 2 or 5 doses of (a) toxoid 
or (b) toxoid + V. cholerae organisms. The primary dose given to 
these animals was administered either orally or i/m, and was 
incorporated in either incomplete adjuvant alone or containing 
mycobacterial glycopeptide. The 2ry and doses were oral and 
incorporated in incomplete adjuvant alone.
III Ileal loop tests, enterotoxin challenge, in guinea-pigs 
immunised with toxoid, by the schedules stated above.
IV Serological tests, for anti-bacterial antibody production, on
sera from guinea-pigs immunised with (a) toxoid + V. cholerae organisms 
or (b) V. cholerae organisms, by the schedules mentioned above.
V Ileal loop tests, viable V. cholerae.challenge, in guinea-pigs
immunised with (a) toxoid, (b) toxoid + V. cholerae organisms or (c)
V. cholerae organisms, by the above schedules.
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A. Immunisation with Cholera Toxoid in a Liquid Paraffin-Gelatin Base
In the first experiment, groups of four guinea-pigs were given 
vaccine containing cholera toxoid in 15% gelatin mixed with innocuous 
liquid paraffin or saline, orally. There was no stimulation of serum 
antitoxin levels with or without the addition of 25O pg of mycobacterial 
glycopeptide ST217, or 25O pg of M. tuberculosis DT whole organisms 
(Table 11).
B. Immunisation with a Single Intramuscular Injection of Toxoid in 
Incomplete Adjuvant Supplemented with Glycopeptides or Whole 
Mycobacteria
The incorporation of 25O pg mycobacterial glycopeptides, ST217 
or ST208, or M, tuberculosis strain DT organisms into the water-in-oil 
emulsion containing toxoid produced a significant stimulation of cholera 
antitoxin response after a single i/m injection (Table 12). Poor 
responses were obtained with toxoid vaccines in incomplete adjuvant or 
in a complete adjuvant incorporating glycopeptide ST210.
C. Oral and/or Intramuscular Primary Immunisation with Toxoid, plus 
One Oral Booster Dose (G.P. 305-520)
In this group of guinea-pigs it was found that two oral doses 
did not produce increased levels of serum antitoxin (Table I5). There 
was no difference in the responses obtained with toxoid given orally in 
incomplete adjuvant with or without the addition of mycobacterial glyco­
peptide, ST208. It was noted, however, that detectable levels of 
antitoxic activity were obtained with ammonium sulphate precipitates of 
extracts of small intestines of these animals. The levels of antiblueing 
activity in the ammonium sulphate precipitates were similar in all groups
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Table 11. Oral Administration of Cholera Toxoid in 15% Gelatin
mixed with Liquid Paraffin or Saline
Guinea- antitoxin PHA reciprocal
pig code units/ml titre/0.025 ml
no.DSTGP Vaccine serum serum
256-259 50 pg toxoid/liquid paraffin/ < 0.6 2
gelatin < 0.6 2
< 0.6 4
< 0.6 -
260-265 50 pg toxoid/saline/gelatin < 0.6 —
< 0.6 4
< 0.6 1
< 0.6 —
264-267 50 pg toxoid/liquid paraffin/ < 0.6 _
250 pg ST217/gelatin < 0.6 -
< 0.6 —
268-271 50 pg toxoid/saline/ 25O pg ST217/ < 0.6 —
gelatin < 0.6 -
< 0.6 —
< 0.6 1
272-275 50 pg toxoid/liquid paraffin/ < 0.6 _
250 pg M. tuberculosis organisms/ < 0.6 -
gelatin < 0.6 -
< 0.6 -
276-279 50 pg toxoid/saline/250 pg < 0.6 mm
M. tuberculosis organisms/gelatin < 0.6 4
< 0.6 —
< 0.6 —
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Table 12. Intramuscular injection of Cholera Toxoid in Incomplete
and Complete Adjuvant Mixtures
Guinea- antitoxin reciprocal
pig code units of
no.DSTGP Vaccine per ml PHA titre
280-285 60 pg Toxoid in 0.1 ml lA, i/m 4.8 8
< 0 .6 1
0 .6 2
0 .6 -
284-287 60 pg Toxoid + 250 pg ST217 in 4.B 8
0.1 ml lA, i/m 153.6 4096
1.2 512
0 .6 1024
288-291 60 pg Toxoid + 250 pg ST208 in 38.4 128
0.1 ml lA, i/m 58.4 2048
58.4 512
1 .2 32
292-295 60 pg Toxoid + 250 pg ST210 in 0 .6 8
0.1 ml lA, i/m 0 .6 4
0 .6 —
0 .6 32
296-501 60 pg Toxoid + 250 pg 58.4 512
M. tuberculosis D.T. in 0.1 ml. 9.6 52
i/m 9.6 64
155.6 64
9.6 4
0.6 8
lA = incomplete adjuvant; Esso Bayol F, 0.5 ml ; 
Arlacel A, 0.2 ml; toxoid, O.5 ml.
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Table 15. Intramuscular and/or oral primary administration of toxoid
in incomplete or complete adjuvant, followed by an oral
booster dose
Guinea- Primary serum reciprocal gut extract
pig code antitoxin of serum antitoxin
no.DSTGP Immunisation units/ml PHA titre/ level
0.025 ml (AD/mlJ..
505-505 60 pg toxoid in lA, in oral < 0.6 4 1.2
capsule < 0.6 4 1.2
< 0.6 - 1.2
506-308 100 pg toxoid in lA, i/m 4.8 32 0.6
19.2 32 2.4
1.2 8 0.6
309-511 60 pg toxoid *f 300 pg ST208 < 0.6 1 1.2
in lA, in oral capsule < 0.6 1 1.2
< 0.6 1 1.2
312-514 100 pg toxoid + 500 pg 4.8 2 0.6
ST208, i/m 1.2 8 1.2
0.6 4 1.2
515-317 60 pg toxoid in lA, in oral 9.6 64 1.2
capsule and 100 pg toxoid 0.6 1 1.2
in lA, i/m 4.8 16 0.6
3I8-32O 60 pg toxoid + 300 pg ST208 4.8 8 1.2
in lA in oral capsule and 4.8 64 0.6
100 pg toxoid + 500 pg ST208 1.2 16 1.2
in lA, i/m
lA = incomplete adjuvant: Octadecane, 2.5 ml; Bayol F, 2.5 ml;
Arlacel, 1.0 ml; saline, 2,5 ml; Wellcome toxoid, 1.0 ml.
All animals received an oral booster of a capsule containing 60 pg 
toxoid in 0.5 ml lA 2 months after the primary inoculation.
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of animals and were not affected by the presence or absence of glyco­
peptide ST208 in the vaccines.
In addition, these ammonium sulphate precipitates produced 
precipitin lines against sheep anti-guinea-pig globulins in gel diffusion 
tests (plate lO).
Serum antitoxin was produced in response to i/m injection of 
toxoid in incomplete adjuvant, however, no stimulatory effect of the 
glycopeptide ST208 was noted. There also appeared to be no advantage 
in administering an oral dose of vaccine simultaneously with the i/m 
primary injection.
D. Primary Oral or Intramuscular Immunisation with Toxoid; Effect 
of Oral Booster Doses
The results of both the neutralisation of intradermal blueing 
and the PHA test demonstrated that no serum antitoxin response was 
obtained after 1, 2 or 5 oral administrations of toxoid in incomplete 
adjuvant, with or without the addition of ST208. However, serum cholera 
antitoxin levels were detectable throughout the 5 month period of the 
test in guinea-pigs immunised by an i/m primary inoculation of toxoid.
The incorporation of mycobacterial glycopeptide ST208 into the i/m 
primary dose resulted in a slight increase in the levels of serum anti­
toxin (Table 14).
E. Measurement of Gut-Associated Antitoxin in Guinea-pigs Immunised 
with Toxoid
A gut-associated antibody response after i/m immunisation with 
cholera toxoid in incomplete adjuvant alone or incorporating glycopeptide 
ST208, was poor even after one or two oral booster doses. Some antitoxin
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Plate 10, Gel diffusion precipitin tests with gut tissue extracts 
and sheep anti-guinea-pig immunoglobulin.
The sera were tested in duplicate against rabbit anti-guinea-pig serum in
the central well of the left unit and sheep anti-guinea-pig serum in the central
of the right unit,
1 - 6  Normal guinea-pig
T - 36 Inoculated guinea pigs Nos, 303, 320, 333, 334, 335, 356, 35T, 358, 377, 
378, 379, 399, 400 respectively.
t
159
3
-P
3H
O
U
0
•H
0
•H
A
•HEo43
,0
43
g
•H
*ë
m
•H
g
I
g
to
o
43
3XÛgS
3
0
'Ü
O43
•H
-H
a
H
I
&
343
3H
O
ü
.3
.gA
•H
Eo
43
<0o
3
3mA
g43ra
8
A
g
O
<0
0
*ë
3
3
1A
1
3«H
gsfà
r— I
I
0
•R
O
+>
•H43
gCQ
3
3
3
0 3
3 >
43
3 0
3 0 A
,0 0
43 A cü
0
Q A VD
m a
co 0
ro 3
%
CM 0
I
g
43 Ai
0 330
A A Ü
430VDQa0on03CM%4^A0
A
g
t
O
A
§
g
•H
"ed
m
•H
bO
•H
:
3
■I
ft
§
ft
s
ft
§
u O
1 A  A  1 A  CM VD VD VD CO -ft  VO
A  UN UN CM UN
CM CM 0  CM
A
VD VO VD VO VD VD -ft -f t  -ft 00 00 CO
0 0 0 0 0  0 CO CO 00 VD VD VD
00 00 00 It— t—
V V V V V V
t i l l A  A  1 -ft 00 CM CM -ft  -ft
VD CM 00 VO VD
A
VD VD VD VD VD VD VD -ft  - ft  -ft 00 00 VD
0 0 0 0 0 0 0 00 CO CO VO VD 00
00 00 on t_  t— UN
V V V V V V V A
1 1 1 1 1 A  A VD CM 00 VD VO CM
UN on UN UN 00
CM CM CM
VD Vû VD VD VD VO VD CO -ft  -ft 00 - f t  VD
0  0  0  b 0 0 0 vo 00 CO VD 00 00
b - 00 00 t— on UN
V V V V V V V A
•H bOhO ftft < 0< 0 H 0
H 0  A UN
on 0 0 . 60 , 0 •H 4-
•H + 0 •HA AA 3 A *' •H •0  *'
•ri A •H <; Q 0 <
0 P Q H X X AX w M 0 0
0 ft 0 0 43 43 0
43 0 43 ‘H 3 •H
0 A bO bObû bOco 0 ft ftOO
f t  A f t  0  3 0
0 CM ft 0 0  CM
0  0 0  A  0 0 0  EH
VO 0 VD CÜ t) A A  CÜ
on -ft UN VO
-ft VD 00 0
00 on on -f
00 VD b- CO
00 UN b - CN
00 00 on on
«0
0
m43
1
0  43
•H
1
9
m
(0
O
UNS
3
0
•■S43
g
•Hü•S
■g
"ân bO
0  3
3  0W fi
•H
CQ
0
ft
<0
O
■R
8
O
3
0
'E
'S
0
A
UN
CM •
1=
P Q  * HS
•  n  Q
UN •*'
C M
*' UN 
3  •g"O *' 
3  3
■g .3
o W
"S
0
1
3ë
î
O
.g
Il I
§  ft a
140
was detected, in the intradermal blueing inhibition test, where a 
single oral dose of toxoid was administered, but the presence of ST208 
did not seem to increase the effect (Table I5).
F. Primary Oral or Intramuscular Immunisation with Toxoid and 
V. cholerae organisms; Effect of Oral Booster Boses
Serum antitoxin was not detected where a purely oral immunis­
ation schedule, using water-in-oil emulsions containing cholera toxoid 
and V. cholerae organisms, was used. However, where i/m primary 
immunisation was used, levels of serum antitoxin were detected throughout 
the three month period of observation (Table 16). The results did not 
indicate that the incorporation of ST208 in the vaccine stimulated an 
increased antitoxin response.
G. Measurement of Gut-associated Antitoxin in Guinea-pigs Immunised 
with Toxoid plus V. cholerae organisms
Low levels of cholera enterotoxin-neutralising antibodies were 
detected in this group of guinea-pigs (Table I7). This response was 
similar to that obtained with guinea-pigs immunised with toxoid alone 
(Table 15).
H. Ouchterlony Gel Diffusion Test
(i) Determination of Optimum Antigen Concentration
A range of H.I.H. toxin concentrations in physiological saline 
(100 pg, 200 pg, 500 pg, 400 pg, 500 pg, 1.0 mg, 2,0 mg, 3.0 mg, 4.O mg, 
6.0 mg and 10 mg/ml) were tested against the following guinea-pig 
antisera;-
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Guinea-pig Route of
Code Ro, Vaccine
RST GP adminis tration
281
285
60 p,g toxoid in incomplete 
adjuvant
i/m
60 |ig toxoid + 250 jjLg ST208 in
289 i/m
incomplete adjuvant
298 60 |ig toxoid + 250 (ig
i/m
500 M. tuberculosis DT in
incomplete adjuvant
Ro precipitin lines were seen with any of the antisera against 
any of the toxin dilutions employed.
Serial dilutions of the toxoid preparation (neat - 1/52) were
tested against the antiserum numbers used above. Lines of precipitation 
were seen against serum numbers 289, 298 and 580 against the neat toxoid. 
The lines became decreasingly distinct with the I/2  and I/4  dilutions 
and were absent with the higher dilutions.
The 1/2 dilution of toxoid was chosen for the study of all 
guinea-pig sera raised against cholera toxoid. The results of 
precipitation are shown on Plate 11 a and b,
(ii) Precipitation between Toxoid and Guinea-pig Antisera, in 
Ouchterlony Double Gel Diffusion
It was apparent that only guinea-pigs immunised i/m with 
preparations containing toxoid stimulated a sufficient level of antitoxin 
to give a positive Ouchterlony test against toxoid (Table 18), In no 
case did precipitation occur with serum from guinea-pigs immunised by a 
purely oral regime.
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Plate 11 a & b. Gel diffusion precipitin tests with guinea-pig
sera and toxoid.
Tox - Wellcome choiera toxoid
Numbers - Guinea-pig experimental numbers
403
V  V
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Table 18. Ouchterlony double diffusion in gel; testing of guinea-pig
antisera against toxoid
Guinea-pig 
Code No. 
bST GP
Immunisation (i/m); 
60 |ig toxoid in lA 
+ 250 |ig adjuvant:-
no. of +ve sera 
no. of -ve sera 
for precipitin 
line formation
G.M. A.U./ml 
( & range )
280-285 nil 4/4 < 5.5(<0 .6-4.8)
284-287 ST217 4/4 4.8(0 .6-155.6)
288-291 ST208 4/4 16.2(1.2-58.4)
292-295 ST210 1/4 0.6( nil)
296-501 M. tuberculosis DT 6/ 6 12.0(0.6-155.6)
Primary immunisation (i/m):
100 (ig toxoid in lA with
octadecane + additions:-
5I8-52O 500 |ig ST208, Oral dose 2/5 5.0(1 .2-4.8)
of 60 |jLg toxoid in lA
with octadecane and 580 ^g
ST208. Oral booster x 1,
377-579 nil 5/5 49.0(58.4-76.8)
580-582 Oral booster x 1, 3/5 58.4( nil)
585-585 Oral boosters x 2. 5/5 58.4( nil)
598-400 500 |ig ST208 5/5 77.6(58.4-155.6'
401-405 500 \is ST208 5/5 97.7(76.8-155.6,
Oral booster x 1. r.
404-406 500 [ig ST208 5/5 76.8( nil)
Oral boosters x 2,
Primary immunisation (i/m):
100 (ig toxoid and 105
V. cholerae in IA with
octadecane + additions;-
491-495 nil 1/5 5.8(2.4-4.8)
494-495 Oral booster x 1. 2/2 9.6( nil)
535-555 500 iig ST208. 5/5 7,6(4 .8-9.6)
556-557 500 [ig ST20B 1/2 27.5(9.6-76.8)
Oral booster x 1.
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In the first group of animals, GP280-301, which were immunised 
with 60 |ig toxoid in incomplete adjuvant supplemented with either 
mycobacterial cells or a glycopeptide preparation, it was noteworthy 
that only one antiserum from the group receiving glycopeptide ST210 gave 
a precipitin line which was in agreement with the results of the i/d 
blueing inhibition test (Table 12). In general, the gel diffusion 
precipitin test results paralleled the antitoxin units/ml.
I. Fluid Accumulation in Guinea-pig Ileal loops in Response to 
Challenge with Cholera Enterotoxin, after Immunisation with 
Toxoid Vaccines
(i) Choice of Measurement
In all ileal loop tests fluid accumulation was recorded both 
as a value of ml/loop and ml/cm of loop. As discussed later (p. 168) 
the relative advantages of the two measurements were questioned. The
coefficients of variation (c.v.) of the "ml" values and the "ml/cm" 
values obtained in guinea-pig groups shown in Appendix 2, Table 2, were 
calculated, i.e.
c .v .  =
X
for each group of 4 ileal loops challenged with the same amount of toxin, 
within each immunisation group.
These results were plotted on Fig 15. If the same degree of
variability was associated with each of these measurements, the points 
on the graph would fall along a line at 45° to the axes. However, the 
points were found to lie distinctly to the left of this line, indicating 
that a greater degree of variability was associated with the measurement 
of "ml" fluid accumulated per ileal loop.
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Figure 1$. Comparison of the Coefficients of Variation (c.v.) of 
the two methods of assessing Fluid Accumulation in 
Ileal Loops
%
c.v
of
"ml"
70
60
50
line of equal c.v
40
50
20
10
60%2010
#
A
immunised
unimmunised
c.v. of "ml/cm"
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The "ml/cm" results were therefore chosen as the best 
indication of fluid accumulation and are presented throughout this 
thesis.
(ii) Fluid Accumulation in Ileal Loops
The results showed that the accumulation of isotonic fluid in 
guinea-pig ileal loops could be reduced by immunisation. No reduction 
was apparent in guinea-pigs given a single oral immunisation of either 
toxoid in incomplete adjuvant alone (dST GP 521-524» Appendix 2, Table l) 
or in incomplete adjuvant + ST208 (PST GP 544-347» Appendix 2, Table l). 
Where either of these oral primary doses was followed by two oral 
administrations of toxoid in incomplete adjuvant alone no protection 
against ileal swelling was seen (DST GP 529-552 and 352-555» Appendix 2, 
Table l). However where the primary dose was followed by only one 
oral booster, protection was seen in both cases (PST GP 525-528 and 
548-551» Appendix 2, Table l), although this was more marked where the 
primary inoculum was toxoid in incomplete adjuvant containing ST208.
In guinea-pigs which had received i/m primary inoculations of 
toxoid in incomplete adjuvant alone (Appendix 2, Table 2), a decrease in 
fluid accumulation was noted only where the primary injection was followed 
with one oral booster of toxoid in incomplete adjuvant (PST GP 569-572).
Where no or two oral boosters were given no decrease was noted (BST GP
565-568 and 575-576). However, where the primary injection mixture 
was toxoid in incomplete adjuvant containing ST208, reductions in fluid 
accumulation were evident in all three vaccine groups, primary injection 
alone or plus one or two oral boosters (DST GP 586-397)*
The results shown in Appendix 2, Tables 1 and 2, were analysed
using a student t-test (Appendix 4)* The t-test results are shown in
150
Tables 19 and 20. Only the group of guinea-pigs which received an i/m 
dose of toxoid in incomplete adjuvant containing glycopeptide ST208, 
is convincingly protected from ileal challenge with enterotoxin, when 
both analyses A and B are considered.
Figures 14 and 15 show a graphical comparison of the mean fluid 
accumulation in groups of immunised and unimmunised guinea-pigs.
Groups of animals in which the fluid accumulation is highly significantly 
reduced compared to the unimmunised value (Analysis B, Appendix 4) are 
indicated. There is a close similarity between the groups mentioned 
above, in which the raw data indicate a decrease in fluid accumulation, 
and the groups which show highly significant decreases, compared to 
control values, on Figs I4 and I5.
J. Agglutination of whole V, cholerae cells by Sera from Animals 
Immunised with Vaccines containing 7. cholerae organisms
Sera from all guinea-pigs immunised with whole V. cholerae were 
tested using the microtitration assay. It was not possible to test 
gut-tissue extracts due to their floccular nature, since buttons of 
unagglutinated vibrios could not be distinguished.
It was possible to obtain only very low titres, usually l/2 or
1/4.
K. Agglutination of Vibrio "H" and "0" Cell Suspensions by 
Selected Antisera
Guinea-pig antisera were selected from animals which had 
received whole V. cholerae organisms in an immunisation schedule known 
to be efficient in serum antitoxin production. The agglutination 
titres were recorded (Table 21).
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No agglutination of the "0" suspension occurred with the test 
sera^ however agglutination of the "H” suspension was noted at a 1/8 
serum dilution,
L. Complement-fixing Antibody Response to Immunisation with 
V. cholerae organisms Alone or plus Toxoid
Complement-fixing anti—V. cholerae antibodies were detected in 
low titres in the sera of all animals given V. cholerae-containing 
vaccines (Table 22). No relative advantage of oral or i/m primary 
inoculation, or for the inclusion of glycopeptide ST208 was observed.
The response obtained where V» cholerae alone was used for immunisation 
appeared to be slightly higher than that obtained where V. cholerae and 
toxoid were administered,
M. fluid Accumulation in Guinea-pig Ileal Loops in Response to
Challenge with viable V. cholerae, after Immunisation with Toxoid 
or V. cholerae organisms, or Both
The vaccines tested in this study were not capable of eliciting 
marked protection of guinea-pigs from ileal-loop challenge with 2 x 10^ 
viable V. cholerae. When the mean value of fluid accumulation was 
calculated for each group of four animals (Appendix $), slightly 
reduced values (ml/cm) were noted in the following vaccine groups
(a) Three oral doses of toxoid alone in incomplete adjuvant, where 
ST208 was incorporated in the primary dose (GP 442-445» Appendix 
3, Table l).
(b) One i/m dose of toxoid in incomplete adjuvant containing ST208, 
followed by two oral doses of toxoid alone in incomplete adjuvant 
(GP 454-457, Appendix 3, Table 2).
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Table 22. Complement-fixing antibacterial antibody response to
immunisation with V. cholerae organisms alone or plus toxoid
Reciprocal of CRT after
Guinea-pig 
Code No. 
BST GP
Primary Immunisation
1 month 
no
booster
2 months 
1x0*3 ml 
oral booster 
after 6 weeks
3 months 
2x0.3 ml 
oral boosters 
after 6 & 10 
weeks
470-478 60 |ig toxoid with 6x10^ 16 16 32
V.cholerae in lA, oral 16 16 8
capsule 16 16
491-499 100 pg toxoid with 10^ 8 32 32
V.cholerae in lA, i/m 16 52 32
8 32
512-520 60 pg toxoid with 6x10^ 32 32 16
V,cholerae and 300 pg 32 8 16
ST208 in lA, oral capsule 16 32
533-541 100 pg toxoid with 10^ 32 32 64
V. cholerae and 500 iig 32 32 64
ST208 in lA, i/m 32
554-562 6x10^ V.cholerae in lA, 32 64 32
oral capsule 32 32 32
32 64 16
575-583 10^ V.cholerae in lA, 64 64 64
i/m 64 64 32
596-604 6x10^ V.cholerae with 128 32 64
300 pg ST208 in lA, 32 32 64
oral capsule 64 64
617-625 10^ V.cholerae with 64 128 64
500 pg ST208 in lA, i/m 32 32 64
128 64
CRT = Complement fixation titre/0,025 ml serum.
lA = incomplete adjuvant: Octadecane, 2.5 ml ; Bayol R, 2.5 ml;
Arlacel, 1.0 ml; 1.9 % 10^ V. cholerae in saline, 3.5 ml; 
or in 2.5 ml and toxoid, 1.0 ml.
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(c) Three oral doses of toxoid + V. cholerae in incomplete adjuvant, 
where ST20Q was incorporated in the primary dose (GP 5O8-5II,
Appendix 3, Table 3).
(d) One i/m dose of toxoid + V. cholerae in incomplete adjuvant 
containing ST208, followed by one oral booster dose of toxoid +
V. cholerae in incomplete adjuvant (GP 525-528, Appendix 3, Table 4)* 
A student t-test was used to analyse the results obtained in 
Appendix 3» No highly significant decrease in "ml/cm" accumulated in 
test loops of the immunised animals, compared to unimmunised animals, 
was noted in this group of guinea-pigs. (Tables 23-28).
A typical ileal loop response to challenge with viable 
V. cholerae is shown in Plate 12.
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Plate 12, Rluid accumulation in guinea-pig ileal loops sixteen 
hours after injection of viable V. cholerae.

DISCUSSION
l66
1. Purification of Crude Enterotoxin
One of the problems in the purification of cholera enterotoxin 
is the spontaneous conversion of toxin to toxoid (Pinkelstein ^  al, 
1971b). Mosley ^  ^  (1970a) recommended borate gelatin saline 
(B.C.S.) for making toxin dilutions in the i/d blueing test as the 
gelatin acts as a protective colloid (see p. 29).
It was decided to use the B.C.S. of Mosley et al in gel 
filtration procedures. A combination of Sephadex G—100 and G—200 
filtration provided a toxin-containing peak. Crude culture medium 
products were removed as a brown band on G—100, Method A (p. 104). A 
similar result was obtained when G—100 and G—200 columns were run in 
series, Method B (p. 107).
It was noted in these studies that the toxin was eluted 
directly following the void column volume. This was unexpected with 
enterotoxin of 84k daltons, particularly with Sephadex G-200 which has 
a retention range up to 200k daltons, It was concluded that this
effect was due to the use of B.G.S., containing gelatin, as eluant, A
decrease in the effective exclusion limit was possibly caused by the 
presence of gelatin within the Sephadex beads, thus reducing the pore 
size.
Consequently, it was apparent that an effective toxin-containing 
preparation was obtained using a one-step filtration procedure on G-200 
with B.G.S, as eluent (see Fig 8). The toxin-containing fractions 
eluted from the G-200 column (method C, p. 107) were pooled and tested 
in the rabbit i/d blueing test, whereupon it was found that 2 |ig of the
protein contained in this peak represented 1 B.D. This was in
comparison to the crude (NIH) preparation used as the starting material,
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4 |ig of which equalled 1 B.D. This result was encouraging in view of 
the observation by Duhamel _et al (1970) that an increase in specific 
activity did not accompany purification of cholera toxin, because of 
the spontaneous loss of activity during the purification process.
Using method C, there was little difference between the elution 
profiles obtained with the crude NIH toxin and the culture filtrate of 
V. cholerae NCTC 7254* As described previously this organism was used 
throu^out this study.
As far as can be ascertained no other workers have used BGS as 
eluant in purification procedures and it would seem that this simple 
one-step technique provides enterotoxin preparations which retain 
biological activity.
2. Biological Tests in Cholera Research
It became apparent during this study that there were numerous 
factors which had to be taken into consideration in biological tests.
A. Intra-dermal Blueing
The toxoid was prepared by treatment of V. cholerae culture 
filtrate with formalin. Toxoid prepared by this method was noted by 
Finkelstein (I976) to be unstable and to revert to low levels of 
toxicity. The observation that the Wellcome toxoid contained 40
B.D./ml was not unexpected*’, however, it indicates the need to consider 
the presence of active toxin in vaccines, since it is known that active 
toxin can'profoundly influence the immune response (see p. 184 ).
In these studies the blueing activity of the NIH crude toxin 
was measured and it was shown that 4 pg = 1 B.D. The data from the 
National Institute of Health indicated that 5 PS = 1 B.D.; the slight 
difference was probably due either to the prolonged storage of the
168
freeze-dried toxin or to the fact that rabbits and not guinea-pigs were 
used.
In one instance during an i/d blueing inhibition test no areas 
of blueing were found on the rabbit skin, although eighty different 
injections, including eight containing active toxin, were administered. 
There seemed to be no explanation for the lack of response in this 
animal, other than the marked inter-animal variation in sensitivity to 
i/d injection of cholera toxin (Craig, I968, see p. 51)* Craig 
concluded /that a titration of toxin of known potency should be included 
in each animal. This conclusion is endorsed by the discovery of a 
non-responder rabbit in the present work.
Initial experiments showed clear-cut areas of blueing in the 
skin of hairless, hr hr mice. The injection of 4 pg NIH toxin (l B.D. 
as determined in rabbit i/d blueing tests) was also found to result in 
a 7 mm diameter area of blueing on the inner surface of the skin of 
hairless mice. Unfortunately, because of the necessity to include a 
titration of active toxin in each animal it was impracticable to use 
mice routinely. The test proved to be useful, however, for detecting 
enterotoxic activity associated with peak fractions from Sephadex 
columns•
B. Ligated Ileal Loop
Several variables associated with the ileal loop test influence 
the measurement of fluid accumulation, and hence toxin neutralisation 
in vivo. (a) The convoluted surface of the intestine makes accurate 
measurement of a 5*0 cm loop difficult. (b) After injection of toxin 
the muscular layers of the intestine stretch to allow fluid 
accumulation. This process is limited by a maximum stretch value, which
169
causes the plateau effect shown with high doses of toxin (Fig ll),
A reduction in fluid accumulated ( ~ f l u i d / l o o p  or ^0.7 ml fluid/cm
loop, found on the upper plateau in loops containing 250-1000 jig
enterotoxin) is indicative of considerable toxin-neutralising activity 
in the intestine. Conversely, the neutralising activity against low 
doses of toxin (5-25 pg) is not possible to detect. For these reasons 
it was decided to use the higher dose levels and test for complete 
neutralisation.
In one non-immunised guinea-pig, weighing 250 g, purchased 
from Porcellus Animal Breeding Ltd., ileal loops injected with 250 pg,
500 |ig and 1 mg of enterotoxin contained considerably less fluid than 
accumulated in similar loops in adult non-immunised guinea-pigs.
Although no similar studies have been performed in guinea-pigs, one of
the factors considered in the standardisation of the rabbit ileal loop 
test (see p. 49) was the age of the animal. All other ileal loop tests 
in this work were carried out in adult guinea-pigs, and to reduce other 
interanimal variables each test, including the toxin titration, was 
carried out in several animals.
Ileal loop results are generally presented as a value of ml of 
fluid accumulated per cm of loop (see p. 49)» However, it is necessary
to point out the limitations of this practice. An identical "ml/cm”
result may be obtained for loops which differ greatly in the volume of 
fluid accumulated, e.g. 10 ml/lO cm = 1.0 and 5 ml/5 cm = 1.0. There 
are two possibilities which explain why the latter loop contains 5 ml as 
opposed to 10 ml:- (a) the initial length of loop tied off ( ~ 5 cm) did 
not stretch significantly beyond 5 cm and could only accommodate a 
maximum of 5*0 ml fluid. If this volume was the maximum which could 
accumulate in a 5*0 cm loop the practice of presenting results as a ratio
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is valid* (b) conversely, the animal may have been immunised and anti­
bodies present in the gut prevented maximum fluid accumulation. In 
this case, the 5*0 ml of accumulated fluid may be insufficient to 
stretch the loop beyond the 5 cm originally ligated. Thus, the reduction 
in fluid accumulation could be obscured by presenting results as the 
ratio of ml/cm.
For these reasons the results of ml fluid per loop were also 
considered. However, data in this form are also questionable. Due to 
the convolutions of the gut and contractions of the muscular wall it is 
impossible to measure an exact 5*0 cm loop. Where maximum fluid 
accumulation occurs the volume of fluid is controlled, at least partly, 
by the length of ligated loop, as mentioned above. Evidence from 
control experiments suggests that the volume of accumulated fluid may 
depend on the particular segment of. gut used. Loops (5*0 cm) were 
distended by injecting saline, and were found to rupture after injection 
of 4*0”7*0 ml. Although the stretching time in control experiments 
was accelerated it would seem that the element of variation among 
results expressed as ml of fluid is probably high. This conclusion 
was supported when the coefficients of variation of "ml" and "ml/cm" 
values were considered (Fig 15)• The results of ileal loop tests were 
therefore presented in the accepted form of volume/length.
An assessment of the protective activity of a particular vaccine 
was by consideration of "ml/cm" results and the results of statistical 
analyses A and B (Appendix 4)* It became apparent that where the raw 
data indicated a decrease in fluid accumulation this was confirmed by 
the t-test analysis B (where the decrease in fluid accumulation between 
immunised and unimmunised animals was considered).
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It is generally accepted, now, that the intestinal fluid
accumulation caused by cholera enterotoxin is the result of increased
levels of cAMP in mucosal cells (see p. 57 )• However, Cedgard et al
(1978) presented evidence showing that cholera toxin caused a 50%
increase in blood flow in feline small intestine after exposure of the
intestinal mucosa to enterotoxin. Despite the observed doubling of
mean blood flow in the mucosa-submucosa, no change in blood flow in
muscle tissue was noted. These workers suggested that such haemo-
dynamic changes in the intestine may be at least partly involved in the
pathogenesis of cholera.
In the present study it was noted that where guinea-pigs were
protected from ileal loop challenge by immunisation, the volume of fluid
accumulating in "control" loops injected with BGS, was less than the
volume in non-protected animals. This observation was difficult to
explain in terms of the cAMP mechanism since (a) leakage of the toxin
-vku'CQ. vA ols
from test to control loops was unlikely-due 4©- the- presence--ef an 
interloop and (b) cholera toxin acts on cells to which it is bound, i.e. 
there is no known lateral transmission of adenyl cyclase activation 
along the intestine.
However, the observation becomes explicable if, as suggested 
by Cedgard et al (1978), cholera toxin can induce increased blood flow
to the whole intestine and cause a ^neral efflux of fluid. In this
case immunisation would presumably decrease the toxic effect and there­
fore prevent, to some extent, the increase in blood flow.
If this is so, protection against ileal loop challenge with
enterotoxin in immunised guinea-pigs is probably best indicated by 
t-test analysis B, where the 4 loops in the immunised animals are 
compared to the 4 loops in the non-immunised group.
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Consideration of enterotoxin-challenged loops by t-test 
analysis A indicates groups of guinea-pigs in which the test loops do 
not contain significantly more fluid than the control loops injected 
with B.G.S. This is indicative of complete neutralisation of entero­
toxin by groups of immunised guinea-pigs, only where analysis B has also 
indicated protection (e.g. GP586-597, Table 20). Obviously where 
analysis B did not indicate protection the result of analysis A may have 
been affected by the effect suggested by Cedgard ^  ^  (1978).
5. Immunisation of Mice with Cholera Vaccines
A variety of experiments was done in mice, using both toxoid 
and V. cholerae organisms in vaccines, in an attempt to determine the 
most suitable combination of adjuvant and antigen concentrations to add 
to vaccines.
There is substantial evidence that serum antibodies raised 
against cholera antigens are capable of eliciting protection against the 
disease. For example, Burrows and Kaur (1975) noted that high levels 
of serum antitoxin were found during convalescence or in asymptomatic 
cholera infections, which indicated the importance of these antibodies 
in human beings. In rabbits Svennerholm and Holmgren (1977) found that 
s/c immunisation with V. cholerae BPS and enterotoxin gave rise to a 
serum and gut-associated antibody response, and resulted in greater 
levels of protection than enteral immunisation, which gave rise only to 
a gut-associated response. This suggested a significant contribution 
of serum antibodies to protection against intestinal challenge with 
V. cholerae or its enterotoxin. Also in a series of studies, 
summarised by Pierce, Sack and Sircar (1977), a correlation was found 
repeatedly between serum antitoxin and levels of protection against 
cholera infection in dogs.
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A. Effect of Adjuvant
The present work demonstrated that it is possible to stimulate 
the serum antibody response to cholera toxoid using whole mycobacterial 
cells or water-soluble glycopeptide. Consideration of Pig 12 shows 
that 15-60 (Jig of M. tuberculosis whole organisms and IO-4O |ig toxoid, or 
with 15-60 pg of mycobacterial glycopeptide,ST208,and 1.25-40 pg toxoid 
stimulated antitoxin production. It is notable that water-soluble 
glycopeptide was more adjuvant-active, on a weight basis, than whole 
mycobacterial cells, and stimulated an antitoxin response to 1.25 pg of 
cholera toxoid (Table 7)*
B. Comparison of NIH Toxin and Toxoid
The apparent difference in immunogenicity of cholera toxin 
(NIH) and cholera toxoid may be explained by their composition. The 
NIH crude enterotoxin contains a variety of vibrio cell products and 
culture medium constituents, as well as cholera toxin. Thus although 
80 pg and I60 pg of this material was injected i/p per mouse, the actual 
dose of toxin antigen would be considerably lower. The toxoid 
preparation was immunopurified, so the amount of this material injected 
would correspond to the toxoid antigen dose per mouse.
It was reported that native cholera toxin was more immunogenic 
than its toxoid (Holmgren ^t al, 1972) and the method of toxoiding may 
affect the antigenicity of the molecule (Holmgren and Svennerholm, 1977î 
Pierce et 1977)# In the present work as a crude toxin preparation 
was used it is not possible to comment on the antigenicity, and the 
difference is attributed to purity of the two preparations.
Verwey et ^  (1975) suggested that less purified preparations 
of cholera toxin were capable of eliciting higher levels of antitoxin
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than purified forms, possibly through the adjuvant effect of 
contaminating LPS. No such effect was found in the present work and 
Rappaport at al (1976) believed that small amounts of somatic antigen 
did not exert an adjuvant effect on cholera toxoid,
C. Composition of Vaccines
It has been suggested (Pinkelstein, 1976; Germanier et al, 
1977; Holmgren ^  1977a; Svennerholm, and Holmgren, 1977) that it
may be advantageous to use both V. cholerae somatic and toxin antigens 
in a vaccine. However, measurable quantities of V. cholerae LIB may be 
able to exert an adjuvant effect on cholera toxin (Verwey et_ 1975» 
Germanier et 1977) and cholera toxin is certainly adjuvant-active 
in some cases (Lindholm £t al, 1977)# It is therefore of importance 
to know whether or not the presence of LPS in a vaccine affects the 
immune response to enterotoxin and vice versa.
Prom the results obtained for A.U./ml of serum from mice 
immunised with combined vaccines, the presence of V. cholerae did not 
appear to influence the antitoxic immune response to any extent, either 
in saline or incomplete adjuvant. The low PHA titres obtained are 
difficult to account for since both the i/d blueing inhibition test and 
the PHA test monitor levels of the same antibody. The discrepancy in 
results is at least partly accounted for by the limitations of the PHA 
test (see p.193 ).
The toxoid used in these studies was found to revert to low 
levels of toxicity (see p. Ill) and therefore may have been capable of 
increasing the immune response to V. cholerae when injected simultan­
eously with the organisms. However this was not indicated by the 
complement fixation titres obtained. The lower titres obtained in some
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cases may be an indication that a low level of toxoid present in 
the vaccine preferentially competes with the somatic antigens of 
V, cholerae. The exception to this was found with 40 M-g toxoid plus 
1 X 10^ V. cholerae organisms in saline. This effect appears to be 
overcome by the incorporation of the two antigens in incomplete adjuvant 
(see Table 10).
4. Immunisation of Guinea-pigs with Cholera Vaccines
A. Mineral Oil Component of Vaccines
At the commencement of this study it was decided to use 
innocuous "liquid paraffin, refined for medicinal use as emollient" as 
the oil in water-in-oil emulsions. A preliminary study was carried 
out to investigate the possibility of immunising guinea-pigs by oral 
administration of cholera toxoid. The results obtained with liquid 
paraffin in the suspending medium were generally disappointing. It was 
not possible to elicit a serum antibody response by purely oral 
immunisation. No conclusions could therefore be drawn about the 
relative advantage of using whole mycobacteria or water-soluble glyco­
peptide, or about the incorporation of liquid paraffin into the adjuvant 
mixture.
Subsequently, Stewart-Tull et ^  (1976) showed that the length 
of the carbon chain of the hydrocarbon component of mineral oils was 
important to the stimulation of the immune response by adjuvants. 
Subsequently, all experiments were done using Bayol F preparations, known 
to contain predominantly long chain hydrocarbons (nC^^E^g-nCggS^g), and 
octadecane (CH^(CH2)-j^ C^H^ ) •
B. Mycobacterial Component of Vaccines
It was possible to stimulate the immune response in guinea-pigs
176
to cholera toxoid, by incorporating either whole mycobacteria or 
water-soluble glycopeptide preparations into water-in-oil emulsions 
(Table 12, GP Nos. 280-501). In one instance, i.e. with ST210, poor 
results were obtained and this was attributed to slight variations in 
the glycopeptide-preparation procedure.
With Freund's complete adjuvant the variability in response 
within the group was partly accounted for by the difficulty in obtaining 
an even suspension of organisms in the vaccine mixture. Thus each 
animal did not necessarily receive the same amount of adjuvant.
However, with the glycopeptide preparations, the animals received more 
closely equalised inocula as the material was in the form of a proper 
solution (Stewart-Tull ^  al, 1975)* The observed differences in 
response in the latter groups of animals are attributed to interanimal 
variation.
C. Route of Administration of Toxoid Vaccines (G.P.505-520)
The observation in this study that it is not possible to 
stimulate serum antibody production by oral immunisation, has been 
corroborated by the work of Svennerholm and Holmgren (1977). After 
immunisation of rabbits with cholera antigens (V. cholerae LPS and 
enterotoxin) they monitored the production of specific antibodies in 
different tissues and related the response to the route of immunisation. 
Enteral immunisation stimulated antibody formation in intestinal tissue 
and Peyer's patches but not in the spleen and no serum antibodies were 
detected.
Guinea-pigs 5I8 and 519 which were given simultaneous oral 
and i/m primary inocula of toxoid in incomplete adjuvant containing 
glycopeptide ST208 followed by one oral booster dose, gave precipitin
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lines in the Ouchterlony test. The results of A.U./ml obtained for 
this group of guinea-pigs (Table 15) indicated that there was no distinct 
advantage in giving the dual primary immunisation. The gel diffusion 
results (Table 18) may be an indication that this conclusion is not 
completely correct since no precipitin line was obtained where animals 
were given separate oral or i/m primary doses of this particular 
vaccine (i.e. G.P, Nos 5O8-5II and 512-514 respectively).
The results in Table I5 did not allow conclusions to be drawn 
about gut-associated antibody production in response to i/m immunisation 
alone, since all animals received a subsequent oral booster dose. 
Svennerholm and Holmgren (1977)» however, found parenteral immunisation 
(s/c) to induce antibody production in the spleen and intestinal tissue. 
Similarly the recent results of Svennerholm ejt ^  (1977) suggest that 
parenteral immunisation may result in a secretory antibody response at 
mucosal surfaces.
Although a correlation exists between serum antibody titres 
and levels of protection against cholera (Burrows and Kaur, 1975»
Holmgren and Svennerholm, 1977; Pierce ^  al, 1977)» a similar 
observation for gut-associated antibody levels has not been reported. 
Pierce and Sack (1977) found protection against virulent challenge in 
dogs, immunised by a parenteral-oral sequence, after antitoxin levels 
in intestinal washings had declined. These workers suggested that 
intestinal immunity could best be measured by challenge experiments. 
Pierce and Reynolds (1975) showed that the jejunal secretory immuno­
logical system of dogs apparently possessed immunological memory, and 
a rapid secondary antibody response to locally administered antigen 
could Occur. It is therefore of significance to note that in the 
present investigation an intestinal antibody response was obtained.
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although at a low level. Further experiments would be required to 
determine whether the stimulation of this gut-associated antibody 
response was an indication that immunological memory in the gut had been 
established. Unfortunately such experiments, in which the time between 
the primary and oral booster dose administration would be extended, were 
not possible within the time scale of the present investigation.
The method used here to measure gut-associated antibody was
L
similar to that employed by Kaur ^  ^  (l97l)« The luminal contents 
were, removed from the intestine since Aziz et ^  (I968) had shown both 
faeces and succus entericus to nullify enterotoxin activity, which 
would have interfered with the i/d blueing inhibition test. This crude 
method of obtaining gut-associated antibody does not, therefore, isolate 
secretory antibody present in the lumen of the gut, and probably does 
not obtain all of the antibody associated with mucosal cells. In 
addition, no account is taken of antibody degradation by proteolytic 
enzymes which may be present in these preparations. That antibodies 
are isolated at all by this method is verified in Plate 10, where the 
gut tissue extracts were tested by Ouchterlony gel diffusion against 
anti-guinea-pig globulin antiserum. The method is useful, therefore, 
to detect the presence of an intestinal antibody response (gut-tissue 
extracts from six unimmunised guinea-pigs were found to contain less 
than 0.1 A.U./ml) and not to quantitate the extent of this response 
accurately.
Lastly, it was observed by Kaur at ^  (I97I) that variability 
in the levels of antitoxin in gut homogenates was reduced on precipit­
ation with 50% (NH.) SO , after which consistent results were obtained.42 4
This conclusion was disputed in this study, since all homogenates were
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precipitated before testing. Replicate tests of the protein solutions 
obtained did not necessarily yield identical results of antiblueing 
activity. It is realised that thawing the preparations from -20^0 may 
have allowed proteolysis of antibody, since some results varied between 
the initial test and subsequent tests at later dates.
D. Frequency of Administration of Toxoid Vaccines (GP 333-406)
Some protection against fluid accumulation in the ileal loop 
test could be obtained by a purely oral immunisation schedule (Fig I4). 
However the protective response in guinea-pigs given i/m primary doses 
of toxoid in both incomplete adjuvant alone or incomplete adjuvant plus 
ST208, was superior to the response obtained with oral priming with 
incomplete adjuvant alone or plus ST208, respectively (Appendix 2,
Tables 1 and 2).
The finding that i/m priming elicits a greater protective 
response was corroborated by Pierce and colleagues (pierce and Reynolds, 
1975; Pierce, 1976; Pierce and Sack, 1977; Pierce et al, 1977) who 
consistently observed that parenteral priming with cholera toxoid, in 
rats and dogs, induced a greater response in the intestine after oral 
boosting, than did oral priming followed by oral boosting. It was 
suggested that protection in dogs, immunised by a parenteral-oral 
sequence, resulted from secretory antibody elaborated in the lamina 
propria of the gut. This conclusion was reached since protection, 
against intrajejunal challenge with V. cholerae or its enterotoxin, was 
evident after the serum antibody response to the parenteral primary 
dose had diminished.
In this study the serum antitoxin levels induced by i/m priming 
did not greatly diminish over the three month period of the experiment.
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It is impossible therefore to state that antibody derived from the serum 
was not responsible, at least in part, for the protection observed. 
Alternatively, where a purely oral schedule was employed, protection of 
the guinea-pigs presumably did result from an antibody response at the 
surface of the gut, since serum antitoxin titres were not detected 
(GP nos 335-343 and 356-364, Table I4).
That detectable levels of immunity to enterotoxin challenge in 
the ileal loop were stimulated by two oral immunisations is of note.
It has been observed previously that oral immunisation requires repeated 
administration of antigen to produce any protective effect (Pierce and 
Sack, 1977). For example, Pierce ejt al (1977) found attempts to 
immunise dogs by the oral route to be "strikingly ineffective."
The relative success of the oral immunisation scheme used here 
may result from the administration of toxoid in a water-in-oil emulsion 
enclosed in a gelatin capsule. Previously, fluid forms of toxoid were 
used in attempts to stimulate gut-associated antibody responses. For 
example, rats were either "immunised" orally, by replacing their drinking 
water with a toxoid solution, or intra-intestinally by injecting toxoid, 
in fluid form, directly into the lumen of the gut (Pierce and Gowans, 
1975). Craig and Cebra (1975) suggested that the difficulty encountered 
in stimulating an immune response in the intestine could be explained if 
gut-associated lymphoid tissue lacked or had a less efficient antigen 
trapping system than other types of lymphoid tissue. Stimulation of 
gut-associated immune mechanisms is also further complicated by the 
enzymic degradation of the immunising antigen and its constant removal 
from the intestine by peristalsis.
The use of a water—in—oil emulsion possibly overcomes the 
problem of expulsion of the antigen from the gut. This material is
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relatively "sticky", and in some guinea-pigs, could be seen to have
i
adhered to the intraluminal surface. This adherence would presumably 
retard the removal of antigen and localize it in the gut where it may 
interact with gut-associated lymphoid tissue.
The incorporation of the oral vaccine in a gelatin capsule may 
have helped to overcome a second major problem with oral immunisation, 
namely the effect of gastric acidity. The dénaturation of proteins by 
acid obviously greatly affects their antigenicity and is therefore 
undesirable. Where the vaccine was contained in a capsule, the capsule 
itself would have to be destroyed before the vaccine could be attacked. 
Thus the use of these capsules may prevent or at least decrease the 
exposure of antigen to gastric acidity. Similarly, the water-in-oil 
emulsion may provide some protection for the toxoid against the 
proteolytic enzymes in the small intestine.
In guinea-pigs where i/m priming was used, glycopeptide ST208 
was obviously adjuvant-active, both in terms of serum antitoxin 
production (Table I4, GP nos 398-406) and induction of levels of 
protection against ileal loop challenge with enterotoxin (Table 20, GP 
nos 386-397)* Protection, measured as a decrease in fluid/cm of ileal 
loop, was apparent in these guinea-pigs against all challenge doses of 
toxin.
When starting this work it was considered worthwhile to 
investigate mycobacterial adjuvants in oral immunisation. This prelim­
inary study showed no distinct advantage in incorporating mycobacterial 
glycopeptide ST208 in oral vaccines (Table I9), Nevertheless better 
results might emerge if a broad range of adjuvant concentrations was 
studied. Pierce and Sack (1977) drew attention to the lack of knowledge
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about substances which are adjuvant-active at mucosal surfaces. They 
pointed out that if such substances exist, it might be possible to 
simplify oral immunisation schedules and also reduce the dosage of 
antigen. However it must be borne in mind that such adjuvant 
substances may also have the capacity to induce hypersensitivity to other 
antigens present in the gut, e.g. food antigens. If this were so, the 
use of these substances would be unacceptable.
It is accepted that a gut-associated immune response is due to 
the production of IgA at the mucosal surface (Craig and Cebra, 1975» 
Guy-Grand, Griscelli and Vassal11, 1975). A mechanism whereby 
antigenic stimulation at the mucosal surface can result in this IgA 
response has gradually emerged (Marsh, 1975» Solomon and Taub, 1976; 
Hall, Hopkins and Orlans, 1977» Beh, 1977» McWilliams, Phillips- 
Quagliata and Lamm, 1977). Although Marsh (1975) concluded that after 
antigenic stimulation, maturation of small lymphocytes to antibody 
secreting plasma cells occurred within the interepithelial cell spaces, 
the other groups were in favour of maturation occurring at a site other 
than the gut. Stimulated immunocytes were thought to migrate from 
Peyer's patches, following the path shown in Pig 16, before "homing" 
back to the small intestine. Maturation of the lymphocytes was thought 
to occur at some point during this migration, probably in the mesenteric 
lymph nodes (McWilliams at 1977) so that on return to the lamina 
propria of the gut, via the blood stream, they are capable of antibody 
secretion.
Since cholera is prevalent in the developing countries, the 
advantages of having a simple method of immunising large sections of the 
community are obvious. For example, the requirement for highly skilled 
personnel to administer the vaccine would be abolished if an oral
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Figure 25. The proposed route of migration of gut-assocla.ted 
small lymphocytes
Mesenteric
Heart
circulation
Thoracic
duct
Mesenteric
lymph
nodes
Small > 
intestine
PP
PP
PP = Peyer * s patches
184
immunisation programme could be employed. One of the major problems 
found with cholera immunisation in human beings has been the limited 
duration of protection from infection (see p. TO ), However, 
encouraging results (Pierce, 1976) have been obtained which suggest 
that using oral immunisation after initial parenteral priming may 
lengthen the duration of protection. Pierce suggested that the 
parenteral-oral immunisation sequence may elicit a very rapid secondary 
response in the gut to the antigen, with the interruption of the disease 
process within its incubation period. He considered that if dogs 
could be protected against a viable challenge of approximately 1 x 10^^
V . cholerae within a 12 hr incubation period by such a secondary response, 
it was not unlikely that human beings could similarly be protected from 
infection, where the infecting dose may well be lower, and where the 
average incubation period is 90 hr.
In the present study, regardless of i/m or oral priming, the 
protective response induced was superior after one than after two oral 
booster doses (Figs 14 and I9). This response is similar to that 
noted by Pierce ^  ^  (1977) who found that as the time between the 
administration of the s/c primary injection and the oral booster dose 
was increased, the mucosal immune response to cholera toxoid was reduced 
rather than stimulated. The toxoid preparation used in this work, as 
in much of Pierce*s work, is a formal toxoid which was shown, in the 
rabbit i/d blueing test, to revert to low levels of toxicity (see p. 111). 
It is well documented that active cholera toxin may act as an adjuvant, 
probably throu^ its effect on small lymphocytes (Horthrup and Fauci,
1972; Chisari and Northrup, 1974> Chisari, Northrup and Chen, 1974» 
Holmgren, Lindholm and Lonnroth, 1974; Kateley and Friedman, 1975»
It It
Douglas, Zuckerman and Ooka, 1976; Lonnroth and Lonnroth, 1977). The
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resultant immune response is dependent on the time at which cholera toxin
is administered in relation to the antigen (Holmgren and Lindholm, 1976;
Lindholm _et al, 1977)« It was found that 1 pg of cholera toxin
stimulated I ^  and IgG antibody formation to sheep erythrocytes when the
toxin was given simultaneously with the antigen. Given two days after
the antigen the toxin caused a suppression of the antibody response.
o r
A further injection of cholera toxin two^three days before secondary 
antigen injection decreased the anamnestic IgG response; given 
simultaneously there was an increase in the number of antibody producing 
cells.
Is it possible that repeated administrations of cholera toxoid, 
known to revert to toxin (p. Ill), cause^ suppression of the immune 
response to the toxoid in a similar manner to the suppression of the 
immune response to sheep red blood cells by cholera toxin?
An alternative to this conclusion was suggested by Svennerholm 
et al (1977) who thought it possible that the difficulty in boosting 
mucosal responses by local administration of antigen, was due to pre­
existing antibodies in the gut preventing contact between the 
immunising antigen and the submucosal lymphoid tissue. If this is 
correct the second oral toxoid booster used in this work would be 
incapable of producing a stimulatory effect due to the presence of 
antitoxin in the intestine as a result of the primary inoculation and 
the first oral booster. The protection which was evident at the third 
month challenge date, where an i/m injection of toxoid in incomplete 
adjuvant containing glycopeptide ST208 was the primary dose (Table 20,
GP nos 594-557), would probably be due to the immune response to the 
primary and secondary doses, which would have fallen off slightly by 
this time.
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Craig and Cebra (1975) suggested that IgA antibody synthesis 
in the gut may contribute to circulating IgA, however no evidence of 
this was obtained (Table I4) even after two oral immunisations which 
stimulated some levels of antibody formation in the gut, as judged 
from protection studies (Fig I4). The serum antitoxin response elicited 
by i/m priming did not decline over the duration of three months 
(Table 14)• Since two or three oral doses did not result in detectable 
serum antitoxin levels, it is considered unlikely that the serum antibody 
titre stimulated by i/m injection was maintained by an additive effect 
of oral boosting.
Sera from guinea-pigs which received an i/m primary dose of 
toxoid in incomplete adjuvant alone or supplemented with glycopeptide 
ST20B (GP nos 577-585 &rid 558-406) showed lines of precipitation in 
Ouchterlony gel diffusion tests. No precipitin lines occurred with 
sera from animals immunised purely by the oral route (Table 18),
No correlation existed between the serum antitoxin titres 
obtained above and levels of protection against ileal loop challenge, 
where similar vaccination schedules were used. This was expected where 
purely oral immunisation was used since levels of protection were 
probably due to IgA production in the intestine, V/here i/m priming was 
used some contribution of serum antibody to the protective response may 
have Occurred. It was noteworthy that a single i/m dose of toxoid in 
incomplete adjuvant + ST208 elicited protection against ileal loop 
challenge with enterotoxin, whereas i/m injection of toxoid in incomplete 
adjuvant alone did not (Fig 15)* In contrast, similar serum antitoxin 
responses were produced by both vaccines (Table I4).
The latter point raises the question of the effect of myco­
bacterial glycopeptide ST20B on the intestinal immune response. In
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general, researchers are reluctant to assume that the serum antibody 
response to immunisation reflects the immune status of the gut. For 
example, Rappaport ejb al (1976), concluded that low levels of somatic 
antigen (LPS) did not exert an adjuvant effect with respect to serum 
antibody production against cholera toxoid. However, they did not 
rule out the possibility that such levels of somatic antigen may have 
some effect on intestinal antitoxin responses to parenteral immunisation 
with toxoid. From the results discussed above it seems possible that 
glycopeptide ST206 is capable of producing a stimulatory effect on 
intestinal immune mechanisms, after parenteral administration (GP nos 
586-589, Appendix 2, Table 2) which is not evident from serum antibody 
titres (Table I4)*
Since i/m priming resulted in greater protection against 
enterotoxin challenge in ileal loops than did oral priming, it is 
impossible to dismiss the potential contribution of serum antibodies to 
the protective response. However the difference in response following 
i/m and oral priming may alrsc t© due -to the suggestion that i/m priming 
induces a greater level of immunological memory in the gut than does 
oral priming (Pierce and Gowans, 1975î Pierce and Reynolds, 1975»
Pierce and Sack, 1977» Pierce ^  1977)*
The levels of protection in guinea-pig nos 52I-406 bore no 
relation to the gut-associated antibody responses observed (Table I5), 
where similar immunisation schedules were used. Also results obtained 
with guinea-pig nos 505-520 (Table I5) for gut-associated antibody, 
showed no correlation with the results from these animals. Previously, 
responses were evident after i/m plus one oral administration^ however 
no response was apparent in guinea-pigs 577-585 or 598-406, using
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similar vaccines. In addition, with guinea pigs 505-305 and 509-511 
(Table 15) gut-associated antitoxin levels were evident after two oral 
doses of toxoid, while, in Table 15, gut-associated antitoxin levels 
were not detectable after one, two or three oral toxoid doses. It is 
difficult to reconcile the differences in these two sets of results.
One possible explanation is that gut extracts were tested five months 
after preparation for GP 505-520, and eight months after preparation, 
for the group 555-406. The tissue-extracts were stored at -20°C during 
this time, and the natural stability of the preparations may have been 
affected.
E. Incorporation of V. cholerae Organisms into Vaccines (GP 410-616)
The fluid volumes obtained with ileal loop challenges with 
V. cholerae were generally greater than those obtained with enterotoxin 
challenge. This effect was thought to be due to the osmotic activity 
of peptone water in which the vibrios were injected. Control loops 
injected with BGS contained less fluid than control loops injected with 
peptone water, presumably because BGS did not cause such an influx of 
water into the intestinal lumen. It should be noted that 0.1 ml volumes 
of 2% proteose peptone containing 2 x 10^ V. cholerae organisms, used 
for virulent challenge, did not contain detectable enterotoxin.
Unfortunately, due to the high levels of fluid accumulation 
induced by injection of peptone water, it was impossible to draw any 
conclusions from analysis A (Appendix 4) t-test results. In several 
groups of animals there was no significant difference between "ml/cm" 
in challenge and control loops (Tables 25-28), which normally might have 
indicated protection. However from the raw "ml/cm" data (Appendix 5)
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it is obvious that these guinea-pigs were not protected. Statistical 
assessment of these results was therefore dependent on analysis B 
(Appendix 4)1 which, it is realised, may also have been affected by the 
influence of the osmotic activity of peptone water. Protection against 
V . cholerae challenge may not have been obvious due to the small 
differences in fluid accumulation in loops receiving V, cholerae in 
peptone water and those receiving only peptone water (c,f. Appendix 5» 
Table ?).
Wo highly significant reduction in fluid accumulation between 
immunised and non-immunised guinea-pigs was found in any of the groups 
of animals challenged with viable V. cholerae (Tables 23-28),
The immunising dose of V. cholerae used in this series of 
experiments was 1 x 10^ organisms per animal with i/m injection, and 
6 X 10^ organisms with oral administration (Appendix 3, Tables 3“6).
The immune response in human beings to cholera vaccination is known to 
be dose dependent, the maximum dose (approx, 1 x 10^) which can be 
administered is limited by the inherent endotoxic properties of the 
organisms (see p. TO). In order to avoid adverse reactions to the 
vaccine in guinea-pigs, lower numbers of organisms were chosen^ however 
it appears that the dose employed may have been insufficient to stimulate 
a significant response. A higher dose of organisms mi^t have improved 
the immune response.
It was disappointing that vaccination schedules which were 
shown to protect guinea-pigs against ileal challenge with enterotoxin 
(Table 20, GP 386-397) did not elicit detectable protection against 
challenge with viable V. cholerae (Table 24, SP 446-457)• Apart from 
the difficulties mentioned above, in distinguishing protection in these 
studies, there are several possible explanations for the lack of
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protection elicited by these toxoid vaccines against V. cholerae 
challenge. First, with enterotoxin challenge, these vaccines were 
shown to elicit protection against quantities of toxin up to 1 mg. 
Possibly the enterotoxin released by the vibrios, on viable challenge, 
exceeded this amount, and overwhelmed the intestinal immunity. Due 
to the rapid binding of enterotoxin to mucosal cells, studies which 
quantitate the amount of enterotoxin released by V. cholerae in vivo are 
not possible. Secondly, as mentioned (p. 12 ) V. cholerae also 
produces substances such as mucinase, which allow penetration of the 
mucous layer in the intestine by the vibrios. Thus delivery of toxin 
to sensitive epithelial cells by vibrios in this location may be more 
efficient than simple injection into the lumen of the intestine. It 
may therefore be more difficult for intestinal antibodies to interrupt 
toxin-ganglioside binding.
The latter point raises the question as to whether it is 
valid to aim immunisation programmes at producing a purely antitoxic 
immunity. Holmgren and Svennerholm (1977) favoured a vaccination 
schedule which induced antitoxic and antibacterial immunity. They 
found a 100-fold higher degree of protection in rabbits against challenge 
with live vibrios resulted from immunisation with a combination of 
V . cholerae and enterotoxin, than resulted from immunisation with 
either of the two antigens alone. This effect was thought to be due 
to interference with two separate events in the pathogenesis of cholera, 
by antibacterial and antitoxic antibodies.
The serum antitoxin response obtained using vaccines containing 
V. cholerae organisms and toxoid (Table 16) was compared to that 
obtained after administration of toxoid alone (Table 14)* With purely
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oral inuminisation the lack of serum antitoxin response was similar 
in both vaccine groups. However where i/m primary doses were 
administered the A.U./ml results were markedly lower with the combined 
vaccine group, despite the use of similar vaccination schedules and 
toxoid doses. The inclusion of V. cholerae in the vaccines might have 
been expected to enhance the antitoxin response due to the adjuvant 
action of the vibrio LPS (Verwey et 1975)»however no evidence of 
this was obtained (Table 16).
There were a number of differences between the guinea-pigs used 
in Table I4 and Table 16, which may account for the results obtained. 
First, the oral immunisation of the latter group of animals was carried 
out without prior introduction of sodium bicarbonate into the drinking 
water for 18 hr. This was done to avoid the stimulation of acid 
secretion in the stomach which may result from prolonged exposure to 
bicarbonate. Although this may have affected the response to orally 
administered vaccine it could not possibly account for the observed 
decrease in serum antitoxin titre on i/m immunisation.
A second factor which may have influenced the response was the 
use of a different preparation of Arlacel A. It was not possible to 
obtain Arlacel from the original supplier and therefore a different 
product had to be purchased. The latter product is known to possess 
some different characteristics since it softened the gelatin capsules 
used for oral immunisation, which did not occur with the original 
Arlacel A preparation.
Thirdly, at this stage in the work the demand for guinea-pigs 
could not be met by the departmental stock, which supplied all other 
animals. Guinea-pigs were therefore purchased from Porcellus Animal 
Breeding Ltd., and for reasons of economy these were young animals of
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200-250 g in weight. These animals did not tolerate transportation 
well, and took several weeks to adjust to their new environment and 
different diet. Thus, at the time of immunisation these guinea-pigs 
were considerably smaller than the group which received vaccines 
containing toxoid alone (Table I4), and were less well adapted to the 
animal house environment. These facts, perhaps with the influence of 
the other variables mentioned above, probably account for the poorer 
serum antitoxin response obtained in this group of guinea-pigs. It 
would seem obvious for future investigations to examine closely the 
effects of age and weight of animals and the nature of vaccine components.
Where V. cholerae organisms were included in the i/m primary 
vaccines (GP nos 491-499 and 553“54l) precipitin lines against toxoid 
occurred with only a few sera (Table 18) and never where 3 months had 
elapsed between primary immunisation and withdrawal of blood. These 
results correlate with those obtained for A.H./ml (Tables I4 and 16) in 
which a distinct reduction in antitoxin titre was found in animals given 
an inoculum of V» cholerae organisms together with the toxoid.
Since it was not possible to agglutinate V, cholerae with the 
sera examined in this study, and since it was not possible to attribute 
protection against ileal loop challenge with V. cholerae to an anti­
bacterial immune response, the results obtained for the complement 
fixation test were not surprising (Table 22). To reiterate the conclusion 
drawn above, the dose of V. cholerae used in this study was probably 
not sufficient to induce a significant antibacterial immune response.
Thus antibacterial antibodies were not detected by protection tests or 
agglutination tests, and were barely detectable using the C.P.T. method.
The observation that V. cholerae alone gave a sli^tly 
improved C.P.T. response than V. cholerae 4- toxoid vaccines, is probably
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explained by the reasons mentioned previously, since the latter vaccine 
was administered to those animals obtained from Porcellus Animal Breeding 
Ltd.
5. P.H.A. Test
The results obtained using this method of determining the anti­
toxin content of sera, were rather variable when sera from animals of 
the same vaccine group were compared. The correlation between PHA titre 
and antiblueing activity of individual sera found by Pinkelstein and 
Peterson (1970) was not evident in the present work. One of the dis­
advantages of this method is that the amount of antigen fixed to the red 
cells at the coating stage varies on different occasions, even when the 
same antigen preparation at the same concentration is used. The degree 
of agglutination which occurs on addition of antibody is proportional to 
the amount of antigen coating the red cell. Thus the results obtained 
on replicate titrations of the same antisera tested against different 
coated-red-cell preparations may yield different titres. Apart from 
being extremely time saving, the major advantage of the Titertek 
apparatus is that it allows large numbers of sera to be tested against 
the same red-cell suspension, and therefore partly overcomes this problem.
A difficulty was also noted in the coating of red cells with 
different antigen preparations. The use of crude cholera toxin (N.I.H.) 
at a concentration of 1.0 mg/ml of sensitising solution was unsuccessful. 
This was possibly due to a concentration effect since a crude toxin 
preparation was used successfully by Hochstein, Peeley and Richardson 
(1970) to coat erythrocytes. These workers used a concentration of 
200,000 B.D./ml of sensitising solution (which would require an equivalent 
amount of I3IH toxin of 800 mg/ml) in comparison to the 250 B.B./ml
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(1,0 mg/ml) used in this work. Since other antigens, e.g. ovalbumin 
are known to sensitise at the level of 200 |ig/ml (Herbert, 1975) It was 
considered that 1000 |jig/ml should be sufficient.
Cholera toxin purified by method G (see p. 1^ 7), at concen­
trations of 200 fig or 400 |xg/ml of sensitising solution, was also used 
unsuccessfully in an attempt to coat erythrocytes for the P.H.A. test. 
Removal of contaminating antigens during purification should not 
interfere with haemagglutination by antisera raised against a purified 
toxoid preparation. The concentration of the toxin antigen in this 
preparation was also thought to account for the apparent failure of the 
antigen-coating process.
The (HH^)2S0^-partially purified toxin preparation (see p. 88) 
yielded satisfactory results. Its use was supported by Hochstein et af 
(1970) who noted that the presence of somatic antigen in crude cholera 
toxin preparations did not interfere with the specificity of the PHA test,
It is stressed that owing to the indefinite nature and 
variability of cholera toxin-binding to erythrocytes, the results of the 
PHA test were considered a qualitative assessment of the serum antitoxin 
response to different vaccines. The results of the i/d blueing 
inhibition test were considered to give a more accurate indication of 
the antitoxin levels obtained,
6. General Discussion
Over the past few years there has been much research into 
producing a long-lasting immunity to cholera. Although a great variety 
of vaccines and vaccination schedules have been tested, no acceptable 
solution has emerged. The pathogenesis of the disease is now well 
documented and the development of disease symptoms has been averted by
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many workers, either by preventing adhesion of vibrios to the mucosa, 
using whole cell or cell fraction vaccines, or by preventing enterotoxin- 
binding to epithelial cells, using toxoid vaccines. Unfortunately, 
the relative lack of knowledge, until recently, about gut-associated 
immune mechanisms, together with the difficulty in quantifying intestinal 
immunity has made the task of finding the most effective route and 
frequency of immunisation extremely difficult,
Fluid replacement therapy for cholera is now so effective that 
it is tempting to adopt this as the major line of defence against lethal 
infection, in preference to immunisation, particularly since fluid 
replacement is a more economical alternative than repeated immunisation 
of large sections of the community. However, the sheer volume of 
isotonic fluid required to treat each cholera patient (Carpenter, 1976) 
makes this a rather impractical therapy in epidemics. A more 
important point is that, although fluid replacement reduces mortality 
rates, it does nothing to decrease the cholera infection rate and 
maintains the source of infection in the community.
Cholera is one of the leading causes of morbidity in the 
developing countries at the present time, and as such a serious attempt 
to eradicate the disease should be made. In principle eradication should 
not be difficult; it requires the education of the public in personal 
hygiene. In practice, however, this is an immense task; a plentiful 
piped water supply to each household and an adequate sewerage system are 
two prerequisites of such an eradication programme. Obviously such 
developments, in rural India for example, are unlikely in the foreseeable 
future, and for this reason it seems worthwhile to pursue the search for 
an efficient vaccine, which, if incapable of eradicating the disease, 
will at least reduce the infection rate.
196
A number of recent developments in cholera research have 
introduced alternatives to the well tried, but relatively inefficient 
whole cell vaccine. A crucial step in the pathogenesis of cholera is 
the adhesion of vibrios to the mucosal surface of the gut. This may 
be prevented by the presence of antibacterial antibodies in the gut, 
which agglutinate the organisms in the lumen from where they are rapidly 
expelled (see p. 66). It has also come to light that motility of the 
vibrios is in some way involved in the colonisation of the intestine 
(see p. 13 ) and already workers such as Eubanks ejk ^  (1977) and Yang 
et al (1977) have suggested that vaccines containing flagellar fragments 
elicit protection against infection in experimental animals.
As mentioned previously. Pierce and co-workers have studied 
immunisation with toxoid preparations in depth, and have come to the 
conclusion that a parenteral-oral immunisation schedule is preferential, 
in terms of stimulating gut-associated immunity, to the purely parenteral 
cholera immunisation sequence used at present. However these workers 
noted a difficulty in the timing of administration of oral boosters 
(see p. l84 ). As discussed this was possibly due to low levels of 
reversion of toxoid to active toxin and a subsequent effect on small 
lymphocytes. However, it is now possible to completely purify toxin 
B-subunits from the active subunit, thereby abolishing the risk of 
reversion to activity (Holmgren and Svennerholm, 1977).
The use of a combined vaccine containing V. cholerae LPS and 
enterotoxin was favoured by Svennerholm and Holmgren (1977) since 
administration of both antigens leads to greater protection than either 
antigen alone. However, the problem with using LPS as an immunogen, 
as is the case with whole cell vaccine, is the likelihood of inducing
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Immediate or delayed toxicity reactions at the site of injection, after 
repeated immunisation. Holmgren and Svennerholm (1977) suggested that 
it may he possible to isolate and perhaps synthesise the imrauno- 
determinants of the LPS molecule which would be free of endotoxic 
activity. Thus combined vaccines containing enterotoxin B-subunits 
together with LPS-immunodeterminants or flagellar fragments, if 
appropriate, offer a hopeful solution to the cholera vaccine problem.
As suggested by Pierce ^  al (1977) the incorporation of 
vaccines in adjuvant mixtures may increase the duration of protection (a 
central problem in cholera immunisation) by stimulating higher peak 
antibody titres which take longer to fall below levels which afford 
protection. Thus if a reasonably innocuous adjuvant preparation can be 
found, this will be of great potential value.
As outlined by Stewart-Tull et ^  (1975) the injection of 
adjuvant mixtures containing heat-killed whole mycobacteria into the 
lungs of rabbits resulted in the formation of caseous lesions in the 
lung tissue, similar to the tuberculous cavities found in the lungs of 
tuberculous patients. Ho such lesions were produced by their water- 
soluble glycopeptide preparation, which also lacked the ability to 
induce polyarthritis in rats (Pearson and Wood, 1959; Watson, Pearson 
and Sharp, I96O) associated with other adjuvant-active substances, and 
the toxicity for mice associated with the presence of cord factor 
(Asselineau, Bloch and Lederer, 1955)*
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SUMMARY
The ultimate aim of this project was to produce immunity in 
guinea-pigs against ileal loop challenge with either V. cholerae entero­
toxin or live organisms. Several parameters were examined in order to 
achieve this aim. First, the possibility of using the adjuvant-active, 
water-soluble glycopeptides, prepared from culture filtrates of 
Mycobacterium tuberculosis, was explored in immunisation schedules with 
cholera antigens. Second, the effect of the route of vaccine admin­
istration on the resultant immune response was studied, and third, the 
advantage of giving multiple doses of vaccine was considered.
Extensive studies on the i/p inoculation of mice with cholera 
toxoid demonstrated that the water-soluble glycopeptide, ST217, was 
indeed adjuvant-active, on injection with toxoid in a water-in-oil 
emulsion, and caused greatly increased serum antitoxin titres to be 
produced. The adjuvant effect of this water-soluble glycopeptide, on a 
weight basis, was superior to that obtained using whole mycobacterial 
cells, i.e. Freund*s complete adjuvant.
Regarding the route of vaccine administration, it was noted that 
i/m immunisation of guinea-pigs caused the production of serum 
antibody and also levels of protection against ileal loop challenge with 
cholera enterotoxin. Oral immunisation did not allow the ■ production 
of serum antibodiesJ however, slight protection against ileal challenge 
was evident, presumably due to the induction of an intestinal antibody 
response. The levels of protection noted after oral immunisation were, 
without exception, lower than those obtained on i/m administration of 
the same vaccine.
Where multiple immunisation schedules were employed the levels
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of protection in guinea-pigs from ileal challenge with enterotoxin were 
improved by following an initial primary oral or i/m immunisation with 
an oral booster dose after 1 month. The administration of a second 
oral booster dose 2 months after the primary inoculation did not 
further boost the protective levels, which in all vaccine groups were 
lower than those obtained after the primary plus one booster dose.
The incorporation of the water-soluble glycopeptide, ST208, 
in the i/m primary inoculation mixture, resulted in increased levels of 
protection against enterotoxin challenge, as compared to toxoid in 
incomplete adjuvant. This increase in response was maintained through­
out the three month period of observation.
Protection of ileal loops from challenge with viable V. cholerae 
was not evident in this study, regardless of vaccine content, or the 
route and frequency of administration.
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APPENDICES
Al
Appendix 1
Ileal loop response to injection of graded doses of N.I.H. toxin
N.I.H.
toxin 
dose (ng)
ml fluid/ 
cm ileal loop X S M
5 0.570.65 0.51 0.14
10 0.550.6 0.48 0.12
12.5 0.54
0.49 0.515
0.02
25
0.52
0.51 0.515 0
50
0.39
0.43
0.52
0.54
0.47 0.04
100 0.520.56 0.54 0.02
200 0.48
0.51 0.495 0.01
250
0.75
0.73
0.66
0.59
0.74
0.69 0.03
500
0.7
0.65
0.58
0.71
0.7
0.67 0.02
1000
0.79
0.71
0.64
0.6
0.69
0.79
0.7 0.03
0 0.37 0.01
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Table 7« Fluid accumulation in ileal loops challenged with
2 X 10 V. cholerae
Control 
Guinea-pig 
Code Eo. 
D8T GP
Challenge loop
X
ml/cm s
Control
ml/cm
loop
X
s
634 0.76 0.45
635 0 .9 0.6
636 0.73 0.88 0.64 0.69
644 0.83 0.13 0.83 0.15
645 0,86 0.65
646 1.11 0.92
647 1.0 0.75
All
Appendix 4
Statistical Analysis of Ileal Loop Test Results
The X and standard deviation (s) values for each group of 
immunised guinea-pigs and unimmunised guinea-pigs was calculated.
The overall s value for group variation was obtained by summing 
the s values of immunised animals x 4 (no. of animals per group) and the 
s value- of the unimmunised animals x 6 or 7 (no, of animals per group 
with toxin or V. cholerae challenge respectively), and dividing by the 
total number of observations,
A 1-tail t-test was used since it was unreasonable to expect 
a dose of toxin to produce less fluid accumulation than saline. Also, 
neutralised toxin, due to immunisation, should produce an equal amount 
of fluid accumulation to saline.
Two different comparisons were applied to the results:—
A. the mean "ml/cm" in loops injected with toxin or V. cholerae were 
compared to the loops injected with B.G.S. or proteose peptone 
respectively
B. the mean "ml/cm" in loop in immunised animals was compared to that 
in unimmunised guinea-pi^.
For comparison A. the formula used was:-
Ax = s , t.
where Ax = x. - x t s
x^ = ml/cm given by toxin or V. cholerae challenge
x^ = ml/cm given by B.G,S. or proteose peptone
n^ = no of loops challenged with toxin or V. cholerae
n^ = no of loops injected with B.G.S. or proteose peptone.
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For comparison B, the formula used was:- 
Ax = S.t.
"im "c
where ^x = x - x.c im
x^ = ml/cm in control guinea-pig loops
^im ~ in immunised guinea-pig loops
n^ = no of control guinea-pigs
n. = no of immunised guinea-pigs, im
In both cases;-
S = the overall standard deviation for (i) toxin
challenged animals or (ii) V, cholerae challenged 
animals, where appropriate 
t = the value obtained from statistical tables at the 
5^ 0 and probability levels on substituting the 
appropriate no, of degrees of freedom, e.g. 
comparing immunised to unimmunised animals on toxin 
challenge is a 4 + 6 comparison which has 8 degrees 
of freedom,
With comparison A:-
the AX obtained, indicates by what amount x, must exceed x 
for the values to be significantly (t at the 5% level) or highly 
significantly different (t at the 1% level). Protection from toxin
or V. cholerae challenge would be indicated in cases where there was no
significant difference in the x values.
In Tables 19 and 20, and 23-28, the results of this analysis 
are given ass-
+ = no significant difference
- - significant difference at the T — level
- = significant difference at the P = 1% level.
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With comparison B:-
the A X value obtained indicates by what amount x^ must exceed 
^im significant or highly significantly different. Protection
from challenge would be indicated in cases where the x^^ value was 
highly significantly lower than the x^ value.
In Tables 19 and 20, and 23-28, the results of this analysis 
are given as:-
+ = significant difference at the P 1% level
- = significant difference at the P ~ 5% level
“ = no significant difference.
